patient_filename,text,processed_outputs
TCGA-AA-A00U.670DA42C-A894-45FC-9785-17BB52AE81F7,"Diagnosis: Extended hemicolectomy specimen with two invasive, moderately differentiated. adenocarcinomas with infiltration of the pericolic fatty tissue and status following. endoscopic resection of a further adenocarcinoma. Multiple tubular adenomas with. moderate dysplasia (synonym: low-grade intra-epithelial neoplasia). Two lymph node. metastases. Tumor-free resection margins in the region of the mucosa. Tumor-free. omentum. Tumor classification: adenocarcinoma, G2 pT3 (mult/3) n1 (2/116) L0 V0 R0.","Invasive, moderately differentiated adenocarcinomas with infiltration of the pericolic fatty tissue. Tumors composed of glandular formations with moderate dysplasia and nuclear pleomorphism. Multiple tubular adenomas with moderate dysplasia. Lymphovascular invasion not identified. Perineural invasion not identified. Two lymph node metastases with capsular infiltration. Tumor-free resection margins in the region of the mucosa. Omentum free of tumor. No necrosis identified. Adenocarcinoma with a grade of G2, with tumor cells showing nuclear atypia and increased mitotic activity."
TCGA-BH-A18P.D24BB508-6E9A-4CF7-93C6-975E79F6E86D,"PAIIENI MISTOKY: The patient is. a -year-old female. Clinical history is not provided Site Code : breast, lower inner quadrant. PRE-OP DIAGNOSIS: Left breast cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Left total mastectomy. +$. ADDENDA: Addendum. Fluorescence in situ hybridization analysis was performed on block 1D using the DNA probe for Her-2/neu gene. The. ratio of Her-2/neu gene signals to chromosome 17 centromere signals was determined to be 2.05. Therefore, the. interpretation is: borderline amplification of the Her-2/neu gene. que. ves. My signature is attestation that I have personally reviewed the submitted materiali. Addendum. ESTROGEN/PROGESTERONE AND HER-2/NEU REPORT. Using appropriate positive and negative controls, the test for the presence of these hormone receptor proteins is. performed by the immunoperoxidase method, and reported according to the consensus statement on adjuvant. therapy for breast cancer, of. A positive ER or PR tumor shows any nuclear immunostaining, and is. semiquantitated as indicated below. Semiquantitative Statement. ER positive. Percent cells staining as: (0 95%; 1+ 5%, 2+ 0%, 3+ 0%). PR negative. Percent cells staining as: (0 100%, 1+ 0%, 2+ 0%, 3+ 0%). HER-2/NEU DAKO HERCEPTEST: A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE. THAN 10% OF THE TUMOR CELLS. HER-2/NEU IS INTERPRETED AS WEAKLY POSITIVE ISCORE 2+I. NOTE: Her-2/Neu FISH was ordered and will be subsequently reported. The Her-2/neu and estrogen/progesterone receptor assays were performed with FDA approved. methods. FIÃ‘AL DIAGNOSIS: PART 1: LEFT BREAST, TOTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA, 2.0 CM, NOTTINGHAM SCORE 7/9 (tubules 3, nuclei 2, mitosis 2),. LOCATED IN THE LOWER INNER QUADRANT AND EXTENDING TO THE LOWER OUTER QUADRANT. B. TUMOR COMES TO WITHIN 0,1 CM FROM THE INNER LOWER OF QUADRANT MARGIN. C. MICROCALCIFICATION ASSOCIATED WITH TUMOR. D. DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 2, SOLID TYPE WITH COMEDO NECROSIS,. REPRESENTING 10-15% OF THE TUMOR VOLUME. E. MARGINS FREE OF TUMOR. F. REMAINING BREAST TISSUE WITH FIBROCYSTIC CHANGES, SCLEROSING ADENOSIS AND. MICROCALCIFICATION. G. SKIN AND NIPPLE NOT REMARKABLE. H. THREE LYMPH NODES NEGATIVE FOR TUMOR. PART 2: LEFT AXILLA, SENTINEL LYMPH NODE #1, EXCISIONAL BIOPSY. ONE LYMPH NODE NEGATIVE FOR TUMOR, CONFIRMED BY NEGATIVE AE1/AE3 IMMUNOSTAIN. PART 3: LEFT AXILLA, SENTINEL LYMPH NODE #2, EXCISIONAL BIOPSY -. ONE LYMPH NODE NEGATIVE FOR TUMOR, CONFIRMED BY NEGATIVE AE1/AE3 IMMUNOSTAIN. COMMENT: Estrogen and Progesterone receptors and HER-2/Neu will be performed on block 1D and the result will follow in a. separate report.","Infiltrating ductal carcinoma with Nottingham score, located in the lower inner quadrant and extending to the lower outer quadrant. Tumor composed of cells with variable nuclear features and mitotic activity. Ductal carcinoma in situ, nuclear grade 2, solid type with comedo necrosis, representing a portion of the tumor volume. Tumor comes to the margin, with margins otherwise free of tumor. Remaining breast tissue shows fibrocystic changes, sclerosing adenosis, and microcalcification. Microcalcification associated with tumor. Three lymph nodes negative for tumor. Skin and nipple not remarkable."
TCGA-UW-A7GX.F489FC43-C5D4-42F0-8397-A115A9ACDB89,"Diagnosis: Kidney, right, laparoscopic radical nephrectomy. Histologic tumor type/subtype: renal cell carcinoma, chromophobe subtype, eosinophilic variant. Sarcomatoid features: not identified. Histologic grade (if applicable): 2 (of 4, Fuhrman classification). Tumor size (greatest dimension): 7.2 cm. Tumor focality: unifocal. Extent of tumor invasion (if present specify if macroscopic or microscopic): Extra-capsular invasion into perirenal adipose tissue: not identified. Gerota's fascia: n/a. Renal sinus: not involved. Major veins (renal vein or segmental branches, IVC): not involved. Ureter: not involved. Lymphatics: not involved. Surgical margins: Extracapsular soft tissue margin: not involved. Renal vein margin: not involved. Ureter margin: not involved. Adrenal gland: not received. Lymph nodes: none received. Other significant findings: none. AJCC Stage: pT2a pNx pMx. Clinical History: /O male with right renal mass. Gross Description: Received is one appropriately labeled container, additionally labeled ""right kidney."" It consists of a. radical nephrectomy specimen (17.1 x 7.7 x 6.8 cm) consisting of kidney (14.6 X 7.2 X 4.7 cm, 427 gram). The upper pole has a 7.2 x 7.2 x 7.0 cm well circumscribed soft, pink/tan solid mass with focal. hemorrhage and necrosis (20%). The mass expands the capsule, does not go through it, and is. 0.4 cm from the perinephric adipose tissue margin (inked blue). The mass is 1.5 cm from the renal sinus. The renal vein is free of mass. The uninvolved cortex medulla is well demarcated, red/brown without. additional masses. No hilar lymph node candidates are identified. Adrenal gland is absent. Block summary: A1 - ureter, renal vein and artery margins, en face. A2 - renal sinus (perpendicular). A3,A4 - perpendicular of mass closest to the perinephric adipose tissue margin. A5-A7 - additional sections of mass. A8 - normal kidney from inferior pole. Light Microscopy: Light microscopic examination is performed by Dr. Sections show irregular nests of eosinophilic cells with punched out perinuclear clearing. By H & E alone,. the differential diagnosis includes eosinophilic variant of chromophobe carcinoma, as well as granular. variant of clear cell carcinoma. To clarify lineage, immunostains and Hale' S colloidal iron stain. were performed, and show reactivity for CK7 and Hale' S colloidal iron, with no reactivity for RCC. The. immunophenotype supports the above diagnosis.","Renal cell carcinoma, chromophobe subtype, eosinophilic variant, with irregular nests of eosinophilic cells and punched out perinuclear clearing. Histologic grade 2 of 4, Fuhrman classification. Tumor is unifocal. Extra-capsular invasion into perirenal adipose tissue not identified. Renal sinus not involved. Major veins not involved. Ureter not involved. Lymphatics not involved. Surgical margins not involved, including extracapsular soft tissue margin, renal vein margin, and ureter margin. Adrenal gland not received. Lymph nodes not received. Focal hemorrhage and necrosis present. The mass expands the capsule and is well circumscribed. Uninvolved cortex and medulla are well demarcated. No hilar lymph node candidates identified."
TCGA-85-6175.616d5519-7f8d-4eb0-b78a-6a90c84616ff,Asterand. BCR. Case ID. Subject ID. LUNG TISSUE CHECKLIST. Specimen type: Pneumonectomy. Tumor site: Lung. Tumor size: 10 X 10 X 4 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Well differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,"Squamous cell carcinoma, well differentiated, with no other tumor nodules, lymph nodes, lymphatic invasion, venous invasion, or margin involvement specified, and no evidence of neo-adjuvant treatment or additional pathologic findings noted."
TCGA-DD-A4NJ.36C3150D-343E-4B3F-A5D7-1AE978246648,"DIAGNOSIS: A. Liver and gallbladder, right lobe, wedge resection and. cholecystectomy Multifocal moderately differentiated. hepatocellular carcinoma forming 2 separate nodules (4.4 x 4.2 x 3.0. cm and 0.6 x 0.6 x 0.6 cm). The largest nodule is located 3.9 cm. from the closest surgical margin. No definitive vascular invasion. identified. All margins of resection are negative for tumor. The. non-neoplastic liver shows mildly active (grade 1 of 3). steatohepatitis with mild portal fibrosis (stage 1 of 4). The. gallbladder shows chronic cholecystitis. A single pericystic lymph. node is negative for tumor.",Multifocal moderately differentiated hepatocellular carcinoma forming separate nodules. The tumor is composed of cells with variable nuclear features and cytoplasmic characteristics. No definitive vascular invasion identified. All margins of resection are negative for tumor. The non-neoplastic liver shows mildly active steatohepatitis with mild portal fibrosis. The gallbladder shows chronic cholecystitis. A single pericystic lymph node is negative for tumor.
TCGA-XE-AAOD.B84B10F5-4CB6-4BB6-AFF7-CEE6603380E7,"SURGICAL PATHOLOGY TISSUE REPORT. - Specimen Source: RIGHT TESTICLE AND TUBE. - Gross Exam Date : - Physician: Pager No. : ADDENDUM REPORT FOR. The choriocarcinoma is strongly positive by HCG and CAM5.: 2, while the. seminoma and the intratubular germ cell neoplasia are positive for C-. Kit. The seminoma is negative for CAM5.2 immunostains. The CD-30 is. negative. These findings support the diagnoses: 1) MIXED GERM CELL TUMOR WITH SEMINOMA (80%) , CHORIOCARCINOMA (20%). right radical orchiectomy (see note). 2) TUMOR MEASURES 3 CM WITH AREAS OF NECROSIS AND HEMORRHAGE. 3) TUMOR LIMITED TO TESTES. 4) NO INVASION OF EPIDIDYMIS NOTED. 5) LYMPHOVASCULAR INVASION NOTED. 6) SURGICAL MARGINS FREE OF TUMOR. 7) INTRATUBULAR GERM CELL NEOPLASIA. 8) SEMINIFEROUS TUBULES WITH EVIDENCE OF SPERMATOGENESIS AND. ATROPHY. CLINIC/WARDINURSING STATION. INFT. COST CODE. SURGICAL PATHOLOGY TISSUE REPORT. Operative Procedure: RIGHT RADICAL ORCHIECTOMY. Specimen Source: RIGHT TESTICLE AND TUBE. - Gross Exam Date: - Physician: Pager No. : DIAGNOSIS (based on GROSS and MICROSCOPIC examination) : 9) MIXED GERM CELL TUMOR WITH SEMINOMA (80%). , CHORIOCARCINOMA (20%). right radical orchiectomy (see note). 10) TUMOR MEASURES 3 CM WITH AREAS OF NECROSIS AND HEMORRHAGE. 11) TUMOR LIMITED TO TESTES. 12) NO INVASION OF EPIDIDYMIS NOTED. CLINIC/WARD/NURSING STATION. IN FT. COST CODE. SURGICAL PATHOLOGY TISSUE REPORT. Operative Procedure: RIGHT RADICAL ORCHIECTOMY. Specimen Source: RIGHT TESTICLE AND TUBE. - Gross Exam Date: - Physician: Pager No. 13) LYMPHOVASCULAR INVASION NOTED. 14) SURGICAL MARGINS FREE OF TUMOR. 15) INTRATUBULAR GERM CELL NEOPLASIA. 16) SEMINIFEROUS TUBULES WITH EVIDENCE OF SPERMATOGENESIS AND. ATROPHY. Note: pT2NXMX. Special stains pending. notified on. at. GROSS DESCRIPTION: The specimen is received in one part, unfixed, labeled with the. patient's name,. and ""right testicle and tube. consists of a 60-gram orchiectomy specimen including 4.5 x 3.5 x 3-cm. testis, 3 x 0.7 x 0.4-cm epididymis, and 10 cm in length and 1.5 cm. in diameter spermatic cord. Right next to the epididymis there is a. 3 x 1.8 x 1.8-cm white-tan to pink-tan, fleshy, well-circumscribed. mass with focal areas of hemorrhage and necrosis. There is no gross. involvement of the tunica albuginea. The remaining testicular. parenchyma is grossly unremarkable. The spermatic cord consists of. vas deferens, arteries, and veins, and is unremarkable. R8. Cassettes: 1 to 2. Tumor. 3. Tumor and tunica vaginalis. 4. Tumor and epididymis. 5. Tumor and adjacent testis. 6. Spermatic cord resection margin. CLINIC/WARD/NURSING STATION. INPT. COST CODE. SURGICAL PATHOLOGY TISSUE REPORT. Operat. RIGHT RADICAL ORCHIECTOMY. Specimen Source: RIGHT TESTICLE AND TUBE. - Gross Exam Date: - Physician: Pager No. : Spermatic cord midportion. 8. Spermatic cord peritesticular portion. CLINIC/WARD/NURSING STATION. INFT. COST CODE. ]. 1. SURGICAL PATHOLOGY TISSUE REPORT.","Mixed germ cell tumor with seminoma and choriocarcinoma, seminoma comprising 80% of the tumor and choriocarcinoma 20%. Tumor limited to testes with no invasion of epididymis noted. Lymphovascular invasion present. Surgical margins free of tumor. Intratubular germ cell neoplasia identified. Seminiferous tubules show evidence of spermatogenesis and atrophy. Tumor exhibits areas of necrosis and hemorrhage."
TCGA-SP-A6QH.C1B7A19E-D055-425B-AB0F-E2CFB3339385,"Amended. Facility: Specimen(s) Received. 1. Adrenal: Left Resection. 2. Lymph-Node: Para-aortic Supra Hilar node?. 3. Gallbladder. 4. Lymph node: Supra pancreatic lymph node. 5. Retroperitoneum: vonhippel-landay syndrone. 6. Vessel: Portal vein tissue. 7. Reperitoneum. 8. Pancreas: Whipple. Diagnosis. 1. Pheochromocytoma: Adrenal (left) adrenalectomy specimen. See microscopic description. 2. Extra-adrenal paraganglioma: Ganglia, 1 of 3 (para-aortic suprahilar) biopsies. 3. No pathological diagnosis: Gallbladder. No pathological diagnosis: Lymph node, 1. - cholecystectomy specimen. 4. No pathological diagnosis: Lymph node, 1 (supra-pancreatic) biopsy. 5,6,7. Infiltrating neuroendocrine carcinoma: Soft tissue (#5 site not specified, portal vein and retroperitoneum) biopsies. See comment. 8. Well-differentiated pancreatic neuroendocrine carcinoma, 5 cm in largest diameter, head of pancreas; multiple benign. cysts, all resection margins negative, extending to within microscopic distance of the inked anterior margin: Pancreas. No pathological diagnosis: Lymph nodes, 7. No pathological diagnosis: Stomach. No pathological diagnosis: Duodenum. - Whipple's resection specimen. See synoptic report. Comment. Specimens 5,6 & 7. The biopsies consist of soft tissue with infiltrating cells that exhibit significant freezing artifact that. precludes an accurate interpretation of morphology, however immunohistochemistry confirms positive for synaptophysin,. cytokeratin 19 and focal reactivity for chromogranin; they are negative for tyrosine hydroxylase. The immunoprofile. supports a diagnosis of neuroendocrine carcinoma and is similar to that of the pancreatic tumor. Synoptic Data. Specimen Type: Pancreaticoduodenectomy (Whipple resection), partial. Tumor Site: Pancreatic head. Tumor Focality: Unifocal. Tumor Configuration: Infiltrative. Tumor Size: Greatest dimension: 5.0 cm. Additional dimensions: 3.2 cm. Other Organs Submitted: Gallbladder. Other. left adrenal gland. Functional Type: Pancreatic endocrine tumor, secretory status unknown. Extent of Invasion: Tumor limited to pancreas. No regional lymph node metastasis. Number of regional lymph nodes examined: 9. Number of regional lymph nodes involved: 0. Distant metastasis. Margins: Margin(s) involved by invasive carcinoma. Margin(s) involved by invasive carcinoma - Other: SPECIMENS 5 (NOT SPECIFIED),. 6 (PORTAL VEIN) AND 7 (RETROPERITONEUM). Venous/Lymphatic (Large/Small Vessel) Invasion (V/L): Absent. Perineural Invasion: Absent. Mitotic Activity: Absent. Immunohistochemistry: Synaptophysin: positive. Chromogranin: positive. Insulin: focally positive. Glucagon: negative. Somatostatin: negative. Pancreatic polypeptide: negative. Gastrin: negative. Serotonin: negative. CK 19: positive. Ki-67: <1%. Other (specify): VIP: negative. Additional Pathologic Findings: Other: PanIN1 and serous adenomas. Clinical History. Tumour of the pancreas. Gross Description. 1. The specimen labeled with the patient's name and as ""adrenal left resection"" consists of an adrenal gland with adherent. fatty tissue; it weighs 100.2 g and measures 9.5 x 6.3 x 4.7 cm. It is painted with silver nitrate. After the fat is removed, the. adrenal with its mass weighs 78 g and measures 6 X 6.5 x 5.0 cm. On section the cut surface is solid brown tan with areas. of hemorrhagic discoloration,. 1A-O representative sections submitted. 2. The specimen container labeled with the patient's name and as ""paraaortic suprahilar node"" contains a piece of. fibrofatty tissue that measures 3.5 x 2.5 x 1.5 cm and contains 3 nodules that measure 0.4 x 0.4 x 0.3cm to 1.5: x 1 x. 0.6cm. The nodes are submitted in toto. 2A. 1 nodule bisected. 2B. 2 nodules. 3. The specimen is labeled with the patient's name and as"" gallbladder"". . Resection specimen: Gallbladder. MEASUREMENTS: Length 9 cm. Maximum diameter 3.5 cm. DESCRIPTION OF GALLBLADDER: Serosa: smooth. Adventitial surface: size: 7 x 2.5 cm appearance: Normal. Wall: Intact; 0.1 cm average thickness. Mucosa: velvety. Contents: Green bile; no stones. Cystic duct: - stenosis: No. - stone in lumen: No. - intraluminal tumor: No. Cystic duct lymph node: 1, measuring 0.4 x 0.2 x 0.2 cm. FOCAL LESIONS: No. TISSUE BANKING: No. Representative sections are submitted as follows: 3A. cystic duct, body and fundus. 3B. node. 4. The specimen labeled with the patient's name and as ""supra pancreatic lymph node"" consists of a lymph node that. measures 0.9 x 0.9 x 0.6 cm. 4A. bisected and submitted in toto. 5. The specimen labeled with the patient's name and as ""von Hippel landay lymph node"" consists of a fragment of tissue. that measures 0.3 x 0.3 x 0.2 cm. The specimen is frozen for intraoperative consultation. 5A. frozen section block resubmitted. 6. The specimen labeled with the patient's name and as ""portal vein tissue"" consists of a fragment of tissue that measures. 0.5 x 0.3 x 0.2 cm. The specimen is frozen for intraoperative consultation. 6A. frozen section block resubmitted. 7. The specimen labeled with the patient's name and as ""retroperitoneum"" consists of a fragment of tissue that measures. 0.4 x 0.3 x 0.2 cm. The specimen is frozen for intraoperative consultation. 7A. frozen section block resubmitted. 8. The specimen labeled with the patient's name and as ""Whipple"" consists of a Whipple resection including pancreas. head, distal stomach, duodenum. Fixation: fixed. Dimensions: - stomach: length along greater curvature: 4.5cm, circumference at proximal margin 17 cm; circumference at. - - common bile duct: length: 4.8cm, circumference at proximal end: 1.3 cm; circumference at mid-point: 1cm. duodenum: length: 28cm circumference proximal: 7.5 cm circumference distal: 7.8cm. pylorus: 4.5cm. circumference at distal end: 1 cm. - pancreas: 4.5 cm SI x 3 cm AP x 7.5 cm ML. - ampulla: length: 1cm, circumference: 0.6cm. TUMOR: Location: head of pancreas; 1.2 cm from distal pancreatic margin. Configuration: solid. Dimensions: 3.2 cm SI x 5 cm ML x 3 cm AP. Characteristics: yellow, white, fibrous; partly calcified. Estimated extent of invasion: approaching anterior surface. OTHER LESIONS/FINDINGS IN REMAINDER OF PANCREAS: multiple cysts containing clear fluid in the remaining. pancreas ranging in size from 0.2 to 1.3 cm. GROSS APPEARANCE OF STOMACH: Normal. GROSS APPEARANCE OF DUODENUM: normal. GROSS APPEARANCE OF AMPULLA: normal. - tumor. no. - periampullary tumor: no. GROSS APPEARANCE OF COMMON BILE DUCT: -appearance of mucosa normal. -stenosis: no. -intraluminal tumor. no. -tumor invading wall: no. MARGINS: Painted: - distal pancreatic margin: India ink. - posterior pancreatic margin: silver nitrate. - retroperitoneal pancreatic margin: green ink. Distance of tumor to posterior/retroperitoneal margin of pancreas: 0.1 cm. Distance of tumor to distal margin of pancreas: 1.2 cm. Distance of tumor to CBD margin: 2.5cm. REGIONAL LYMPH NODES: Peri-CBD lymph nodes: number: 1 size range: 0.4 cm. Peri-pancreatic lymph nodes: number: 3;size range: 0.8 to 1.6cm. Peri-gastric lymph nodes: number: 2 size range: 0.3 to 0.8 cm. OTHER FINDINGS: The specimen overall has a pale gray appearance. Tissue Banking: no. Representative sections are submitted as follows: 8A. distal pancreatic margin en face. 8B. retroperitoneal margin perpendicularly cut. 8C. posterior pancreatic margin. 8D. common bile duct margin en face. 8E-G. proximal en face gastric margin. 8H-I. distal en face duodenal margin. 8J. mid CBD. 8K. ampulla. 8L-M. tumor approaching anterior surface pancreas. 8N-O. tumor. 8P-Q. cystic areas of pancreas. 8R. CBD node. 8S. 2 lymph nodes. 8T. one peripancreatic node bisected. 8U. 2 peripancreatic nodes bisected. Quick Section Diagnosis. 5A - Portal vein tissue - Fibrotic tissue with aggregates of atypical cells, suspicious for a malignant neoplasm. Await. permanent sections. Slide received: 6A. Retroperitoneum - Fibrotic tissue with aggregates of atypical cells, suspicious for a malignant neoplasm. Await. permanent sections. Slide received: 7A. Retroperitoneum - Fibrotic tissue with aggregates of atypical cells, suspicious for a malignant neoplasm. Await. permanent sections. Slide received: Microscopic Description. 1. Site: left adrenal gland. Tumour size: 6.5 x 6.2 x 4.7 cm. Histological pattern: Classical nested. Cell type: polygonal (chief cells) and spindle (sustentacular cells). Mitoses: 1 per 50 HPF. Necrosis: absent. Other: extensive stromal hyalinization. Lymphovascular invasion: absent. Perineural invasion: absent. Extent/depth of invasion: Underlying medullary hyperplasia: negative. Lymph nodes: Number examined: none. Number involved: none. Metastasis: not known. Immunohistochemistry: i) synaptophysin: ii) chromogranin. iii) S-100. iv) tyrosine hydroxylase.","Pheochromocytoma of the left adrenal gland with a classical nested histological pattern, composed of polygonal and spindle cells, and extensive stromal hyalinization. No necrosis, lymphovascular invasion, or perineural invasion identified. Extra-adrenal paraganglioma in one of the para-aortic suprahilar lymph node biopsies. Infiltrating neuroendocrine carcinoma in the soft tissue biopsies of the portal vein and retroperitoneum, with a similar immunoprofile to the pancreatic tumor. Well-differentiated pancreatic neuroendocrine carcinoma with a solid configuration, and multiple benign cysts in the pancreas. No pathological diagnosis in the gallbladder, lymph nodes, stomach, or duodenum. Tumor approaching the anterior surface of the pancreas, with no regional lymph node metastasis. Margins involved by invasive carcinoma in the retroperitoneal pancreatic margin. No mitoses or perineural invasion identified. Immunohistochemistry positive for synaptophysin, chromogranin, and S-100, and negative for tyrosine hydroxylase."
TCGA-BR-8367.3ecfc05d-6535-4b71-ad28-6696b9d0995f,"Microscopic Description. Stomach with a plate-like tumor. Adenocarcinoma of the stomach,. of 12 X 7 cm in its size, with the. G3; with the presence of signet. whole wall invasion. cells, superficial ulceration,. Fatty tissue lymph nodes are up. perigastric fat invasion. Multiple. to 1 cm in their diameter, soft,. foci of perineural invasion are. hyperemic; omentum is. observed. Fifteen lymph nodes. hyperemic. were examined, nine lymph nodes. demonstrated metastases. Omentum demonstrated. hemorrhages. Diagnosis Details. Comme. nts. Tumor Features: Ulcerated, Tumor. STOMACH TISSUE CHECKLIST. Extent: Perigastric fat , Venous. Invasion: Absent, Margins: Specimen type: Gastrectomy. Absent, Treatment Effect: Tumor site: Fundus. Tumor size: 7 X 0 X 12 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Subserosa. Lymph nodes: 9/15 positive for metastasis. (Greater and lesser omentum 9/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None. Lateralit. y.","Adenocarcinoma of the stomach with a plate-like growth pattern, composed of poorly differentiated cells, including signet ring cells. The tumor exhibits superficial ulceration and whole wall invasion, with perigastric fat invasion and multiple foci of perineural invasion. Lymph nodes show metastases, with nine out of fifteen lymph nodes positive for metastatic disease. The omentum is hyperemic with hemorrhages. The tumor is ulcerated, with lymphatic invasion not specified, and venous invasion absent. Perineural invasion is observed, and margins are uninvolved. Non-neoplastic findings include hyperemic fatty tissue and omentum with hemorrhages."
TCGA-81-5910.9d6e4a44-727e-4713-842e-a75ded996614,"SPECIMEN. A. VOCAL CORD(S) - 1. Right false vocal fold. B. SOFT TISSUE - 2. Left parietal mass (FS). C. SOFT TISSUE - 3. Dura on top of tumor. D. SOFT TISSUE - 4. Left parietal mass (additional tissue). CLINICAL INFORMATION. Lesion on voice box; left parietal brain tumor. GROSS DESCRIPTION. Received in four parts labeled. Part A is additionally labeled ""right false vocal cord"" and consists of two tan-white soft tissue fragments,. measuring 2 mm and 5 mm, which are entirely submitted as (A1) with a two-step tag. Part B is received fresh in the frozen section room and additionally labeled ""left parietal mass (frozen. section) and consists of a 15 X 11 X 3 mm aggregate of red-tan soft tissue fragments, which are entirely. frozen as FSB1. There is also an additional 18 X 13 X 4 mm aggregate of soft tissue, 2/3 of which is. submitted as shap frozen for the. The remaining tissue from FSB1 is submitted as (B1). and the additional tissue is submitted as (B2). Frozen section diagnosis by. Left parietal mass, FSB1 -- ""Glioblastoma multiforme."". Part C is additionally labeled ""dura on top of tumor"" and consists of a 3.3 x 2.7 x 0.1 cm portion of. glistening white-pink fibrous tissue, which is entirely submitted as (C1) and (C2). Part D is additionally labeled ""left parietal mass (additional tissue)"" and consists of a 2.3 x 2.2 x 1.1 cm. portion of tan-pink soft tissue. The cut surfaces consists of tan-pink parenchyma with no gross lesions. The specimen is entirely submitted as (D1) and (D2). MICROSCOPIC DESCRIPTION. Step sections of the right false vocal cord specimen show several fragments which include. nonkeratinizing squamous epithelium overlying submucosa. The epithellum and submucosa are not. inflamed. Focally, the surface orthokeratotic layer shows numerous budding yeast forms consistent with. Candida spectes. Inflammation is not seen. No evidence of squamous dysplasia is found. The features. are of Candidiasis without any evidence of tissue invasion by the Candida organisms. Sections of the left parietal mass show features of a glioblastoma multiforme, This is a cellular neoplasm. with some areas show a moderately extensive necrosis. Microvascular proliferation (endothelia!. proliferation) is prominent multiple areas. The malignant glial cells have pleomorphic, hyperchromatic. nuclei with many areas showing indistinct cytoplasmic borders. Some areas include neoplastic. gemistocytic astrocytes with eccentrically placed nuclei and a moderate amount eosinophilic cytoplasm. Peri-necrotic pseudopalisades in which neoplastic cells surround necrotic tumor are present. Multinucleate tumor cells are relatively uncommon. No sarcomatous elements are found. The malignant. cells are strongly positive with immunohistochemical stain to GFAP. An appropriate control has been. verified. Areas to suggest an oligodendroglial component are not identified,. Sections C (dura) showed dense membranous connective tissue. No evidence of a neoplasm is seen. Inflammation is not evident. Sections D also show a glioblastoma multiforme, similar in appearance to the tumor described in the. second specimen. has reviewed representative slides of the parietal mass in this case and concurs. FINAL DIAGNOSIS. RIGHT FALSE VOCAL CORD. Candidiasis (noninvasive). Benign keratinizing squamous mucosa and submucosa. No evidence of dysplasia. LEFT PARIETAL MASS. Glioblastoma multiforme. DURA ON TOP OF TUMOR, EXCISION. Normal dense membranous connective tissue consistent with dura. LEFT PARIETAL MASS (ADDITIONAL). Glioblastoma multiforme.","Right false vocal cord shows nonkeratinizing squamous epithelium overlying submucosa without inflammation, and numerous budding yeast forms consistent with Candida species are seen on the surface, features of Candidiasis without tissue invasion. Left parietal mass is a glioblastoma multiforme, a cellular neoplasm with moderately extensive necrosis, microvascular proliferation, and pleomorphic, hyperchromatic nuclei with indistinct cytoplasmic borders. Neoplastic gemistocytic astrocytes with eccentrically placed nuclei and eosinophilic cytoplasm are present, and peri-necrotic pseudopalisades are seen. Multinucleate tumor cells are relatively uncommon, and no sarcomatous elements are found. The dura on top of the tumor shows dense membranous connective tissue without evidence of neoplasm or inflammation. The additional left parietal mass also shows glioblastoma multiforme, similar in appearance to the initial tumor description."
TCGA-RC-A7SB.5B9D93C9-3051-4E0C-97B1-25E9CDD9CFE1,"A. Liver. poster for segmentectomy: HEPATOCELLULAR CARCINOMA with focal sarcomatous differentiation. Tumor number : two. Sateilite nodule: no. Location : S6. S7. Gross type: vaguely nodular (S7) and nodular with per inodular extension (S6). Size(cim): 2.5x2.5x2.4cm (S6) and 1.5x1.5x1.4cm (S7). Differentiation: The worst differentiation: Edmondson grade IV. The major differentiation: Edmondson grade 11. Histologic type: microtrabecular and pseudoglandular. Cell type: Hepatic and Spindle. Tumor necrosis : no. Hemorrhage : no. Fatty change : no. Fibrous capsuie : 1) complete (S6), 2) No capsule(S7). Infiltration of capsule : yes. Septum formation : yes. Surgical margin invasion : no(margin of the clearance: 0.5mm at ""S7"" mass). Serosa invasion: no. Portal vein invasion : no. Bile duct invasion : no. Hepatic vein invasion : no. Hepatic artery invasion : no. Microvessel invasion : no. Intrahepatic metastasis : no. Multicenteri ic occurrence : yes. T stage : pT2. Non-tumor liver. Chronic hepatitis : yes. Etilogy : HBV. Grade, Tobular : minimal. Grade, portoperiportal : none. Stage(fibrosis) : no. Cirrhosis : no. Dysplastic nodule : no. Ouctal epithelial dysplasia : no. Other liver disease : Fatty change. macrovesicular (about 10%). B. Falciform ligament. excision: No pathologic abnormality. C. Gallbladder. cholecystectomy: Cholesterol polyps. D. Tissue labeled as ""LN"". biopsy: Fibroadipose tissue only. < Result of immunohistochemical stain>. Hepatocyte ( block A3 and A5): Positive in tumor cells. Cytokeratin 19 ( block A3 and A5) : Negative in tumor cells. Cytokeratir 7 (block A3 and A5): Focal positive in tumor cells. Cytokeratin 7 (block A7) Bile duct positive. Vimetin (block A3); Focal positive. Cam5.2 (block A3); Positive. < Result of special stain, block A7 >. fron: Negative. A. The specimen received in formalin is a product of segmentectomy of liver,. measur ing 16.5x8x4.5cm and weighing 230gm. The capsular surface and. par enchymal resection margin are clear. On serial sections. there is a multinodular. confluent expanding nodular type mass, measuring 2.5x2.5x2.4cm The mass. abuts capsule and the cut surface is whitish solid. Also noted is a well defined. greenish mass, measuring 1.5x1.5x1.4cm. The mass is abutting capsule and is. 0. 1cm apart from parenchymal resection margin. This mass is 3cm apart from the. Targer mass. Remaining parenchyma is unremarkable. Representative sections. are embedded in 7 cassettes. (Aland2-Targer mass one plane, A3and4-larger. mass one plane. A5-small mass one plane. A6-small mass one plane. A7-normal liver). B. The specimen received in formalir is a Tump of adipose tissue, clinically labeled. as ""falciform Ligament"" measuring 12x3x1.5cm. On serial section, there is. no definite mass. Representative sections are embedded in one cassette. C. The specimen received in formalin is a gallbladder, measuring 7x2.5x2.5cm. The external surface is unremarkable. On opening. there is a black stone. measuring 0.8cm in diameter. The mucosa is greenish velvety appearance with. several tiny yellowish polyps. measuring up to 0.1cm. The wall measures 0.2cm. in thickness. Representative sections are embedded in one cassette. D. The specimen received in formalin is a compartmentalized lymph node. Entirely embedded in one cassette. H&E(10). MT(1), RTC(1). D-PAS(1). Tron(1). Cytokeratin 7(3). Hepatocyte (2). Cytokeratin 19 (2), Vimetin (1). Cam5,2(1).","Hepatocellular carcinoma with focal sarcomatous differentiation, displaying microtrabecular and pseudoglandular patterns, composed of hepatic and spindle cells. The tumor shows Edmondson grade IV worst differentiation and Edmondson grade II major differentiation. Tumor necrosis and hemorrhage are not identified. A fibrous capsule is present in one nodule, with infiltration of the capsule and septum formation. Surgical margin invasion is not observed. Serosa, portal vein, bile duct, hepatic vein, and hepatic artery invasions are not identified. Microvessel invasion and intrahepatic metastasis are not present. Multicentric occurrence is noted. Non-tumor liver shows chronic hepatitis with minimal tubular and no portoperiportal activity, without cirrhosis or dysplastic nodules. Fatty change, macrovesicular, is seen in about 10% of the liver. The falciform ligament and lymph node biopsy show no pathologic abnormality, while the gallbladder contains cholesterol polyps."
TCGA-KV-A6GD.516173EA-A413-434E-9F9A-0A1A107C5B3C,"DATE OBTAINED: DATE RECEIVED: DIAGNOSIS. 1. SOFT TISSUE, PERIRENAL FAT, EXCISION: FIBROADIPOSE TISSUE WITH FOCAL ACUTE. INFLAMMATION; NEGATIVE FOR CARCINOMA. 2. RIGHT RENAL MASS, PARTIAL NEPHRECTOMY: PAPILLARY RENAL CELL CARCINOMA (SEE. COMMENT). Histologic type: Sarcomatoid features: Papillary carcinoma, type 2 (chromophil cell) Careinoma, posidary. identified renal cell 8260X3. Tumor Necrosis. Present (~35%); see comment. Tumor size: 6.5 cm. Fuhrman nuclear grade: Grade 2, focal 3. Tumor focality: Unifocal. Macroscopic extent of tumor: Confined to renal parenchyma. Microscopic extent of tumor: Confined to renal parenchyma. Lymphatic/vascular invasion: Absent. Margins: Negative parenchymal resection and perinephric soft tissue margins. Non-neoplastic kidney: Renal parenchyma with patchy chronic inflammation and blood vessels with mild. peripheral vascular disease. Adrenal gland: Not present. Lymph nodes: No nodes submitted. pTNM: pT1b. AJCC STAGE: Stage I. COMMENT. The tumor necrosis could have occurred spontaneously however it is associated with the prior core biopsy site, so biopsy-induced. necrosis is also possible. Prior studies on the core biopsy. showed positive CK7 and positive AMACR consistent with. papillary carcinoma. #1 & #2: 88307, 88329. Clinical Diagnosis and History: Right renal mass. Tissue(s) Submitted: 1: PERITONEAL FAT. 2: RIGHT RENAL MASS. Gross Description: # 1 is received in formalin labeled perirenal fat and consist of a 8 x 8 x 1 cm fragment of adipose tissue submitted partially surfaced in. Specimen by a glistening fascia. The specimen is serially sectioned to reveal no gross lesions. Representative sections are. blocks 1A to 1B. Specimen #2 labeled right renal mass is received fresh for intraoperative consultation and consists of 195 grams, black 9.5 on (L-M) the x 7.0. (S-I) perinephric x adipose tissue and then serially sectioned to reveal a 6.5 x 6.5 x 3.5 cm tumor ant about 4 mm to 35% parenchymal necrosis). 6 cm (A-P) partial nephrectomy specimen. The specimen is inked blue in the parenchymal margin and the. margin and confined to the renal parenchyma. The tumor cut surface is variegated and necrotic (approximately A. small amount of tumor is procured for. Representative sections are submitted as follows: 2A: Perirenal fat. 2B-C: Tumor to parenchymal margin. 2D-E: Tumor to perinephritic fat. 2G-H: Tumor to adjacent kidney and representative tumor. Intraoperative Consult Diagnosis. MASS MEASURES - ~4MM FROM THE CLOSEST PARENCHYMAL MARGIN.","Papillary renal cell carcinoma with sarcomatoid features, showing papillary carcinoma, type 2, with tumor necrosis present. Fuhrman nuclear grade is Grade 2, focal 3. Tumor is unifocal and confined to renal parenchyma. Lymphatic/vascular invasion is absent. Margins are negative for parenchymal resection and perinephric soft tissue. Non-neoplastic kidney shows renal parenchyma with patchy chronic inflammation and blood vessels with mild peripheral vascular disease. Adrenal gland is not present. No lymph nodes are submitted. Tumor necrosis is associated with the prior core biopsy site, suggesting possible biopsy-induced necrosis. Prior studies on the core biopsy showed features consistent with papillary carcinoma."
TCGA-EY-A1GW.52C26330-540E-4409-ACDF-4D56EA1E7D7F,"Diagnosis: A: Omentum, omentectomy. - Involved by high grade endometrioid adenocarcinoma. B: Uterus and cervix, hysterectomy: Location of tumor: uterine fundus. Histologic type: endometrioid adenocarcinoma of the endometrium with extensive eosinophilic change, 3.5 cm in. greatest dimension (see comment). Histologic grade (FIGO): FIGO grade 3 (architectural grade 3, nuclear grade 3). Extent of invasion: Myometrium. Myometrial invasion: outer half. Depth: 1.3 Wall thickness: 2.1 Percent: 62%. Serosal involvement: none identified. Lower uterine segment involvement: none identified. Cervical involvement: none identified. Adnexal involvement (see below): none identified. Other sites: omentum, pelvic gutter, and bowel serosa involved by endometrioid adenocarcinoma (see parts A, C and D). Cervical/vaginal margin and distance: widely free of tumor. Lymphovascular Space Invasion: none identified (see comment). Regional lymph nodes: not applicable. Other Pathologic findings: Cervix. - Chronic cervicitis with cystically dilated endocervical glands and a tunnel cluster. Endometrium. - Atrophic endometrium. Tumor estrogen receptor and progesterone receptor immunohistochemistry results: Estrogen receptor Positive 1 to 2+, 60%. Progesterone receptor Positive 1 to 2+, 30%. AJCC Pathologic stage: pT1b pNx pM1. FIGO (2008 classification) Stage grouping: IVB. These stages are based on information available at the time of this report, and are subject to change pending additional. information and clinical review. Ovary, right, oophorectomy: - Epithelial inclusion cyst. - Physiologic changes. Ovary, left, oophorectomy: - Epithelial inclusion cysts. - Physiologic changes. Fallopian tube, right, salpingectomy: - No specific pathologic abnormality. Fallopian tube, left, salpingectomy: - No specific pathologic abnormality. C: Soft tissue, gutter implant, removal. - Involved by high grade endometrioid adenocarcinoma. D: Colon, right hemicolectomy. - Appendiceal and bowel serosa involved by high grade endometrioid adenocarcinoma. - Surgical resection margins free of tumor. Comment: Histologic examination reveals tumor with solid and cribriform growth patterns. Cells show enlarged nuclei with. markedly prominent nucleoli and abundant eosinophilic cytoplasm. Immunohistochemical stains were performed and. tumor cells are positive for CK 7 and show patchy positivity for p53. Immunostains for CK 20, p16, and p63 are negative. Morphology and immunoprofile support the above diagnosis. Findings in one area raised the possibility of. lymphovascular space invasion. However, immunostains for CD31 and CD34 do not convincingly show intravascular. tumor. Clinical History: with endometrial cancer. Gross Description: Received are four appropriately labeled containers. Container A is additionally labeled ""omentum."" It holds a 43 x 13 x 2.0 cm fragment of omentum. Within the omentum. there are multiple white, soft, well circumscribed nodules ranging from 0.5 to 14.5 cm. Sections of the nodules are. submitted in blocks A1-A3 with the remaining tissue retained in formalin. Container B: Adnexa: present. Weight: 118 grams. Shape: pear shaped. Dimensions: height: 11.2 cm. anterior to posterior width: 5.0 cm. breadth at fundus: 6.0 cm. Serosa: tan/pink, focally erythematous with a 1.1 x 0.6 cm tan, slightly nodular area on the left anterior wall. Cervix: 2.1 x 2.0 cm with a 0.4 cm patent os. length of endocervical canal: 1.7 cm. ectocervix: tan/pink and focally erythematous. endocervix: tan and trabeculated. Endomyometrium: length of endometrial cavity: 4.5 cm. width of endometrial cavity at fundus: 4.5 cm. tumor findings: dimensions: 3.5 x 3.3 x 2.9 cm. appearance: tan/white, soft, exophytic. location and extent: attached to the dome extending into the myometrium. myometrial invasion: yes; outer one half. thickness of myometrial wall at deepest gross invasion: 1.7 cm (mass comes to within 0.5 cm of the serosal surface). other findings or comments: none. Adnexa: Right ovary: dimensions: 1.5x1.0x0.6cm. external surface: tan and smooth. cut surface: tan/yellow and unremarkable. Right fallopian tube: dimensions: 4.2 cm in length X 0.3 cm in diameter. other findings: the outer surface is tan/red and glistening; the cut surface reveals a pinpoint patent lumen. Left ovary: dimensions: 1.3 X1.1 x 0.6 cm. external surface: the outer surface is tan and smooth. cut surface: tan, firm and unremarkable. Left fallopian tube: dimensions: 3.5 cm in length x 0.4 cm in diameter. other findings: the outer surface is tan/red and glistening; the cut surface reveals a pinpoint patent lumen. Lymph nodes: n/a. Other comments: none. Digital photograph taken: no. Tissue submitted for special investigations: tumor submitted to Tissue Procurement. Block Summary: B1 - anterior cervix, lower uterine segment, bisected section. B2 - posterior cervix, lower uterine segment, bisected section. B3 - tumor with respect to serosal surface, perpendicular. B4,B5 - tumor and adjacent myometrium. B6 - abnormality on anterior serosal wall. B7 - additional section of anterior endomyometrium. B8 - additional section of posterior endomyometrium. B9 - right ovary (entirely submitted). B10 - right fallopian tube. B11 - left ovary (entirely submitted). B12 - left fallopian tube. Container C is additionally labeled ""right gutter implant."" It holds a triangular shaped piece of red/brown firm tissue, 9.0. x 7.5 x 1.5 cm. Within the tissue there are multiple white soft, ill-defined nodules. The specimen is sampled in blocks C1-. C3, with the remaining tissue retained in formalin. Container D is additionally labeled ""cecum, distal ileum, ascending colon and appendix."" It holds a right hemicolectomy. The segment of terminal ileum measures 2.5 cm in length x 3.5 cm in circumference and is contiguous with the. cecum/ascending colon, part of the transverse colon (33 cm in length x up to 6 cm in circumference). The attached. appendix is 4.5 cm in length x 0.3 cm in diameter. On the outer surface of the appendix there is a red/brown firm. nodule, 0.4 x 0.4 cm. The nodule comes to within 1.5 cm of the proximal aspect of the appendix. On section, the. appendix has a patent unremarkable lumen. The serosal surface on the ascending colon just past the cecum is covered. with red/brown, firm tissue approximately 10.0 x 5.0 cm. On section, this tissue has a white creamy cut surface and does. not appear to invade into the bowel wall. The terminal ileum, cecum, ascending colon, and part of the transverse. colon. tan/pink and glistening mucosa. No mucosal based masses are noted. A 2.5 cm in greatest dimension tan firm, creamy. lymph node is present at the mesenteric vascular pedicle margin. Also within the specimen container there is an additional segment of small bowel, 5.5 cm in length x 1.5 cm in diameter. The bowel is received stapled. The serosal surface at one of the stapled margins is discolored red/brown. The. remainder of the serosa is tan/pink and glistening. Opening reveals tan/pink folded, unremarkable mucosa. Also present within the specimen container are two fragments of red/brown firm tissue, 11.0 x 7.5 x 2.5 cm in. aggregate. On section the cut surface is tan/red and soft. The specimen is sampled per block summary. Block summary: D1 - proximal and distal mucosal margins (right hemicolectomy). D2 - appendix. D3 - serosal implant. D4,D5 - serosal implant and bowel wall. D6 - additionally submitted fragment of small bowel margin with red/brown firm tissue, en face. D7 - opposite margin. D8 - section of additionally submitted red/brown firm tissue. Light Microscopy: Light microscopic examination is performed by Dr. For cases in which immunostains are performed, the following applies: Appropriate internal and/or external positive and. negative controls have been evaluated. Some of the immunohistochemica reagents used in this case may be. classified as analyte specific reagents (ASR). These were developed and have performance characteristics determined by. the. 1. These reagents have not been cleared or. approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not. necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for. research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as. qualified to perform high complexity clinical laboratory testing. Attending Pathologist: I have personally conducted the evaluation of the above specimens and have. rendered the above diagnosis(es).","High grade endometrioid adenocarcinoma involves the omentum, uterus, and cervix. The tumor has a solid and cribriform growth pattern, with cells showing enlarged nuclei, markedly prominent nucleoli, and abundant eosinophilic cytoplasm. Myometrial invasion is present, involving the outer half of the myometrium. Serosal involvement is not identified. Cervical and lower uterine segment involvement are not identified. Adnexal involvement is not identified. The omentum, pelvic gutter, and bowel serosa are involved by high grade endometrioid adenocarcinoma. Lymphovascular space invasion is not convincingly identified. The tumor cells are positive for estrogen and progesterone receptors. Chronic cervicitis with cystically dilated endocervical glands and a tunnel cluster are noted in the cervix. Atrophic endometrium is present. The right and left ovaries show epithelial inclusion cysts and physiologic changes. The right and left fallopian tubes do not show specific pathologic abnormalities. The colon and appendix are involved by high grade endometrioid adenocarcinoma, with tumor present on the serosal surface, but not invading into the bowel wall. Surgical resection margins are free of tumor."
TCGA-CV-7103.da0635c4-493b-4d58-905a-cb5e82c19b59,"Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. DIAGNOSIS. PARTIAL GLOSSECTOMY, LATERAL TONGUE: DEEPLY INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED. Focal moderate dysplasia at medial/anterior aspect of surgical. margin. Remaining surgical margins free. (B). ANTERIOR MEDIAL MARGIN: Minor salivary gland and skeletal muscle, no tumor present. JUGULAR CHAIN LYMPH NODE, LEVELS II, III AND IV: METASTATIC SQUAMOUS CARCINOMA IN 1 OF 3 LYMPH NODES FROM LEVEL II. METASTATIC SQUAMOUS CARCINOMA IN 1 OF 3 LYMPH NODES FROM LEVEL III. Two lymph nodes from level IV, no tumor present. SUBMANDIBULAR GLAND AND LEVEL I LYMPH NODE: Four lymph nodes from level I, no tumor present. salivary gland, no tumor present. (E). ADDITIONAL LEVEL IV: Two lymph nodes, no tumor present. POSTERIOR HARD PALATE: oral melanotic macule. (G) TEETH: Teeth, gross only. Entire report and diagnosis completed by: GROSS DESCRIPTION. (A) PARTIAL GLOSSECTOMY, LATERAL TONGUE - A partial glossectomy with an. overall measurement of 8.0 X 3.8 X 2.0 cm. An ulcerated contracted and. slightly raised light-tan and firm lesion (2.0 X 1.0 X 0.6 cm). The tumor is. surrounded by normal mucosa and is about 0.8 cm from the deep margin. of. resection. The specimen is submitted entirely from anterior to posterior as. follows. SECTION CODE: A1-A9, margins of resection; A10-A18, sequential sections. of the normal and tumor from anterior to superior. FS/DX: FOCAL MODERATE DYSPLASIA AT MEDIAL/ANTERIOR ASPECT, OTHER FOCAL. AREAS DENUDED, REMAINING FREE (GILCREASE). (B) PATIENT'S ANTERIOR MEDIAL MARGIN - A pink-Lar tissue fragment (2.1 X 1.0. X 0.3 cm). INK CODE: Blue - anterior. SECTION CODE: B, submitted in toto for frozen section. FS/DX: MINOR SALIVARY GLAND, NO TUMOR PRESENT. (C). JUGULAR CHAIN LYMPH NODE LEVEL II, III, IV (SUTURE AT LEVEL II) -. An. irregular, pink-red soft tissue fragment (10.0 X 3.2 X 0.8 cm) which is. oriented by the surgeon. A level III, IV and V on the report corresponding to. the traditional level II, III, and IV respectively. Breast suture is marking. the lymph node at level II. Multiple lymph nodes vary in size from 0.4 cm to. 1.5 cm respectively. Some lymph nodes are firm. Lymph nodes are submitted in. six cassettes. SECTION CODE: C1, C2, lymph nodes level III corresponding to traditional. level II. C1, two lymph nodes; C2, one lymph node bisected; C3-C5, lymph. nodes from level IV (corresponding to traditional level III) with C3 and C4,. one lymph node bisected; C5, two Tymph nodes; C6, two lymph nodes from level V. (corresponding to level IV for traditional level IV). (D) SUBMANDIBULAR GLAND AND LEVEL I LYMPH NODE, SUTURE ON FASCIA OF LYMPHATIC. - An irregular, pink-red soft tissue fragment (9.0 X 3.5 X 2.5 cm) with. a. submandibular salivary gland (5.0 X 2.5 X 2.3 cm). A black surgical suture is. present marking the facial lymphatic chain. The submandibular salivary gland is grossly unremarkable. Four lymph. nodes are dissected from the perisalivary gland. The lymph nodes vary in size. from 0.4 cm to 0.8 cm in greatest diameter. They are grossly unremarkable. SECTION CODE: Representative sections are submitted in four cassettes: D1-D2, representative sections of salivary gland; D3, three lymph nodes;. D4,one lymph node. FS/DX: MINOR SALIVARY GLAND, NO TUMOR PRESENT. (E) ADDITIONAL LEVEL IV - An irregular, yellow-pink soft tissue fragment (2.5. x 2.0 X 0.3 cm). No invasive lymph node identified. Specimen submitted. entirely in two cassettes E1 and E2. (F) POSTERIOR HARD PALATE - A single Tradment of pale tan tissue (0.2 cm in. greatest dimension) . Submitted in F. (G) TEETH - Multiple teeth and fragments of teeth (5.5 X 5.0 x 3.5 cm in. aggregate). The specimen is for gross identification only. SNOMED CODES. T-53000 T-C4100.","Deeply invasive squamous cell carcinoma, moderately differentiated, with focal moderate dysplasia at the medial/anterior aspect of the surgical margin. Remaining surgical margins are free of tumor. Metastatic squamous carcinoma is present in one of three lymph nodes from level II and one of three lymph nodes from level III. No tumor is present in two lymph nodes from level IV, four lymph nodes from level I, or the submandibular gland. An oral melanotic macule is identified on the posterior hard palate. The tumor exhibits invasive characteristics, with no mention of necrosis or specific nuclear features. Lymphovascular invasion is not described. The surgical margins are involved by dysplasia, but not by invasive carcinoma. Minor salivary gland and skeletal muscle are present at the anterior medial margin, with no tumor identified."
TCGA-ET-A3BN.285F05E8-2C8E-4D4A-968C-AE1F3D5882FE,"SPECIMEN TAKEN: FINAL DIAGNOSIS. 1) THYROID (TOTAL THYROIDECTOMY): SPECIMEN TYPE: Total thyroidectomy. TUMOR SITE: Right lobe. HISTOLOGIC TYPE: Papillary carcinoma. TUMOR SIzE: Greatest dimension: 3 cm. FOCALITY: Unifocal. LYMPH NODES: None submitted. EXTENT OF INVASION. PRIMARY TUMOR: pT2: Tumor > 2 cm but <4 cm, limited to thyroid. REGIONAL LYMPH NODES: pNx: Cannot be assessed. DISTANT METASTASIS: pMx: Cannot be assessed. MARGINS: Margins are uninvolved. VENOUS/LYMPHATIC INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: Thyroiditis (mild).",Papillary carcinoma of the thyroid with unifocal tumor in the right lobe. The tumor is limited to the thyroid. No lymphatic or venous invasion identified. Margins are uninvolved. Mild thyroiditis present. No lymph nodes submitted for examination.
TCGA-AK-3428.1454ec74-1c64-44a6-bf9f-dca88073f6a0,"Clinical History/Diagnosis: Left renal mass. Source of Specimen(s). A: Left kidney,adrenal and para aortic lymph nodes. B: Additional para aortic tissue. Gross Description: Received in two parts. Source of Tissue: 1. Labeled #1 ""left kidney, adrenal, para-aortic lymph. nodes"". Frozen Section Diagnosis: 1FS CLEAR CELL CARCINOMA AS. Gross Description: Received fresh for frozen section diagnosis is a kidney. with attached perinephric fat weighing 1988.28 gm and measuring 24 x 14.5. x 11.5 cm. Examination of the hilum reveals the vascular resection. margins. Grossly, the ureter appears to insert in the region of the lower. pole. The venous resection margin appears to be free of tumor; however,. upon opening the vein, adherent tumor thrombus is identified. No tumor is. present at the resection margin itself. Bivalving the kidney reveals a. large, yellow-orange and hemorrhagic tumor occupying the majority of the. kidney. There is some recognizable renal parenchyma identified in the. lower pole of the kidney. The tumor measures approximately 12 X 9.5 x 9. cm. A representative section of the tumor is submitted for frozen section. analysis. The frozen residue will be submitted for permanent analysis. A. section of the tumor is submitted for cytogenetic analysis. Sectioning. through the remainder of the specimen reveals tumor invading into. perinephric fat, grossly 2 mm from the inked margin. An adrenal gland is. identified measuring approximately 9 x 2 x 0.5 cm. There is a nodule. within the adrenal measuring 0.7 x 0.5 X 0.3 cm. The specimen is. dissected for lymph nodes and possible lymph nodes are submitted. Representative sections of the specimen are submitted. Designation of Sections: 1FS frozen section, 1A vascular and ureteral. resection margins, 1B tumor thrombus within vein, 1C tumor extending into. perinephric fat (with inked margin), 1D tumor section with possible. vascular invasion, 1E tumor section with kidney and perinephric fat, 1F. section of tumor, 1G-1K possible lymph nodes, 1L section of adrenal. including nodule. Summary of Sections: 13 1FS through 1L - multiple. Source of Tissue: 2. Labeled #2 ""additional para-aortic tissue"". Gross Description: Received fresh is a portion of fibrofatty tissue. measuring 2 X 1 x 0.5 cm. No gross lymph node is identified. The entire. specimen is submitted. Designation of Sections: 2A. Summary of Sections: 1 2A,2. Final Diagnosis: 1. Kidney, left, adrenal, and para-aortic lymph nodes (radical. nephrectomy): - Renal cell carcinoma, clear cell type (12 cm); Fuhrman nuclear grade 2,. invading through the renal capsule into the perinephric fat. - Tumor thrombus is present within the renal vein. - Carcinoma is approximately 2.5 mm from the inked perinephric fat. margin. - Negative vascular and ureteral margins. - Four negative lymph nodes (0/4). - Adrenal gland with benign lipomatous inclusion. 2. Additional para-aortic tissue (excision): - Fibroadipose tissue, no lymphoid tissue seen, no tumor seen.","Renal cell carcinoma, clear cell type, with tumor composed of cells having clear cytoplasm and distinct cell borders, Fuhrman nuclear grade 2. Tumor invades through the renal capsule into the perinephric fat. Tumor thrombus is present within the renal vein. Carcinoma is close to the inked perinephric fat margin. Vascular and ureteral margins are negative. No lymph nodes are involved by tumor. Adrenal gland shows a benign lipomatous inclusion. Perinephric fat is involved by tumor. No tumor is identified in the additional para-aortic tissue, which consists of fibroadipose tissue without lymphoid tissue."
TCGA-VQ-A8PU.B3E4F95C-B684-4B3B-857F-BE164A289051,"PRIMARY SITE: Stomach (Body). 1 - ""Stomach + spleen + pancreas tail + small intestine"": Adenocarcinoma: Histological pattern observed: tubular. Histological grade: III - poorly differentiated. Measure of the longest axis of the tumor: 11.5 cm. Ulceration: present. Involvement of: Mucosa. Muscularis mucosae. Submucosa. Muscularis propria. Adjacent adipose tissue. Other structures: pancreas. Type of tumor invasion: spiculated. Inflammatory reaction: moderate. Tumor implantation in perivisceral adipose tissue: not detected. Proximal and distal margins: absence of neoplastic involvement. Neural infiltration: not detected. Lymphatic vascular invasion: present. Blood vascular invasion: not detected. Lymph nodes: Involved: 1/6. Capsular transposition: not detected. Ratio of involved/dissected lymph nodes: 1/6. Conglomerated lymph nodes: not detected. Greater omentum: absence of neoplastic involvement. Spleen: absence of neoplastic involvement. Note: Lauren's classification - intestinal pattern. 2 - ""Duodenal margin"": Absence of neoplastic involvement. 3 - ""Lymph node 8A"": Lymph node uninvolved by neoplasia (0/3). 4 - ""Esophageal margin"": Absence of neoplastic involvement.","Adenocarcinoma with a tubular histological pattern, poorly differentiated, grade III. Tumor involves mucosa, muscularis mucosae, submucosa, muscularis propria, and adjacent adipose tissue, including pancreas. Type of tumor invasion is spiculated. Moderate inflammatory reaction present. Tumor implantation in perivisceral adipose tissue not detected. Neural infiltration not detected. Lymphatic vascular invasion present. Blood vascular invasion not detected. Lymph nodes involved, with 1 out of 6 lymph nodes showing involvement. No capsular transposition or conglomerated lymph nodes detected. Greater omentum and spleen show absence of neoplastic involvement. Proximal and distal margins, duodenal margin, and esophageal margin all show absence of neoplastic involvement. Lauren's classification indicates an intestinal pattern."
TCGA-A6-4107.ead64351-1c48-40cf-88d1-acea2f34a4ea,"SPECIMEN. Right colon. CLINICAL NOTES. PRE-OP DIAGNOSIS Right colon cancer. GROSS DESCRIPTION. Received fresh labeled ""right colon"" is a previously. unopened 17 cm. segment of proximal right colon with. attached 13.5 cm. of distal ileum surfaced by smooth to slightly. scabrous tan-pink serosa with a copious amount of attached. mesocolon. and mesentery. A 4.7 cm. unremarkable appendix ranging from 0.5 to. 0.8 cm. in diameter is present. The proximal and distal margins. measure 4.0 and 6.5 cm. in circumference respectively. On opening,. there is a circumferential, 7.8 x 4.6 cm. lobulated soft tan-pink. lesion 8 cm. distal to the ileocecal valve. A portion of tumor and. a portion of normal are submitted for tissue procurement as. requested. On sectioning, the tumor has a maximal thickness of 1.4. cm. and appears to grossly extend through the muscularis focally. The tumor is greater than 3 cm. from the inked free serosal. surface. The ileal mucosa is finely nodular tan-pink with irregular folds. and. the wall averages 0.5 cm. in thickness. The uninvolved colonic. mucosa is unremarkable glistening tan-pink with irregular folds. and. the wall averages 0.5 cm. in thickness as well. Multiple soft to. slightly rubbery tan pink-red tissues in keeping with lymph nodes. measuring up to 1.4 cm. in greatest dimension are recovered from. the. attached mesocolon and mesentery. Representative sections are. submitted in 17 blocks as labeled. RS-17 -. BLOCK SUMMARY : 1 - Proximal and distal margins; 2-5 - central. tumor; 6 - closest inked radial serosal surface subjacent to tumor;. 7. - ICV; 8 - random ileum and colon; 9 - appendix; 10-12 - eight. whole lymph nodes per cassette; 13, 14 - six whole lymph nodes per. cassette; 15, 16 - one trisected lymph node per cassette; 17 - one. GROSS DESCRIPTION. bisected lymph node. MICROSCOPIC DESCRIPTION. A summary of the microscopic findings for this right colon. resection is in the template below. Histologic type: Invasive adenocarcinoma. Histologic grade Moderately differentiated. Primary tumor (pT) : Tumor invades through the muscularis propria. into the superficial pericolonic fat (pT3). Proximal margin: Negative for tumor. Distal margin: Negative for tumor. Circumferential (radial) margin: Negative for tumor. Distance of tumor from closest margin: 19 cm from distal margin. Vascular invasion : Not identified. Regional lymph nodes (pN) : Metastatic adenocarcinoma is identified. in 2/28 lymph nodes (pN1b). Non-lymph node pericolonic tumor: Not identified. Distant metastasis (pM) : Can not evaluate pMx. Other findings The appendix demonstrates endometriosis. COMMENT: MSI testing was requested by the surgeon. Block 2 has. been sent to. for MSI testing and that report will be. sent to. office. 5. DIAGNOSIS. A. Colon, right, ileocolectomy : Invasive moderately differentiated adenocarcinoma, invasive. through muscularis propria into fat (pT3). DIAGNOSIS. 2of 28 lymph nodes positive for metastatic adenocarcinoma. (pN1b). Resection margins are negative for carcinoma. Appendix with endometriosis.","Invasive adenocarcinoma, moderately differentiated, with tumor invasion through the muscularis propria into the pericolonic fat. The tumor is composed of cells with a glandular growth pattern and exhibits moderate nuclear pleomorphism. No vascular invasion is identified. Metastatic adenocarcinoma is present in some lymph nodes. The resection margins, including the proximal, distal, and circumferential margins, are negative for tumor. The appendix shows endometriosis, and no non-lymph node pericolonic tumor is identified."
TCGA-42-2591.f4c9e6c0-c6bf-4793-a5de-c85c347b4097,"CCGA-42-2591. SPECIMEN. A. Right tube and ovary. B. Left tube and ovary. C. Uterus and cervix. D. Omentum. E. Omental lymph node. F. Right gutter peritoneal biopsy. G. Paraaortic lymph node. H. Right pelvic lymph node. I. Left pelvic lymph node. CLINICAL NOTES. PRE-OP DIAGNOSIS: Ovarian cancer. FROZEN SECTION DIAGNOSIS. A). Right fallopian tube and ovary, excision - Serous carcinoma. B) Left fallopian tube and ovary, excision - Serous carcinoma. GROSS DESCRIPTION. A. Received fresh for frozen section labeled ""right tube. and ovary"" is a 441 gram (post incision and fixation),. 18.5. x 13.5 x 9.7 cm. bosselated white pink to tan yellow cystic. structure with an associated, fimbriated, 7.5 cm. pink purple. fallopian tube along one aspect. The tube ranges from 0.3 to 0.7. cm. in diameter with a pinpoint stellate lumen on sectioning. On. opening, the specimen is multiloculated containing grumous brown. fluid and friable yellow white debris. Multiple soft to slightly. rubbery tan white papillations are present throughout the locules. which measure up to 14 cm. in greatest dimension. There is also a. moderate solid component to the specimen (constituting. approximately. 40% of the overall volume), which is glistening to chalky tan. white. Two frozen sections are performed (see frozen section diagnosis) . A. portion of the specimen is submitted for tissue procurement as. GROSS DESCRIPTION. requested. Residual ovarian stroma is not identified. Representative. sections are submitted in 18 blocks (fallopian tube represented in. block 1) RS18. B. Received fresh for frozen section labeled ""left tube. and ovary"" is an 1188 (status post partial incision and. fixation), 17.5 x 15.5 X 7.9 cm. bosselated dusky tan pink to tan. white-purple cystic mass with an associated, fimbriated, 4.5 cm. pink purple fallopian tube averaging 0. cm. in diameter along one. aspect. The specimen consists predominantly of glistening to chalky. tan white-yellow red solid tumor with a few cystic locules. containing yellow serous fluid. Two frozen sections are performed. (see frozen section diagnosis). Soft tan pink papillations are. evident within the larger locules. No residual ovarian stroma is. identified. Representative sections are submitted in 17 blocks. (fallopian tube represented in block 1) RS17. C. Received fresh labeled ""uterus and cervix"" is a 93. gram, 6.5 cm. (superior to inferior) by 5.0 cm. (cornu to. cornu) by 4.0 cm. (anterior to posterior) symmetrical uterine. corpus. with attached 3 cm. cervix. The serosa is smooth to slightly. scabrous tan pink-red with a few tan red fibrous adhesions along. the. posterior aspect. The circular 2.7 cm. tan white ectocervix. surrounds a 1. X 0.3 cm. ovoid patent os. Endocervical mucosa is. moderately trabecular pale tan. The triangular, 3. x 2.5 uterine. cavity is lined by flat pale tan pink endometrium averaging 0.2 cm. The myometrium is smooth pale tan pink and measures up to 2.4 cm. in. thickness. No leiomyomata are present. Representative sections are. submitted in 5 blocks as labeled. RS5. BLOCK SUMMARY: 1 - Serosa; 2 - anterior cervix; 3 - posterior. cervix; 4 - anterior endomyometrium; 5 - posterior endomyometrium. D. Received fresh labeled ""omentum"" is a 41.0 X 8.5 X 1.0. cm. portion of soft, lobulated golden yellow adipose. tissue in keeping with omentum. No discrete mass lesion or. GROSS DESCRIPTION. abnormality is identified. Random representative sections are. submitted in 10 blocks. E. Received fresh labeled ""omental lymph node"" is an. irregular, 7.6 X 3.5 x 1.0 cm. portion of soft, lobulated. golden yellow adipose tissue with a slightly eccentric, 2.0 X 1.4. X. 0.7 cm. rubbery tan white nodule (see blocks 1 and 2) Lymphoid. tissue is not present. The specimen is entirely submitted in five. blocks. F. Received fresh labeled ""right gutter peritoneal. biopsy"". is a focally cauterized, 3.1 X 2.3 X 0.2 cm. fragment of. soft tan pink-red membranous tissue which is sectioned and entirely. submitted in two blocks. G. Received fresh labeled ""paraaortic lymph node"" is a. 4.5. X 2.6 X 0.9 cm. portion of soft, lobulated golden yellow. adipose tissue. Six soft tan red tissues in keeping with lymph. nodes. measuring up to 3.5 cm. in greatest dimension are recovered. The. lymphoid tissues are entirely submitted in four blocks as labeled. BLOCK SUMMARY: 1 - Three whole nodes; 2 and 3 - one bisected node. per cassette; 4 - sectioned largest node. H. Received fresh labeled ""right pelvic lymph node"" is. a. 4.9 x 4.5 X 1.9 cm. aggregate of soft, lobulated golden. yellow adipose tissue. Eight soft tan red tissues in keeping with. lymph nodes measuring up to 1.3 cm. in greatest dimension are. recovered. The lymphoid tissues are entirely submitted in four. blocks as labeled. BLOCK SUMMARY: 1 and 2 - Three whole lymph nodes per cassette; 4. and. 5 - one bisected lymph node per cassette. I. Received fresh labeled ""left pelvic node"" is a 6.2 x. GROSS DESCRIPTION. 5.6 X 2.0 cm. aggregate of soft, lobulated golden yellow. adipose tissue. Several intact to fragmented tan pink-red tissues. in. keeping with lymph nodes measuring up to 3.9 cm. in greatest. dimension are recovered. The 1 yyphoid tissues are entirely. submitted. in 6 blocks as labeled. BLOCK SUMMARY: 1 - Seven whole nodes; 2 - five whole nodes; 3 - one. bisected node; 4 - one trisected node; 5 and 6 - largest,. fragmented. MICROSCOPIC DESCRIPTION. Histologic type: Serous carcinoma with a prominent micropapillary. pattern. Primary tumor (pT) TNM (FIGO) : Tumor is present in both ovaries. and. metastatic into regional lymph nodes, PT3C. Sites of tumor beyond ovary in pelvis: Omental lymph node. Regional lymph nodes. Distant metastasis. 14x2, 15x2, 3x5, 4x4. DIAGNOSIS. A. Fallopian tube and ovary, right salpingo-oophorectomy - 18.5. cm. ovary, extensively replaced by a serous carcinoma with a prominent. micropapillary pattern. Tumor is present on the surface of the ovary. Fallopian tube, negative for tumor. B. Fallopian tube and ovary, left salpingo-oophorectomy - 17.5 cm. ovary extensively replaced by a serous carcinoma with a prominent. DIAGNOSIS. micropapillary pattern. Tumor is present on the surface of the ovary. Fallopian tube negative for tumor. C. Uterus and cervix, hysterectomy - Atrophic endometrium. Myometrium with no significant histopathologic abnormality. Cervix with acute and chronic inflammation and reactive. changes. D. Omentum, excision - Three lymph nodes negative for metastatic. carcinoma (0/3). Adipose tissue with chronic inflammation and reactive. mesothelium. E. Soft tissue, omental lymph node, excision - Adipose tissue with. metastatic serous carcinoma and chronic inflammation. F. Soft tissue, right gutter peritoneum, biopsy - Metastatic. serous. carcinoma. G. Lymph nodes, para-aortic, excision - One of six lymph nodes. positive for metastatic adenocarcinoma (1/6). H. Lymph node, right pelvic, excision - Eight lymph nodes negative. for metastatic carcinoma (0/8). I. Lymph node, left pelvic, excision - One of fifteen lymph nodes. positive for metastatic carcinoma (1/15). DIAGNOSIS. micropapillary pattern. Tumor is present on the surface of the ovary. Fallopian tube negative for tumor. C. Uterus and cervix, hysterectomy - Atrophic endometrium. Myometrium with no significant histopathologic abnormality. Cervix with acute and chronic inflammation and reactive. changes. D. Omentum, excision - Three lymph nodes negative for metastatic. carcinoma (0/3). Adipose tissue with chronic inflammation and reactive. mesothelium. E. Soft tissue, omental lymph node, excision - Adipose tissue with. metastatic serous carcinoma and chronic inflammation. F. Soft tissue, right gutter peritoneum, biopsy - Metastatic. serous. carcinoma. G. Lymph nodes, para-aortic, excision - One of six lymph nodes. positive for metastatic adenocarcinoma (1/6). H. Lymph node, right pelvic, excision - Eight lymph nodes negative. for metastatic carcinoma (0/8). I. Lymph node, left pelvic, excision - One of fifteen lymph nodes. positive for metastatic carcinoma (1/15) .","Serous carcinoma with a prominent micropapillary pattern, extensively replacing both ovaries, with tumor present on the surface of the ovaries. Fallopian tubes are negative for tumor. The uterus and cervix show atrophic endometrium, myometrium with no significant histopathologic abnormality, and cervix with acute and chronic inflammation and reactive changes. Omentum contains adipose tissue with chronic inflammation and reactive mesothelium, and three lymph nodes are negative for metastatic carcinoma. However, the omental lymph node, right gutter peritoneum, para-aortic lymph nodes, and left pelvic lymph nodes show metastatic serous carcinoma. The tumor exhibits lymphovascular space invasion and is present in regional lymph nodes. No residual ovarian stroma is identified. The omentum is involved by the tumor, and there is chronic inflammation and reactive mesothelium in the adipose tissue. The lymph nodes show metastatic adenocarcinoma, with some nodes negative for metastatic carcinoma. The tumor has a micropapillary pattern and is present on the surface of the ovary, with metastasis to regional lymph nodes."
TCGA-NJ-A7XG.8EFDF414-12F3-4DF8-BB21-9E8876B727E8,"Clinical Data Repository This report may not match the original report. format. REPORT DATE: FINAL DIAGNOSIS. A. (Level 4R lymph node; excision): One lymph node, negative for carcinoma. B. (AP window node level 5; excision): One lymph node, negative for carcinoma. C. (Level 6 lymph node; excision): One lymph node, negative for carcinoma. D. (Left lung; pneumonectomy): Invasive moderately differentiated adenocarcinoma, present in the upper lobe. and measuring 10 cm, with extensive lymphovascular invasion, extending into. the parietal pleura. Multiple tumor nodules are identified in the left lower lobe. Metastatic carcinoma in 10 of 21 peribronchial lymph nodes. Margins of resection are free. Stage: pT4N1. See note. Attending Pathologist: Resident: INTRAOPERATIVE CONSULTATION. A. FROZEN:LEVEL 4R LYMPH NODE: Negative for malignancy. (A91, tp, smear). Intraoperative consultation pathologist. Intraoperative consultation resident. D. LEFT LUNG. FROZEN ON MARGIN: Negative for malignancy. (D91). Intraoperative consultation pathologist. Intraoperative consultation resident. NOTE. An elastic stain has been evaluated; findings support the above diagnosis. Lung Cancer Summary. Specimen type: Left lung. Procedure: Pneumectomy. Specimen integrity: Intact. Tumor location: Left upper lobe. Tumor focality: Multifocal; separate tumor nodules in different lobes. Tumor size: 10 x 4 x 2.5 cm (gross measurement). Histologic type: Adenocarcinoma. Histologic grade: Grade 2. Treatment effect: Not applicable. Status of margins: Bronchial: Negative. Vascular: Negative. Parenchymal: Not applicable. Pleural: Tumor infiltrates into parietal pleura. Visceral/Parietal pleural invasion: Present. Lymphatic vascular invasion: Present. Lymph node status: Positive (Peribronchial). Extension into other structures: Absent. Non-neoplastic pathology: Absent. TMN stage: pT4N1. GROSS DESCRIPTION. A. The specimen is labeled level 4R lymph node. Received fresh for frozen. section is a piece of soft, black tissue (0.5 x 0.2 x 0.2 cm). Touch preps. and smear are obtained and the specimen is submitted entirely for frozen. section with the remnant placed in cassette A91. B. The specimen is labeled AP window node level V. Received without fixative. is a 1.6 x 1.0 x 0.5 cm anthracotic lymph node. The entire specimen is. submitted in cassette B1. C. The specimen is labeled level VI lymph node. Received without fixative is a. 1.3 x 1.1 x 0.6 cm anthracotic lymph node. The specimen is bisected and. entirely submitted in cassette C1. D. The specimen is labeled left lung. Received fresh for frozen analysis is a. 16 x 14 x 12 cm left lung. The pleural surface shows two areas of adhesions. in the left upper lobe. The first area measures 7 X 7 cm and has attached. fibroadipose tissue, is more lateral and posterior. The second adhesion area. measures 7 X 2 cm and is located anteriorly; both areas are inked blue and the. specimen is serially sectioned to reveal in the left upper lobe a 10 x 4 x. 2.5 cm white-tan mass with areas of necrosis. The mass appears to invade. through the pleura in both areas of adhesions. The mass is also present 1 cm. from the bronchial margin and 1 cm from the vascular margins. There is only a. rim of unremarkable lung tissue in the left upper lobe. The left lower lobe. shows multiple nodules, in a miliary pattern, throughout the lung, ranging in. size from 2 to 8 mm; those nodules are confluent the superior portion of the. left lower lobe. No normal lung tissue is identified in this lobe. The hilar. area shows multiple lymph nodes, ranging in size from 2 to 0.5 cm. The mass. does not appear to cross the fissure. The bronchial margin is submitted for. frozen analysis with the remnants placed in cassette D91. The remainder of. the specimen is submitted as follows: D1 bronchial vascular margin, D2. multiple lymph nodes, D3 one lymph node serially sectioned, D4 one lymph. node bisected, D5 one lymph node bisected, D6 one intact lymph node, D7. one lymph node bisected, D8 and D9 mass and underlying large pleural adhesion. area, D10 mass and underlying small pleural adhesion area, D11 mass and. adjacent pulmonary artery, D12 - mass, D13 and D14 small nodules from the. left lower lobe, D15 confluent nodules from the left lower lobe, D16 left. upper lobe and left lower lobe juction, D17 unremarkable lung from the left. lower lobe, D18 multiple lymph nodes, D19 one lymph node bisected. SPECIMEN(S) RECEIVED. A: FROZEN:LEVEL 4R LYMPH NODE. B: AP WINDOW NODE LEVEL 5. C: LEVEL 6 LYMPH NODE. D: LEFT LUNG. FROZEN ON MARGIN. The above listed tests (if any) were developed and the performance. characteristics determined by. These tests have. not been cleared or approved for commercial use by the U.S. Food and Drug. Administration. The FDA has determined that FDA review is not required for. such in-house assays. (21 CFR 809.30(e)). OPERATIVE INFORMATION. DIAGNOSIS: LUNG CA; PROCEDURE: BRONCHOSCOPY AND MEDIASTINOSCOPY,. THORACOSCOPY. VIDEO ASSISTED. ICD-9(s): 162.3. CPT(s): A; 88305, 88331, 88333, 88334. B; 88305. C; 88305. D; 88309, 88331, 88313. The attending pathologist was physically present when this specimen was. diagnosed, and actively participated in all key decisions.","Invasive moderately differentiated adenocarcinoma present in the upper lobe with extensive lymphovascular invasion, extending into the parietal pleura. Multiple tumor nodules are identified in the left lower lobe. Metastatic carcinoma in peribronchial lymph nodes. Tumor infiltrates into parietal pleura with visceral/parietal pleural invasion and lymphatic vascular invasion present. Bronchial and vascular margins are negative for tumor. Non-neoplastic pathology is absent. Adenocarcinoma is of grade 2 with areas of necrosis. Tumor appears to invade through the pleura. Multiple lymph nodes show metastatic carcinoma."
TCGA-HN-A2NL.CC1EE9E0-BC1A-46ED-A262-7A2B9CC8BBB1,"Sample Preparation. Fresh Frozen. Site of Primary (Event). Site of Tissue. Breast. Year of Sample Collection. Age at Sample Collection (yrs). 56. Sample Comments. Days to Procedure Date. 0. Days to Diagnosis. 7. Type of Procedure. Surgical resection. Site of Primary (Histology). Left breast. Bilateral Disease. Tumour Size (cm). 3.5. Histology. Other. Grade/Differentiation. Grade III (high - poorly differentiated). Pathological T. T2. Pathological N. NO,NOS. Number of Nodes Sampled. 3. Number of Nodes Positive. 0. Clinical M. M0. Histology Comments. Inflitrating mammary carcinoma with lobular features No In Situ. component. SBR (Scarff-Bloom-Richardson) score. 9. ER Status. Negative. PR Status. Negative. HER2 Status. Negative. Lymph Node Metastases. None Documented.","Infiltrating mammary carcinoma with lobular features and no in situ component, displaying high-grade, poorly differentiated morphology. The tumor is composed of cells with notable nuclear pleomorphism and prominent nucleoli, indicative of a Scarff-Bloom-Richardson score of 9. No lymph node metastases are identified, with three nodes sampled and none positive. The tumor exhibits negative estrogen receptor, progesterone receptor, and HER2 status."
TCGA-CV-5432.95f38809-ba7a-43f1-a074-6fdbcf72d1ee,"DIAGNOSIS. LOWER JUGULAR LYMPH NODE: Lymph node, no tumor. TOTAL LARYNGECTOMY, PARTIAL PHARYNGECTOMY, AND BILATERAL NECK DISSECTION. WITH SUBTOTAL THYROIDECTOMY: SQUAMOUS CARCINOMA GRADE 3 INVOLVING LEFT VOCAL CORD, LEFT VENTRICLE,. AND LEFT SUPRAGLOTTIC AREA (THICKNESS OF THE TUMOR 2.0 CM) . Margins of resection free of tumor. Nodular goiter right thyroid. Twenty-five right cervical nodes. Thirty-nine left cervical lymph nodes, no tumor. Specimen designated ""B1 to B13"", mucosal margins of resection free. of tumor. GROSS DESCRIPTION. (A) LOWER JUGULAR LYMPH NODE - Two tan lymph nodes (the largest of which. measures up to 0.6 cm in greatest dimension). SECTION CODE: A, two lymph nodes. (B) TOTAL LARYNGECTOMY, PARTIAL PHARYNGECTOMY AND BILATERAL NECK DISSECTION. WITH SUBTOTAL THYROIDECTOMY - A total laryngectomy with bilateral neck. dissection with overall measurements of 15.0 x 15.0 x 5.5 cm. The laryngeal. component is measuring 9.0 X 6.0 x 3.5 cm. On the left supraglottic area there. is a fungating ulcerated and soft mass measuring 3.5 x 3.5 x 2.0 cm. The tumor. involves the left vocal cord and supraglottic area with impingement on the. midline without involvement of the right glottic area. Tumor extends 2.5 cm in. the supraglottic region. No gross involvement of the soft tissue is identified. and the mucosa surrounding the tumor appears unremarkable. There is an. additional nodule in the left pyriform sinus. There is no connection between. this nodule and the main tumor. The nodule is light-tan, slightly raised and. measuring 1.5 cm x 1.0 x 0.4 cm. SECTION CODE: The specimen is submitted as follows: Mucosal margins for. frozen section as follows: B, posterior cricoid; B2, inferior left pyriform. margin; B3, inferior lateral left pyriform; B4, left ateral pyriform margin;. B5, left superolateral pyriform; B6, left superior pyriform; B7 left lateral. mollecula; B8, midline and right mollecula; B9, right mollecula; B10, right. superior pyriform; B11, right lateral pyriform; B12, right inferior pyriform;. B13, right post cricoid. The tumor is submitted entirely from right to left. and the block code is B14, right transglottic; B15, right supraglottic mucosa;. B16-B31, sequential sections from midline to the left pyriform sinus tumor and. necrosis; B32, B33, from the small nodule in the left pyriform sinus; B34,. right thyroid lobe with a small nodule; B35, section of the left colloid. nodule; B36 five superior right neck lymph nodes; B37, 3 possible right. superior neck lymph nodes; B38, 4 superior right lymph nodes; B39, true right. inferior lymph node; B40-B41, 1 right inferior lymph node; B42, 3 right. inferior lymph nodes; B43, 4 right inferior Tymph nodes; B44, 2 right inferior. lymph nodes; B45, 2 left superior lymph nodes; B46, B47, 1 left superior lymph. node; B48, 3 left superior Tymph nodes; B49, 6 left superior lymph nodes; B50,. 4 left inferior lymph noes; B51, 4 left inferior lymph nodes; B52, 4 left. inferior lymph nodes; B53, 4 left inferior lymph nodes: B54, 3 left inferior. Tymph nodes; B55, 3 left inferior Tymph nodes. FS/DX: SQUAMOUS MUCOSA WITH UNDERLYING FIBROADIPOSE TISSUE AND. FIBROMUSCULAR TISSUE, NO EVIDENCE OF MALIGNANCY. SNOMED CODES. M-80703 T-24455.","Squamous carcinoma grade 3 involving left vocal cord, left ventricle, and left supraglottic area. Tumor composed of cells with marked pleomorphism and hyperchromasia. Margins of resection free of tumor. No tumor identified in twenty-five right cervical nodes and thirty-nine left cervical lymph nodes. Nodular goiter right thyroid. Mucosal margins of resection free of tumor. Tumor involves the left vocal cord and supraglottic area with impingement on the midline without involvement of the right glottic area. Additional nodule in the left pyriform sinus, light-tan, slightly raised, and separate from the main tumor. No gross involvement of the soft tissue identified and the mucosa surrounding the tumor appears unremarkable."
TCGA-49-4494.178a8648-f3cd-46ae-b90a-a45d6715c889,"FINAL DIAGNOSIS. 1. R10 LYMPH NODE (RESECTION) : ONE (1) DIMPH NODE, TOK. TUMOR. LUNG, LEFT UPPER LOBE (LOBECTOMY) : MODERATELY-DIFFERENTIATED. MUCINOUS ADENOCARCINOMA OF THE LUNG (2.5 CM) WITH FOCI OF NECROSIS. TUMOR EXTENDS TO THE PLEURA. BRONCHIAL AND VASCULAR MARGINS ARE. NEGATIVE FOR TUMOR. TWO (2) OF FOUR (4) REGIONAL LYMPH NODES ARE. ?OSITIVE FOR METASTATIC CARCINOMA. UNINVOLVED LUNG SHOWS HEMORRHAGE. EXTENSIVE REMOLDING, SUBPLEURAL SCARRING AND ACUTE AND CHRONIC. INFLAMMATION. 3. LYMPH NODE, AP WINDOW (RESECTION) : ONE (1) LYMPH NODE POSITIVE. FOR METASTATIC ADENOCARCINOMA.","Mucinous adenocarcinoma of the lung with foci of necrosis, tumor extends to the pleura, bronchial and vascular margins are negative for tumor, regional lymph nodes are positive for metastatic carcinoma, uninvolved lung shows hemorrhage, extensive remolding, subpleural scarring and acute and chronic inflammation, lymph nodes are positive for metastatic adenocarcinoma."
TCGA-86-A456.56606792-5083-4F1E-ABEF-711BACF546E6,"Laterality: Tumor is composed of papillary glands, with elongated finger-. like processes lined by moderrately straitified cylindrical or cuboidal cells supported by fibrovascular. connective tissue cores arranging back to back. Nuclei are irregular large, hyperchromatic with. prominent nucleioli. Mitoses are present. Tumor invades in alveolar. The stroma is infiltration of. inflammatory cells. Path Report:LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 1.5x2x2cm. Histologic type: Papillary adenocarcinoma. Histologic grade: Well differentiated. Tumor extent: Visceral pleura. Other tumor nodules: Not specified. Lymph nodes: 0/1 positive for metastasis (Mediastinal lymph node 0/1). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Tumor invades in alveolar. Comments: Left-upper.","Papillary adenocarcinoma composed of papillary glands with elongated finger-like processes lined by moderately stratified cylindrical or cuboidal cells supported by fibrovascular connective tissue cores, arranging back to back. Nuclei are irregular, large, hyperchromatic with prominent nucleoli. Mitoses are present. Tumor invades in an alveolar pattern. The stroma shows infiltration of inflammatory cells. Tumor invades the visceral pleura. No lymphatic or venous invasion specified. No metastasis in the mediastinal lymph node. Tumor margins not specified."
TCGA-VQ-A91Z.07DCD268-1A4A-4B54-82C5-031A6E5E882D,"PRIMARY SITE: Stomach (Antrum). ""Stomach: Adenocarcinoma with the following features: Site: antrum. Histologic pattern: Tubular. Histologic grade II, moderately differentiated. Lauren classification: intestinal type. Largest tumor size: 5.0 cm. Ulceration: present. Local invasion: To adjacent fat tissue. Tumor invasion type. Infiltrative. Inflammatory response. Moderate. Tumor implant in perivisceral fat. Not observed. Proximal margin. Uninvolved by neoplasia. Distal margin. Uninvolved by neoplasia. Neural invasion. Uninvolved by neoplasia. Lymphatic invasion. Present. Blood vessel invasion. Not observed. Greater omentum. Uninvolved by neoplasia. Lymph nodes: Involved by neoplasia: 2 of 19 lymph nodes (2/19). Distribution of lymph nodes: - Greater curvature: 2 of 8 lymph nodes involved by neoplasia (2/8). - Lesser curvature: uninvolved by neoplasia (0/11).","Adenocarcinoma of the stomach with a tubular histologic pattern, moderately differentiated, and intestinal type according to Lauren classification. Tumor shows ulceration and infiltrative invasion into adjacent fat tissue with moderate inflammatory response. Lymphatic invasion is present, but neural invasion and blood vessel invasion are not observed. The greater omentum is uninvolved by neoplasia. Lymph nodes are involved by neoplasia, with involvement noted along the greater curvature. Proximal and distal margins are uninvolved by neoplasia."
TCGA-AA-3502.dd52c1f9-7093-45b8-9c5a-2dedb13e766f,"Diagnosis / Diagnoses: Resected cross-section of the colon with tumor-free resection margins, under inclusion of. a tubular adenoma with mild dysplasia (synonym: low-grade intra-epithelial neoplasia). and a tubulovillous adenoma with focal severe dysplasia (synonym: high-grade intra-. epithelial neoplasia) and with a well to moderately differentiated colorectal. adenocarcinoma (G1 to 2) with infiltration of the lamina muscularis propria and without. regional lymph node metastases (pT2 pNO 0/31) on the base of a further tubulovillous. adenoma with severe dysplasia. Final preliminary results.",Tubular adenoma with mild dysplasia and a tubulovillous adenoma with focal severe dysplasia. Well to moderately differentiated colorectal adenocarcinoma with infiltration of the lamina muscularis propria. No regional lymph node metastases. Tumor-free resection margins. Adenocarcinoma arises from a tubulovillous adenoma with severe dysplasia.
TCGA-BH-A1ET.E66D3DF8-1605-4EFD-AAFA-74F82366FD16,"Procedure Date. Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE of LMP: DATE or LAST DELIVERY: PRE-OP DIAGNOSIS: CANCER LEFT BREAST. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: LEFT SEGMENTAL MAST, LEFT AXILLARY DISS. CLINICAL HISTORY: MATERIAL SUBMITTED: A) LEFT,BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. B) LEFT AXILLARY LYMPH NODE(S PROCUREMENT BY SURGICAL PROCEDURE. ADDENDA: Addendum. MACROSCOPIC DESCRIPTION: Block ""A2"" for ER/PR and HER-2/neu. TINAL DIAGNOSIS: ER/PR RESULTS. IMMUNOPEROKIDASE IDENTIFICATION OF ESTROGEN AND PROCESTERONS RECEPTORS IS CARRIED OUT ON SLIDE ""A2"". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGEN RECEPTOR (95%) AND PROGESTERONE RECEPTOR (80%). THEREFORE, BOTH ARE INTERPRETED AS POSITIVE. HER-2/NBU RESULTS. AS. PER. THE. REQUEST or DR. BAFFONI, c-erb82 (HER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON PREVIOUS MAGEE. BLOCK ""A2"" (BREAST CANCER) USING A 1:300 DILUTION or DARO'S POLYCLONAL ANTIBODY A485. (DIRECTED AGAINST THE INTRACELLULAR DOMAIN or c-erb82) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT CONPLETE. MEDERANE STAINING IS IDENTIFIED. THEREFORE, c-erba2 (HER-2/NEU) IS INTERFRETED AS NEGATIVE (SCORE. 0). FINAL DIAGNOSIS: FINAL DIAGNOSIS: A) LEFT BREAST, SEGMENTAL MASTECTOMY: - INFILTRATING MODERATELY DIFFERENTIATED DUCT CARCINOMA WITH TOCAL LOBUT.AR FEATURES. 2.0 CM. (AS MEASURED ON. GLASS SLIDE), POOR ARCHITECTURAL GRADE, INTERMEDIATED NUCLEAR GRADE (NOTTINGHAN SCORE=6, TUBULES=3, MITOTIC. RATE=1, NUCLEAR PLEOMORPHISM=2) (SEE NOTE) (CROSS REFER. - FIBROCYSTIC CHANGES WITH ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA. - PAPILLOMATOSIS WITH ASSOCIATED MICROCALCIFICATIONS. - MARGINS OF RESECTION ARE FREE OF TUMOR. B) LEFT AXILLARY CONTENTS: - ONE OF NINETEEN (1/19) LYMPK NODES POSITIVE FOR METASTATIC CARCINOMA. NOTE: ER/PR immunoperoxidase assay and Her-2/NEU testing will be performed on block ""A2"".","Infiltrating moderately differentiated duct carcinoma with focal lobular features, poor architectural grade, intermediate nuclear grade, with tubular formation, mitotic activity, and nuclear pleomorphism. Tumor cells have distinct nuclear features. No necrosis identified. Margins of resection are free of tumor. One of nineteen lymph nodes positive for metastatic carcinoma, with tumor cells identified within the lymph node. Non-neoplastic findings include fibrocystic changes with atypical ductal epithelial hyperplasia and papillomatosis with associated microcalcifications."
TCGA-BH-A0DZ.16DE55CE-076E-43D3-84BD-332A79B95EFD,"P.22/33. BIAGNOSIS: AREAST. LEFT. BOTAL MASTECTOMY -. COBULAR NEOPLASIA (ATYPICAL LOBULAR HYPERPLASIA) (sec comment). B. FIBROADENOMÃ€, DUCTAL EPITHELIAL HYPERPLASIA, FIBROCYSTIC CHANGE. C. SKIN AND NIPPLE, NO TUMOR SEEN. PART 2: BREAST, RIGHT, TOTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA, NOS TYPE, MODERATELY DIFFERENTIATED. 8. THE TUMOR IS MULTIFOCAL, MULTICENTRIC, LOCATED AT THE JUNCTION OF UPPER OUTER QUADRANT. (UOQ) AND UPPER INNER QUADRANT (UIO) AS WELL AS IN THE UPPER OUTER QUADRANT (UOO). c. THE TUMOR NODULES MEASURE 2.5 CM (GROSS MEASUREMENT) AND 0.5 CM (MICROSCOPIC. MEASUREMENT) RESPECTIVELY. D. NOTTINGHAM SCORE 6/9 (TUBULES 2. NUCLEAR GRADE 2, MITOSIS 2),OVERALL GRADE 2/3. E. NO DEFINITIVE LYMPHOVASCULAR INVASION IS IDENTIFIED. F. DUCTAL CARCINOMA IN 8ITU, SOLID TYPE WITH COMEDO NECROSIS, NUCLEAR GRADE 3 WITH. LOBULAR EXTENSION, COMPRISING 25% OF THE TOTAL TUMOR VOLUME AND IS PRESENT IN. ASSOCIATION AND AWAY FROM THE INVASIVE CARCINOMA. G. MARGIN3: DEEP AND ANTERIOR MARGISN OF RESECTION ARE FREE OF INVASIVE AS WELL AS IN SITU. CARCINOMA, CLOSEST ANTERIOR MARGIN IS 7MM AWAY. K. ATYPICAL DUCTAL HYPERPLASIA. PREVIOUS BIOPSY SITE CHANGES (I/1 AND #2), ( 3EC COMMENT-2). I. FIBROADENOMA, PSEUDOANGIOMATOUS STROMAL HYPERFLASIA (PASH), COLUMNAR CELL CHANGE. J. SKIN AND NIPPLE, NO TUMOR SEEN. K. ER-POSITIVE, PR-POSITIVE. MER 2/NEU -STRONGLY POSITIVE (IHC 3+ AS WELL AS FISH-AMPLIFICATION),. CROSS REFER. PART 3: #1 SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY-. ONE LYMPH NODE WITH METASTATIC CARCINOMA, THE METASTATIC FOCUS MEASURES 6MM (ON GLASS. SLIDE) FOCAL EXTRACAPSULAR EXTENSION IS IDENTIFIED (1/1). PART 4: #2 SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY. ONE BENIGN LYMPH NODE, NO TUMOR SEEN (0/1). PART 5: #3 SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY -. ONE BENIGN LYMPM NOPE, NO TUMOR SEEN (0/1). PART 6: #4 SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY -. ONE BENIGN LYMPH NODE, NO TUMOR SEEN (0/1). PART 7: NON-SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY-. ONE BENIGN LYMPH NODE, NO TUMOR SEEN (0/1). LATERALITY: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. PROCEDURE: Right. Simple mastactoiny. Upper outer quacrant. SIZE OF TUMOR: Upper inner quadrant. MULTICENTRICTYMOUTIFOCAUTY OF Maximum INVASIVE dimension FOCI: Invasivo component: , 5 on. TUMOR AGGREGATE SIZE: TUMOR TYPE (invasivo component): Sum of the sizes of multiple invasive tumors: 3.0 cm. NOTTINGHAM SCORE: Ductal adenocamino, NOS. Nuclear grade: 2. Tubule formation 2. Milorie activily 2. total Nottingham score: G. ANO|OLYMPHATIC INVASION: No Nottingham grade (1. 2, 3): 2. DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Yes, malignant zonea. Solid. Comedo. SURGICAL MARGINS INVOLVED By INVASIVE of COMPONENT: tumor occupied by In situ component: 25 %. Percent DCIS admixed und outsino of Invasivo carcinoma component. SURG MARGINS INVOLVED BY IN SITU No COMPONENT: PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: LYMPH NODES EXAMINED: 1. METHOD(S) OF LYMPH NODE EXAMINATION: 4. Discrepancy. SENTINEL NODE METASTASIS: H/E stain. ONLY KERATIN POSITIVE CELLS ARE Yes PRESENT: initials Mittory. CUALI,. SIZE OF NODAL METASTASES: LYMPH NODE META8TASIS(-ES) WITH Diameter EXTRACAPSULAR of targest lymph EXTENSION: node motestasis: 8 mm. METASTASES TO IPSILATERAL INTERNAL No Yes MAMMARY LYMPH NODE (IF APPLICABLE): T STAGE, PATHOLOCIC. SKIN INVOLVED (ULCERATION): N STAGE, PATHOLOGIC-. p12. M STAGE, PATHOLOGIC: pN1. ESTROGEN RECEPTORS. pMX. poritive. PROGESTERONE RECEPTORS: HER2/NEU: positive. 3+.","Infiltrating ductal carcinoma, moderately differentiated, with a multifocal and multicentric growth pattern, located at the junction of upper outer and upper inner quadrants. The tumor exhibits a Nottingham score of 6/9, with tubule formation score 2, nuclear grade 2, and mitotic activity score 2, resulting in an overall grade of 2/3. Ductal carcinoma in situ, solid type with comedo necrosis, is present with nuclear grade 3 and lobular extension, comprising 25% of the total tumor volume. No definitive lymphovascular invasion is identified. The deep and anterior margins of resection are free of invasive and in situ carcinoma. Atypical ductal hyperplasia and fibroadenoma are also present. Sentinel lymph node biopsy shows metastatic carcinoma with focal extracapsular extension. Non-sentinel lymph nodes are benign with no tumor seen."
TCGA-D5-6530.5a7b76ed-d0d1-45a6-814c-3dffb6f4b717,"page 1 / 1. Examination: Histopathological examination. Material: 1. Multiple organ resection - cancer of the caecum - right half of the colon with the distal. part of the ileum. Expected time of examination: Clinical diagnosis: Cancer of the caecum - right half of the colon with the distal part of the ileum. Macroscopic description: 30 cm length of the large intestine with a fragment of the mesentery sized 17 x 19 x 5 cm, a 9 cm. segment of the small intestine, and the appendix of 6 cm in length. Cauliflower-shaped, ulcerous. tumour in the mucosa sized 4.5 x 4 x 1 cm. The lesion surrounds 100% of the intestine. circumference and narrows its lumen, is situated 12 cm from the proximal cut line and 20 cm from. the distal cut line. The lesion macroscopically invades through the periintestinal tissue, Minimum. side margin is 4 cm. Microscopic description: Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa tunicae muscularis priopriae. Intestine ends free of neoplastic lesions. Lymphonodulitis reactiva No XV. Examination result: Adenocarcinoma tubulare coli. Tubularadenocarcinoma of the colon y. (G2, Dukes A, Astler - Coller B1, pT2, pNO). Histopathological diagnosis: Adenocarcinoma mucocellulare partim tubulare et mucinosum invasivum ventriculi. Mucocellular and. partially tubular and mucinous invasive adenocarcinoma of the stomach. Metastases carcinomatosae in lymphonodorum (No XVII/XX). Cancer metastases of the lymph nodes (No. XVII/XX). pN3).","Adenocarcinoma tubulare with infiltratio carcinomatosa tunicae muscularis propriae. Intestine ends free of neoplastic lesions. Lymphonodulitis reactiva. Adenocarcinoma tubulare coli, tubular adenocarcinoma of the colon, with lymphovascular space invasion not identified. Tumor confined to the intestinal wall with no extension into pericolonic fat. No tumor involvement at the inked surgical margin. Non-neoplastic intestine shows no significant findings. Lymph nodes show reactive lymphonodulitis and metastases carcinomatosae in some lymph nodes."
TCGA-CN-6012.d754c784-4d68-4d19-9ef8-000fb4575201,"PATIENT HISTORY: CHIEF OMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Lesion of vocal cord/throat. dysphagia. PROCEDURE: Direct laryngoscopy, esophagoscopy. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMO RADIATION: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. FINAL DIAGNOSIS: LARYNX, RIGHT, BIOPSY. INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED, WITH FOCAL. ANGIOLYMPHATIC INVASION. My signature is attestation that I have personally reviewed the submitted. material(s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is submitted in buffered formalin identified as ""right larynx. biopsy"" and is labeled with the patient's name and initials XXX. Fragment (s): Aggregate tissue. Size (s): 3.0 X 1.5 x 0.3 cm aggregate. Cassette (s): A and B (totally submitted). MICROSCOPIC: Microscopic examination substantiates the above diagnosis. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics determined by. the. Department of Pathology, as required by the CLIA. regulations. The testing has not been cleared or approved for the. specific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue fixation. ranges from a minimum of. a maximum of. hours. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of. (""CLIA"") as qualified to perform high-complexity clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Right Larynx Biopsy. Stain/cnt. Block. HHE x 1. A. H&E x 1. A. HHE x 1. B. H&E x 1. B.","Invasive squamous cell carcinoma, moderately differentiated, with focal angiolymphatic invasion. The tumor exhibits squamous cell morphology with evidence of invasion into vascular and lymphatic spaces. No other specific details on tumor architecture or cellular characteristics are provided. The specimen is from the right larynx biopsy, and the diagnosis is based on microscopic examination."
TCGA-AA-3530.76035d5d-d2bb-4616-a9a2-5794a6f1373d,"Diagnosis/Diagnoses: 1. Sections of a polypoid neoplasm of the colonic mucosa with the structure of a tubular. adenoma with high-grade dysplasia or transition to at least intramucosal adenocarcinoma in situ. (synonym according to WHO: high-grade intra-epithelial neoplasia, according to IUCC: pTis). 2.: Small, or only small portions of, tubular adenomas of the colonic mucosa with slight. dysplasia (synonym: low-grade intra-epithelial neoplasia). 3.: Tubular adenoma of the colonic mucosa with high-grade dysplasia and transition to an. intramucosal adenocarcinoma (synonym according to WHO: high-grade intra-epithelial. neoplasia, according to IUCC: pTis). In 1. and 3., no detectable transition to a manifest, deeper colon carcinoma infiltrating the wall. layers. Complete tumor resection - where not already done - is recommended. Diagnosis/Diagnoses. Right hemicolectomy specimen with an ulcerated colon carcinoma in the area of the cecal pole. measuring 4 cm in the largest diameter and displacing the appendiceal orifice, arising from a. tubulovillous adenoma with severe epithelial dysplasia (synonym: high-grade intra-epithelial. neoplasia). Invasive tumor spread as far as the muscularis propria. Appendix with formation of. an obstructive type of mucocele and with persistent or florid chronic appendicitis and. perityphlitis. Oral and aboral resection margin and greater omentum tumor-free. Twenty-four mesocolic and mesenteric lymph nodes tumor-free and with uncharacteristically. reactive changes. Tumor stage therefore pT2 pNO (0/24) L0 V0; G2.",Tubular adenoma of the colonic mucosa with high-grade dysplasia and transition to an intramucosal adenocarcinoma. Ulcerated colon carcinoma arising from a tubulovillous adenoma with severe epithelial dysplasia. Invasive tumor spread as far as the muscularis propria. No detectable transition to a deeper colon carcinoma infiltrating the wall layers in some areas. Oral and aboral resection margin and greater omentum tumor-free. Mesocolic and mesenteric lymph nodes tumor-free. Tumor composed of cells with severe dysplasia and architectural disorder. No lymphovascular invasion identified. No tumor involvement at the resection margins. Non-neoplastic colon mucosa shows persistent or florid chronic inflammation. Appendix with chronic appendicitis and perityphlitis.
TCGA-A8-A06Q.8FE77EF7-C83A-431F-B3BA-D93B5ECC70AF,"Diagnosis: Multifocal moderately differentiated invasive breast carcinoma (larger tumor: moderately differentiated invasive ductal carcinoma (tumor size: 5.3 cm) with focal. signet-ring cell differentiation and focal intraductal components; smaller tumor: moderately differentiated invasive ductal carcinoma (tumor size: 1.5 cm)). Foci of angioinvasion. Diagnosis: 1. Ablated (left) breast sample with further invasive tumor components in the. quadrant of the sample excision cavity and retromamillary (maximum surface spread: 0.8 cm). Dorsal resection margin tumor-free. Tumor classification: NOS, G II, pT3(mult)N2aL1V0R0. (compare E. no. xxxx).","Multifocal moderately differentiated invasive breast carcinoma with focal signet-ring cell differentiation and focal intraductal components. Foci of angioinvasion. Invasive ductal carcinoma with tumor components in the quadrant of the sample excision cavity and retromamillary area. Dorsal resection margin tumor-free. Tumor classification: moderately differentiated, grade II."
TCGA-DK-AA6P.2D499EC2-59F5-462D-A60C-BD19B4BE8E46,"F. Urology. Clinical Diagnosis & History: History of bladder cancer for TURBT. Specimens Submitted: 1: Right lateral wall tumor in. 2: Right lateral wall tumor. 3: Right lateral wall deep. DIAGNOSIS: 1. Right lateral wall tumor in. Tumor Type: Urothelial carcinoma with mixed histologic features, including: NoS and micropapillary types. Histologic Grade: High grade. Pattern of growth of the non-invasive component: Papillary and flat. Local Invasion: Muscularis propria. Vascular Invasion: Identified. 2. Right lateral wall tumor: Tumor Type: Urothelial carcinoma with mixed histologic features, including: NoS and micropapillary types. Histologic Grade: High grade. Pattern of growth of the non-invasive component: Papillary and flat. Local Invasion: Muscularis propria. Vascular Invasion: Identified. 3. Right lateral wall deep: Tumor Type: Invasive urothelial carcinoma, NOS. Histologic Grade: High grade. Pattern of growth of the non-invasive component: Papillary and flat. Local Invasion: Muscularis propria. Vascular Invasion: Identified. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received in. labeled ""right lateral wall tumor"", and consists of multiple pieces of tan soft. tissue. ranging from 0.2 to 1.0 cm. The specimen is entirely submitted one cassette(s). TPS taken. 2). The specimen is received in formalin, labeled ""right lateral wall tumor"", and consists of multiple pieces of tan soft tissue. ranging from 0.2 to 1.1 cm. The specimen is entirely submitted two cassette(s). 3). The specimen is received in formalin, labeled ""right lateral wall deep"", and consists of multiple pieces of tan soft tissue. ranging from 0.2 to 1.0 cm. The specimen is entirely submitted one cassette(s). Summary of Sections: Part 1: Right lateral wall tumor in. Blocks Block Designation. PCs. 1. {not entered}. 6. Part 2: Right lateral wall tumor. Blocks Block Designation. PCs. 2. {not entered}. 12. Part 3: Right lateral wall deep. Blocks Block Designation. PCs. 1. {not entered}. 6.","Urothelial carcinoma with mixed histologic features, including non-invasive and micropapillary types, high grade, with papillary and flat pattern of growth. Local invasion into muscularis propria identified. Vascular invasion present. Tumor cells exhibit mixed growth patterns. No necrosis identified. Muscularis propria invasion present. Vascular invasion identified. No lymph nodes examined. Non-neoplastic bladder mucosa not described."
TCGA-P3-A5QF.9F601C6A-9E16-4ADD-A5B9-3A82384602BB,"CLINICAL DATA: Per Mindscape: Oral cancer. GROSS DESCRIPTION: A) Received fresh for frozen section consultation labeled "" and. designated ""deep margin"" is a 1.2 x 0.7 x 0.3 cm tan-pink soft tissue fragment. The specimen is. entirely submitted for frozen section consultation and now is resubmitted as A1D1FS. B). Received fresh for frozen section consultation labeled "" and designated ""lateral margin"" is. a. 0.7 X 0.5 x 0.2 cm tan-pink mucosa soft tissue fragment. The specimen is inked blue and entirely. submitted for frozen section consultation, and is resubmitted as B1C1FS. C) Received fresh for. frozen section consultation labeled "" and designated ""anterior margin"" is a 0.9 x 0.5 x 0.2 cm. mucosa soft tissue fragment. The specimen is entirely submitted for frozen section consultation. and is resubmitted as B1C1FS. D) Received fresh for frozen section consultation labeled. and. designated ""posterior margin"" is a 0.4 x 0.8 x 0.5 cm tan-pink mucosa soft tissue fragment. The. specimen is inked blue and entirely submitted for frozen section consultation, and is resubmitted. as A1D1FS. E) Received fresh for frozen section consultation labeled "" and designated. ""medial margin"" is a 0.7 x 0.5 x 0.1 cm tan-pink mucosa soft tissue fragment. The specimen is. entirely submitted for frozen section consultation and is resubmitted as E1FS (?). F) Received. fresh, labeled ""maxilla, right"", is a right composite resection specimen comprising posterior. maxilla_ano palatal resection. The specimen is 6.7 cm from anterior to posterior, 4.3 cm from. medial to lateral, and 3.5 cm from superior to inferior. The anterior mucosal surface has two. teeth with silver metal fillings; one is 0.8 cm in greatest dimension, and the other is 1.3 cm in. greatest dimension. A 2.7 x 1.4 cm depressed, indurated lesion is immediately posterior to the. teeth. The lesion has a central 2.2 x 0.6 cm defect consistent with excision of tumor for research. The edge of the lesion is tan-white, dusky, and edematous, and it has a rolled edge. The lesion. extends 0.3 cm from the nearest lateral mucosal margin, 0.5 cm from the nearest posterior. mucosal margin, and 1.1 cm from the nearest medial mucosal margin. The anterior mucosal. margin is 1.8 cm from the lesion. The remainder of the mucosal surface is tan-pink, smooth and. glistening. The underlying soft tissue margins consist of tan-yellow, lobulated adipose tissue and. maroon-brown possible muscle. No definite tumor is identified at the soft tissue surface. The. medial- superior aspect of the specimen has a 3.3 X 1.0 cm mucosal surface consistent with sinus. cavity; the sinus mucosa is tan-pink, smooth and glistening with areas that are red-brown,. roughened, and focally hemorrhagic. The specimen is inked as follows: anterior = red, medial. anterior = black, medial posterior = green, superior = yellow, lateral = orange and posterior =. blue. The specimen is serially sectioned from anterior to posterior to reveal a 5.2 x 4.1 x 3.5 cm,. tan-white, poly-lobulated, firm mass which immediately underlies the previously described. mucosal lesion. The mass appears to abut the posterior, superior, lateral, and medial soft tissue. margins. The mass abuts the posterior aspect of the most posterior tooth, and it does not appear. to extend any farther anteriorly. Representative sections are submitted as follows: F1 - medial. sinus soft tissue margin; F2, F3 - posterior soft tissue margins, perpendicular; F4-F6 - composite. cross section of mid posterior plane of the specimen; F7 - anterior bone margin, en face (decal);. F8-F10 - composite cross section of mid anterior plane of the specimen (decal). G) Received. fresh for frozen section consultation labeled new deep margin"" is a 0.8 x 0.6 x 0.5 cm red-. brown soft tissue fragment. The specimen was entirely submitted for frozen section consultation. and is resubmitted as G1FS. H) Designated ""Right maxilla tumor and all first 5 margins and. normal tongue tissue to research"": No tissue received. Tissue submitted for research in OR per. designation on pathology requisition form received in pathology, not examined in Pathology. I). Received unfixed labeled "" new deep margin #2"" is 0.7 x 0.4 x 0.3 cm tan-white to maroon-. brown soft tissue fragment entirely submitted as I1.J) Received unfixed labeled "" level I, II, III. nodes"" is an 11.2 x 5 x 2.5 cm tan-pink fibrofatty soft tissue segment. Specimen is oriented as. follows: one suture level I, two sutures level II, and three sutures level III. Multiple lymph node. candidates are identified in each level. Level I contains a grossly positive 2.6 x 1.7 x 2.3 cm tan-. white lymph node as well as a 3.7 X 2.6 x 1.4 cm fragment of tan-white, lobulated tissue. consistent with possible salivary gland. Level II contains two grossly positive lymph nodes, the. larger is 3.7 x 2.3 x 2.2 cm and the smaller is 2.2 x 1.4 x 0.9 cm. No grossly positive lymph. nodes are identified within level III. Representative sections are submitted as follows: J1. representative section of grossly positive level I lymph node; J2 - one candidate lymph node. bisected; J3 - four intact candidate lymph nodes (J1-J3 are level I); J4 - representative section of. level I possible salivary gland tissue; J5, J6 - cross-section of larger grossly involved level II. lymph node; J7 - representative cross-section of smaller grossly involved level II lymph node;. J8. - one level II candidate lymph node bisected; J9 - four intact level II candidate lymph nodes; J10. - three level III intact candidate lymph nodes. K) Received in formalin labeled level V lymph. nodes"" is a 3.2 x 1.9 x 1.8 cm tan-pink fibrofatty soft tissue segment. Multiple candidate lymph. nodes ranging from 0.3 to 1.2 cm are identified. Representative sections are submitted as. follows: K1 - six intact candidate lymph nodes; K2 - six intact candidate lymph nodes; K3 - two. candidate lymph nodes, one intact uninked and one bisected and inked black; K4 - three intact. candidate lymph nodes. L) Received in formalin labeled "" level IV lymph nodes"" is a 2.2 x 2 x. 0.6 cm tan-yellow, fibrofatty soft tissue segment. Multiple tan-pink, otherwise unremarkable. lymph node candidates are identified. No gross metastases are identified. Representative sections. are submitted as follows: L1 - two intact candidate lymph nodes; L2 - four intact candidate. lymph nodes. INTRAOPERATIVE CONSIJLTATION: AFS) Deep margin, biopsy: Invasive carcinoma. Margins- Lateral, anterior, posterior, respectively, biopsies: No in. situ or invasive carcinoma. Medial margin, biopsy: No evidence of malignancy. New deep margin: Positive for invasive carcinoma. FINAL DIAGNOSIS: A-G) Deep, lateral, anterior, posterior, and media margins, respectively, biopsies; Oral cavity,. right maxilla, excision; new deep margin, biopsy: Invasive squamous carcinoma, moderately. differentiated, with the following features: 1. Carcinoma size: 6.7 cm in greatest dimension. 2. Margins of resection: a. Lateral, posterior and superior margins of specimen F are involved by invasive carcinoma. b. Separately submitted lateral, anterior, posterior and medial margins (B-E) are negative for in. situ or invasive carcinoma. c. Deep margin and new deep margin, specimens A and G, are both positive for involvement by. carcinoma. 3. High grade squamous intraepithelial neoplasia (so-called carcinoma in situ) component is also. present, best seen in block F5, above invasive carcinoma. No high grade intraepithelial neoplasia. is present in the epithelium at the margins. 4. Carcinoma undermines and erodes into respiratory mucosa of maxillary sinus. 5. Extensive lymphovascular invasion is present, including invasion of large veins (see block. F3). 6. Perineural invasion: Not identified. 7. Carcinoma invades into edge of a minor salivary gland (block F6). 8. The carcinoma has numerous apoptotic cells with vacuolar degeneration. Neoplastic cells are. negative for mucin by mucicarmine stain (blocks F2, F8); with an appropriately positive control. 9. Organizing thrombi in many small veins. 10. Carcinoma invades bone of maxilla, and it is present in the bone at the anterior margin (F7). 11. Minimal pathologic stage, incorporating parts J-L: pT3 N2b MX (AJCC 6th edition, 2002). H) No tissue examined in Pathology; see Gross Description, above, submitted in OR for. research. J) Lymph node, level I, II, and III, excision: Metastatic squamous carcinoma involving 3 of 17. lymph nodes, including 1 of 6 level I lymph nodes, 2 of 8 level II lymph nodes, and 0 of 3 level. III lymph nodes, with the following additional features: 1. Size of largest focus of metastatic carcinoma: 3.7 cm in greatest dimension (gross. measurement of positive level II node). 2. Extracapsular soft tissue invasion: Present. 3. Salivary gland, negative for involvement by carcinoma. K) Lymph node, level V, excision: Metastatic squamous carcinoma involving 1 of 20 lymph. nodes. 1. Size of largest focus of metastatic carcinoma: 0.4 cm in greatest dimension. 2. Extracapsular angiolymphatic invasion is present. No definite extracapsular soft tissue. invasion is seen. L) Lymph node, level V, excision: 4 lymph nodes with no metastatic carcinoma identified. Procedures used to establish the diagnosis: F Mucicarmine stain.","Invasive squamous carcinoma, moderately differentiated, with carcinoma undermining and eroding into respiratory mucosa of maxillary sinus. Extensive lymphovascular invasion is present, including invasion of large veins. Carcinoma invades into edge of a minor salivary gland. The carcinoma has numerous apoptotic cells with vacuolar degeneration. Neoplastic cells are negative for mucin. Organizing thrombi in many small veins. Carcinoma invades bone of maxilla and is present in the bone at the anterior margin. Metastatic squamous carcinoma involving lymph nodes with extracapsular soft tissue invasion and extracapsular angiolymphatic invasion. High grade squamous intraepithelial neoplasia component is also present, above invasive carcinoma. No high grade intraepithelial neoplasia is present in the epithelium at the margins. Perineural invasion not identified. Lateral, posterior, and superior margins of specimen are involved by invasive carcinoma. Deep margin and new deep margin are both positive for involvement by carcinoma. Separately submitted lateral, anterior, posterior, and medial margins are negative for in situ or invasive carcinoma."
TCGA-US-A776.A34AB133-F144-42E4-AC61-505B8DA9554F,"Lab No. A. SPECIMEN TYPE: Whipples. T. H. CLINICAL NOTES: IPMN Whipple's procedure. Coeliac axis. Lymph node. o. L. NOTE: Block A1 neck en face (involved). A2-A5 periuncinate margin. o. FROZEN SECTION REPORT: G. Invasive mucinous (colloid) adenocarcinoma arising from an IPMN is present. The invasive adenocarcinoma is clear of the neck margin. IPMN with moderate. Y. dysplasia extends to the neck margin. SYNOPTIC REPORT FOR WHIPPLE'S RESECTION. MACROSCOPIC: Specimen labelled: Whipple specimen. Specimen Type: Pancreaticoduodenectomy (Whipple's resection), partial pancreatectomy. Specimen dimensions: A. Length of duodenum: 240mm. Length of lesser curve of stomach: 60mm. 1. Length of greater curve of stomach: 75mm. Size of gallbladder: 75mm in length and 35mm in diameter. C. Wall thickness of gallbladder: up to 5mm. A. Calculi in gallbladder: none. Size of and weight of spleen: N/A. Length of bile duct: 35mm. Maximum diameter of bile duct: 3mm. Size of pancreas: 70 X 40 x 30mm. Location of stent: N/A. I. Tumour location: Pancreatic head. There is a tumour, 60 x 45 x 40mm with mucinous appearance. (IPMN on frozen report). There is a colloid focus arising within the IPMN,. 30mm in maximum dimension, likely to be invasive adenocarcinoma. The new margins are inked as follows: neck blue, portal vein bed red,. periuncinate green and posterior black. Lab No. A. SPECIMEN TYPE: Whipples. T. H. Tumour: o. Configuration: infiltrative. Description: mucinous/colloid. L. Tumour Size: o. Greatest dimension: 60 mm. Additional dimensions: 45 x 40 mm. G. Y. Distance of tumour to margins: Pancreatic neck: IPMN at margin seen on frozen section, 40mm from the colloid. component. Periuncinate soft tissue: 30mm. Posterior retroperitoneal: 25mm. Portal vein bed: 13mm. Anterior pancreatic capsule: 30mm. Common bile duct: 45mm. Proximal intestinal/gastric: 70mm. Distal intestinal margin: 185mm. Proximal pancreatic margin (applicable to distal pancreatectomies only): A. N. Additional gross pathologic findings: the attached omental fat is 210 x 110 x. 10mm. A. Block 1-5: as described in frozen section report. Block 6-10: sections of colloid area (likely to show invasive carcinoma). o. Block 11: common bile duct margin. Block 12: distal duodenal margin. M. Block 13: proximal gastric margin. I. Block 14: neck neo-margin in relation to tumour. Block 15,16: tumour in relation to portal vein bed. C. Block 17,18: paired sections - tumour in relation to posterior retroperitoneal. A. margin. Block 19: tumour in relation to posterior retroperitoneal margin. L. Block 20: tumour in relation to periunciniate new margin. Block 21: 2 lymph nodes adjacent to periuncinate new margin. Block 22: 1 lymph node adjacent to anterior capsular surface. P. Block 23: 2 lymph nodes adjacent to posterior soft tissue margin. Block 24: 2 lymph nodes close to tumour. A. Block 25: transverse sections cystic duct and ? cystic duct lymph node. T. Block 26: transverse section body of gallbladder and longitudinal section. H. o. L. C. Y. Lab No. A. SPECIMEN TYPE: Whipples. T. H. fundus of gallbladder. Block 27: 2 lymph nodes. C. L. B) ""Lymph node 8a"". The specimen consists of a lymph node, 16 x 15 x 12mm. Bisected and embedded in 1 block. C. G. C) "" base of coeliac lymph nodes"". The specimen consists of a lymph node, 14 x. 10. x 7mm with mall amount of attached fatty tissue. Bisected and all embedded. in 1 block. MICROSCOPIC: SYNOPTIC REPORT FOR WHIPPLE'S RESECTION: Tumour location: pancreatic head. Histologic type (WHO classification): IPMN (Intraductal papillary mucinous. neoplasm) with associated invasive colloid (mucinous)adenocarcinoma. Histologic grade (TNM grading system): Moderately differentiated. Tumour size: 60 x 45 x 40mm (invasive component 30mm in maximum dimension). Extension out of pancreas: Colloid carcinoma does appear to buige into. peripancreactic fat posteriorly. Small vessel (capillary/lymphatic) invasion: not seen. 1. Large vessel (vein/artery) invasion: not seen. Perineural invasion: not seen. Perineural invasion of retroperitoneal (periuncinate) neural plexus: Not seen. N. Distance of invasive tumour from resection margins: Pancreatic neck: 40mm. Periuncinate soft tissue: 30mm. Posterior retroperitoneal: 25mm. Portal vein bed: 10mm. I. Common bile duct: 45mm. IPMN does extend to the ampulla within the dilated duct system. Lymph nodes from main resection specimen: 0/12. Separately received lymph nodes: 0/2. I. Pathologic Staging (pTNM, AJCC 7th edition 2009). Staged as: IPMN with associated invasive colloid carcinoma. !. Lab No. A. SPECIMEN TYPE: Whipples. T. H. pT: 3. O. pN: o. L. Overall stage: IIA. O. Additional pathologic comments and findings in other resected organs: G. The surrounding pancreas is atrophic with a generalised loss of acinar tissue. Y. There is focal preservation of islets within fibrotic stroma. The common bile duct is largely denuded but no evidence of in-situ or invasive. malignancy is seen. The gallbladder show fibromuscular thickening of the wall with chronic. inflammation. IMMUNOHISTOCHEMISTRY: MUC-1: negative. MUC-2: positive. MUC-5AC: negative. A. MUC-6: negative. CDX2: positive. N. A. These results would indicate that the tumour is of intestinal type. T. SUMMARY: o. Tumour type: IPMN with associated invasive colloid (mucinous). adenocarcinomacarcinoma. M. Tumour grade: moderately differentiated. Tumour location: pancreatic head. I. Tumour size: 60 x 45 x 40mm (invasive component 30mm in maximum dimension). C. Lymph nodes: 0/14. Stage: IIA. A. Margins: IPMN at the neck margin, the invasive component is clear of all. L. margins. P. A. T. H. C. L. C. G. Y. Lab No. A. T. SPECIMEN TYPE: Whipples. H. o. REPORTING PATHOLOGIST: (Electronic Signature). G. Y. N. A. 1. N. I. L. I. I.","Invasive mucinous adenocarcinoma arising from an intraductal papillary mucinous neoplasm with a mucinous appearance and colloid focus. The tumour has an infiltrative configuration and is moderately differentiated. The invasive adenocarcinoma is clear of the neck margin, but the IPMN extends to the neck margin. There is extension of the colloid carcinoma into peripancreatic fat posteriorly. No small vessel, large vessel, or perineural invasion is seen. The tumour is composed of cells with mucinous cytoplasm and has a colloid appearance. The surrounding pancreas is atrophic with a generalised loss of acinar tissue and focal preservation of islets within fibrotic stroma. The common bile duct is largely denuded but no evidence of in-situ or invasive malignancy is seen. The gallbladder shows fibromuscular thickening of the wall with chronic inflammation. No lymph node metastases are identified in 14 lymph nodes from the main resection specimen and 2 separately received lymph nodes. The margins are clear of invasive tumour, but IPMN is present at the neck margin."
TCGA-21-1076.990cc93f-4af3-4af5-8cd7-0bb81133e1be,"Clinical History/Diagnosis: Left Lung Cancer. Source of Specimen(s): A: Portion of 5th Rib. B: Portion of 6th Rib. C: Portion of 7th Rib. D: Portion of 8th Rib. E: Level 9 Lymph Nodes. F: Lymph Node, leve 11. G: Level 5 Lymph Nodes. H: Level 10 Lymph Node. I: Left lung. Gross Description: Received in nine parts. Source of Tissue: 1. Labeled #1, ""portion of 5th rib"". Gross Description: Received fresh with patient name and medical record number labeled. ""portion of 5th rib"". It consists of a jagged fragment of rib measuring 1.5 X 1.0 X 0.9 cm. No suspicious lesions or masses are identified. Submitted entirely in 1A, following. decalcification. Source of Tissue: 2. Labeled #2, ""portion of 6th rib"". Gross Description: Received fresh with patient name and medical record number labeled. ""portion of 6th rib"". It consists of a fragment of rib measuring 1.5 x 0.8 X 0.7 cm. No. lesions or masses are identified. Submitted entirely in 2A. Source of Tissue: 3. Labeled #3, ""portion of 7th rib"". Gross Description: Received fresh with patient name and medical record number labeled. ""portion of 7th rib"". It consists of a jagged fragment of rib measuring 1.5 X 0.9 x 0.8 cm. No suspicious lesions or masses are identified. Submitted entirely in 3A. Source of Tissue: 4. Labeled #4, ""portion of left 8th rib"". Gross Description: Received fresh with patient name and medical record number labeled. ""portion of left 8th rib"". It consists of a fragment of rib measuring 2 X 0.7 X 0.7 cm. No. suspicious lesions or masses are identified. Submitted entirely in 4A. Source of Tissue: 5. Labeled #5, ""level 9 lymph nodes"". Gross Description: Received fresh with patient name and medical record number labeled. ""level 9 lymph nodes"". It consists of two grayish-black lymph nodes measuring 0.5 and 1.0. cm respectively. Submitted in toto in 5A. Source of Tissue: 6. Labeled #6, ""level 11 lymph node"". Frozen Section Diagnosis: 6FS- NO METASTATIC CARCINOMA. Gross Description: Received fresh for frozen section evaluation with patient name and. medical record number labeled ""level 11 lymph node"". It consists of a single brownish-red. lymph node measuring 1.1 X 1.0 X 0.9 cm. It is bisected disclosing a brown glistening cut. surface. Entirely submitted for frozen section and the residue is submitted in 6FS. Source of Tissue: 7. Labeled #7, ""level 5 lymph node"". Gross Description: Received fresh with patient name and medical record number labeled. ""level 5 lymph node"". It consists of a single dark-red nodule measuring 0.6 x 0.4 X 0.4 cm. Submitted entirely in 7A. Source of Tissue: 8. Labeled #8, ""level 10 lymph node"". Gross Description: Received fresh with patient name and medical record number labeled. ""level 10 lymph node"". It consists of three dark-red nodules measuring respectively 0.5,. 0.6 and 0.9 cm in greatest dimension. Submitted in toto in 8A. Source of Tissue: 9. Labeled #9, ""left lung"". Frozen Section Diagnosis: 9FS- BRONCHIAL MARGIN WITH NO TUMOR SEEN. Gross Description: Received fresh for frozen section evaluation with patient name and. medical record number labeled ""left lung"". It consists of a 481 gram right lung specimen. with an overall measurement of 24 X 13 x 6.5 cm. The lower lobe measures 14 X 10 X 6 cm. and the upper lobe measures approximately 15 x 10 X 6 cm. The bronchial margin is. unremarkable. The bronchial margin was procured for frozen section consultation and the. residue is submitted in 9FS. The diaphragmatic surface is normal appearing. Multiple. bronchial and peribronchial lymph nodes are found measuring up to 2 cm and a few are tan. and firm. Vascular margins are unremarkable. On dissection through the hilum, tumor. comes to within 1.4 cm from the margin and closely approaches an airway and vessel. (E and F). Sections disclose a 8 x 8 X 6 cm tumor in the left lower lobe. Tumor grossly is. adhesed to the upper lobe (9J). Tumor is adhesed to the costal soft tissue with rib and. associated soft tissue measuring 10.5 X 9 X 1.4 cm. Sections show no gross invasion into. the costal resection. Tumor is tan and approximately 80% is necrotic. Elsewhere the lower. lobe is pink and spongy while the upper lobe is predominantly red and dense. Designation of Sections: 9A- vascular margin, 9B-9D- hilar and peribronchial lymph. nodes, 9E-9F- tumor approaching hilum, 9G- tumor with pleura, 9H- tumor in relationship. to adjacent lung tissue, 9I- tumor in relationship to costal soft tissue, 9J- tumor in. relationship to left upper lobe adhesion, 9K- uninvolved lower and upper lobes, 9L- costal. resection/ribs, following decalcification. Final Diagnosis: 1. 5th rib (resection): - Unremarkable rib. Hypercellular marrow. 2. 6th rib (resection): - Unremarkable rib. Hypercellular marrow. 3. 7th rib (resection): - Unremarkable rib. Hypercellular marrow. 4. 8th rib (resection): - Unremarkable rib. Hypercellular marrow. 5. Lymph nodes, level 9 (excision): - Two lymph nodes negative for metastatic carcinoma (0/2). 6. Lymph node, level 11 (excision): - One lymph node negative for metastatic carcinoma (0/1). 7. Lymph node, level 5 (excision): - One lymph node negative for metastatic carcinoma (0/1). 8. Lymph nodes, level 10 (excision): - Two lymph nodes negative for metastatic carcinoma (0/2). 9. Lung, left (left pneumonectomy): - Squamous cell carcinoma, moderate to poorly differentiated (8.0 cm). - The visceral pleura is negative for tumor. - The bronchial, vascular and costal resection margins are free of tumor. - Sixteen peribronchial lymph nodes are negative for metastatic carcinoma. (0/16). - Emphysematous changes. - Chronic inflammation with fibrous adhesions to chest wall. - pT2N0Mx.","Squamous cell carcinoma, moderate to poorly differentiated, with tumor cells exhibiting nuclear pleomorphism and prominent nucleoli. The tumor is associated with a significant amount of necrosis. The visceral pleura is negative for tumor. The bronchial, vascular, and costal resection margins are free of tumor. Peribronchial lymph nodes are negative for metastatic carcinoma. The tumor is adhered to the costal soft tissue and associated rib. Emphysematous changes and chronic inflammation with fibrous adhesions to the chest wall are noted. Hypercellular marrow is seen in the resected ribs."
TCGA-BP-4975.e2ff0050-6701-4191-955f-1419b74c95b1,"Clinical Diagnosis & History: ith incidentally diagnosed right renal mass. Specimens Submitted: 1: SP: Kidney, right posterior mid pole, partial nephrecimy. DIAGNOSIS: 1. SP: Kidney, right posterior mid pole, partial nephrectmy. Tumor Type: Renal cell carcinoma = Conventional (clear cell) type. Fuhrman Nuclear Grade;. Nuclear grade III/IV. Tumor Size: Greatest diameter is 5.0 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Small vessel angiolymphatic invasion not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. (ATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. RECUT. Gross Description: 1). The specimen is received fresh for intraoperative consultation and is labeled ""right posterior mid-pole kidney mass; stitch marks. deep margin"". It consists of a 10.2 X 6.5 x 4.5 cm wedge-shaped portian of kidnay with a suture marking the deep margin and. attached fibraadipose tissue measuring 10 x 8,5 x 2.0 cm. Detached fragments of fibroadipose tissue are also identified. measuring 21 X 7.0 X 3.0 cm. The margin is inked black and the specimen is serially sectioned to reveal a well defined,. hemarrhagic variagated yellow mass measuring 5,0 X 3.9 X 3.5 cm, The clearance fram the resection margin is 0.1 cm. The mass. appears to abut the parirenal fat, but is far away from Gerota's fascia. A representative section of the nearest margin is. submitted far frozen section diagnosis. Representatively submitted. Portlons of the tumor are submitted for TPS,. Summary of sections: FSC - frozen section cantrol. T C- tumar with renal capsule. M margin. k-narmal kidney. f - perirenal fat. adm-additional sections of margin. Summary of Sections: Part 1: SP: Kidney, right posterior mid pale, partial nephrectmy. Black. Sect. Sita. PCs. 3. 3. 2. f. 2. 1. fsc. 1. 1. 1. 2. m. 2. 3. tc. 3. Intraoperative Consultation: Note: The diagnases given in this section pertain only ta the. tissue sample examined at the time of the intraoperativa. consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CORTICAL CARCINOMA. MARGIN NOT INVOLVED. PERMANENT DIAGNOSIS: SAME.","Renal cell carcinoma, conventional (clear cell) type with a well-defined, hemorrhagic, variegated yellow mass. Fuhrman nuclear grade III/IV. Tumor composed of cells with clear cytoplasm and distinct cell borders. No necrosis identified. Local invasion not identified. Renal vein invasion not identified. Small vessel angiolymphatic invasion not identified. Tumor appears to abut the perirenal fat. No tumor involvement at the inked surgical margin. Non-neoplastic kidney is unremarkable. Adrenal gland not identified. Lymph nodes not identified."
TCGA-FY-A3RA.370C33BA-DDB3-4DA9-984E-68037C4C5D73,"Physician: : PROCEDURE. Total thyroidectomy. SPECIMEN: A. Left thyroid. Send fresh. No frozen section. B. Right thyroid. HISTORY. Thyroid cancer. GROSS. A. The specimen is submitted fresh in a container labeled with the. patient's name and ""left thyroid. A thyroid lobe measures 5.3 x 3. x. 2.7 cm. The specimen is inked and serially sectioned. A 4 cm. in. greatest dimension discrete encapsulated tan neoplasm has a bulging. soft friable papillary cut surface. A portion is submitted for the. project. Representative sections are submitted in four. cassettes. B. The specimen is received in formalin in a container labeled with. the patient's name and ""right thyroid.' A 4.5 x 2 x 1.3 cm lobe of. thyroid is serially sectioned and is grossly unremarkable. Representative sections are submitted in two cassettes. MICROSCOPIC. Performed. DIAGNOSIS. A. Left thyroid, excision: Papillary carcinoma (see summary below) . B. Right thyroid, excision: No significant abnormality. THYROID CARCINOMA SUMMARY: PROCEDURE: Total thyroidectomy. SPECIMEN INTEGRITY: Right and left sides submitted separately. SPECIMEN SIZE: See gross description. TUMOR FOCALITY: Unifocal. TUMOR LATERALITY: Left side. TUMOR SIZE: 4 cm in greatest dimension. HISTOLOGIC TYPE: Papillary carcinoma. MARGINS: Negative for neoplasm. TUMOR CAPSULE: Totally encapsulated. CAPSULAR INVASION: Focal capsular invasion. LYMPHOVASCULAR INVASION: Not identified. EXTRATHYROIDAL EXTENSION: Not identified. PATHOLOGIC STAGING (AJCC) : pT2, pNx. I. M.D. (Electronic Signature). Completed Action List: on. Type: Title:",Papillary carcinoma of the thyroid with a discrete encapsulated tan neoplasm having a bulging soft friable papillary cut surface. The tumor is totally encapsulated with focal capsular invasion. No lymphovascular invasion or extrathyroidal extension identified. Tumor margins are negative for neoplasm. The right thyroid is grossly unremarkable with no significant abnormality.
TCGA-A8-A06Y.5664F531-9D45-4302-A455-63E46B5EDD26,"Diagnosis: Invasive ductal breast carcinoma (malignancy grade II) with concomitant high-grade comedo-. type DCIS with inclusions also of isolated coarse calcifications (procomponent of tumor. 20%), with confluent manifestations in the tumor nucleus and other DCIS components in the. tumor periphery. Narrow medial safety margin, as already macroscopically documented. Also. rich DCIS formations extending to within 0.5 cm of the dorsal resection line. dye-stained. resection margins are free of atypia. Mastopathic base structure. Tumor classification: pT2 (maximum diameter 2.5 cm) pNO sn (n=3), MX, R0; G2 (LO, V0).","Invasive ductal breast carcinoma with concomitant high-grade comedo-type DCIS and isolated coarse calcifications, showing confluent manifestations in the tumor nucleus and other DCIS components in the tumor periphery. Tumor cells have malignant features with a malignancy grade II. DCIS formations are rich and extend to the resection margins, which are free of atypia after dye-staining. Mastopathic base structure is present. No lymphovascular invasion identified."
TCGA-F2-A44G.65B052FE-569F-462F-881C-1AC795F9CC61,"Diagnosis: A: Liver, segment 2, biopsy. - Liver with no tumor seen, cholestasis. B: Liver, segment 3, biopsy. - Liver with no tumor seen, cholestasis. C: Liver, segment 4, biopsy. - Liver with small hyalinized granuloma, no tumor seen. D: Liver, segment #2, biopsy. - Liver with no tumor seen, cholestasis. E: Liver, left, biopsy. - Liver with small hyalinized nodule and parenchymal. cholestasis, no tumor seen. F: Pancreatic duct margin, biopsy. - Bile duct with no tumor seen. G: Bile duct margin, biopsy. - Bile duct with no tumor seen. H: Gallbladder, cholecystectomy. - Gallbladder with autolysis, no tumor seen. I: Lymph node, portal, biopsy. - Metastatic adenocarcinoma involving 1 of 1 lymph node (1/1). - Size of metastasis 2 mm, with extranodal extension of tumor. identified. J: ancreaticoduodenectomy, Whipple procedure. Tumor Histologic Type: Adenocarcinoma. Histologic grade: Moderately differentiated. Tumor size: 3.5 cm. Extent of invasion: Peripancreatic soft tissues: Involved with tumor. Duodenum: Involved with tumor. Ampulla: Involved with tumor. Lymphatic Invasion: Present. Venous Invasion: Not identified. Perineural Invasion: Present. Margins: Pancreatic neck: En face pancreatic neck margin involved with. tumor. Bile duct: Margin free of tumor. Peripancreatic soft tissues: Very close, <0.1 mm from tumor. Proximal (gastric) : Free of tumor. Distal (duodenal) : Free tumor. Regional lymph nodes (includes lymph nodes from specimens I and. Total number with metastasis: 3. Total number examined: 16. Additional pathologic findings: Focal atrophic changes and. chronic pancreatitis. AJCC PATHOLOGIC TNM STAGE: pT3 pN1. Note: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Intraoperative Consult Diagnosis: An intraoperative consultation is requested by. FSA1: Liver, segment 2, biopsy. - Liver with benign bile duct, no tumor seen. FSB1: Liver, segment 3, biopsy. - Liver with benign bile ducts, no tumor seen. FSC1: Liver, segment 4, biopsy. - Benign bile ducts and fibrous stroma, no tumor seen. FSD1: Liver, segment #2, biopsy. - Liver and benign bile ducts, no tumor seen. FSE1: Liver, left, biopsy. - Benign liver, no tumor seen. Drs. at. FSF1: Soft tissue, ""pancreatic duct margin"", biopsy. - No tumor seen. FSG1: Soft tissue, ""bile duct margin"", biopsy. - No tumor seen. Frozen Section Pathologist: Clinical History. -year-old. with pancreatic cancer. Gross Description : Specimen A is received in an appropriately labeled container,. additionally labeled ""liver segment 2"" and is a 6 X 5 X 5 mm. pink//tan soft tissue fragment, totally submitted as FSA1,. Specimen B is received in an appropriately labeled container,. additionally labeled ""liver segment 3"" and is a 3 X 3 X 2 mm. pink//tan soft tissue fragment, totally submitted as FSB1,. Specimen C is received in an appropriately labeled container,. additionally labeled ""liver segment 4"" and is an 8 X 6 X 4 mm. pink//tan soft tissue fragment, totally submitted as FSC1,. Specimen D is received in an appropriately labeled container,. additionally labeled ""liver segment 3 #2"" and is a 6 X 4 X 4 mm. pink//tan soft tissue fragment, totally submitted as FSD1,. Specimen E is received in an appropriately labeled container,. additionally labeled ""left liver"" and is a 5 X 4 X 2 mm. pink//tan soft tissue fragment, totally submitted as FSE1,. Specimen F is received in an appropriately labeled container,. additionally labeled ""pancreatic duct margin"" is a 3 X 3 X 2 mm. pink/tan soft tissue fragment which is totally submitted as. FSF1,. Specimen G is received in an appropriately labeled container,. additionally labeled ""bile duct margin"" is a 1.0 X 0.4 X 0.4 cm. segment of pink/tan soft tissue which has an identifiable lumen. This is totally submitted as FSG1,. Specimen H is labeled ""gallbladder"" and is an intact 11.5 X 5. 4. X 4.2 cm gallbladder with attached stapled cystic duct. The. serosa is smooth green/tan and glistening. The lumen is. distended with dark green viscid bile and lined by a velvety. dark green mucosa. The wall has a uniform thickness of 0.1 cm. Representative sections are submitted to include the cystic duct. margin in blocks H1-H2. No stones are identified within the. lumen. Specimen I is labeled ""portal node"" and is a 2.4 X 1.3 X 0.6 cm. gray/tan lymph node candidate, serially sectioned and submitted. in Il. Specimen J is labeled ""pancreaticoduodenectomy. . "". Specimen fixation: formalin. Specimen type: standard Whipple. Organs received (Whipple Specimen) : stomach (7.0 x 3.5 cm) , head. of pancreas (3.5 X 2.8 cm), common bile duct (2.4 cm long,. diameter ranges from 0.2 to 0.6 cm complete). Orientation: Inking: common bile duct=yellow, pancreatic. body=blue, uncinate process=black, fatty pancreatic soft. tissue=green, vessels (1.0 X 0.5 cm, complete), adjacent to the. portal vein=red. Tumor location: head of the pancreas and possibly the common. bile duct. Tumor dimensions 3.5 x 2.1 x 2.0 cm. Gross appearance of tumor: yellow/white, solid; no areas of. hemorrhage are identified, potential tumor necrosis at the. center of the mass. Extent of invasion: Confined / non-confined to the pancreas: non-confined. Involvement of the ampulla: possible (distal common bile duct is. stenosed) (J8, complete). Involvement of the duodenum: present. Involvement of the bile duct: possible (distal common bile is. stenosed for the length of 1.2 cm and the proximal common bile. duct is dilated with velvety, erythematous mucosa). Involvement of adjacent vessels: The portal vein groove is. smooth and intact, a 1.0 X 0.5 cm fragment of vessel is present. posterior to the head of pancreas (section J4, complete). Spleen (if applicable) : n/a. Gallbladder (if applicable) : n/a. Stomach (if applicable) : grossly not involved. Surgical margins: Pancreatic body: 0.9 cm. Uncinate (Retroperitoneal) : less than 0.1 cm. Common Bile duct: 3.0 cm. Proximal margin (stomach) : 4 cm. Distal margin (duodenum) : 11 cm. Peripancreatic soft tissues: abuts multiple green inked soft. tissue margins. Lymph nodes: submitted as per block summary. Other remarkable findings: There is a minimal amount of normal. pancreatic parenchyma in the neck region of the pancreas. Digital photograph taken: no. Tissue submitted for special investigation: tumor and normal. submitted for Tissue Procurement Facility. Block summary: (Inking: : common bile duct=yellow, pancreatic body=blue, uncinate. process=black, peripancreatic soft tissue=green, vessel (1.0 X. 0.5 cm complete), adjacent to portal vein=red). J1 - pyloric margin, representative sections. J2 - duodenal margin, representative sections. J3 - pancreatic body margin, en face, include pancreatic duct. J4 - perpendicular section of uncinate margin with red inked. vessel, adjacent to portal vein. J5 - perpendicular section of uncinate process. J6 - perpendicular section of uncinate, with green inked. peripancreatic margin. J7 - remainder of the uncinate process, en face. J8 - ampulla. J9-J10 - pancreatic tumor involving the duodenum. J11 - section of the tumor with common bile duct and pancreatic. duct. J12 - normal pancreatic parenchyma, one bisected lymph node. J13 - five lymph node candidates. J14 - one lymph node candidate, bisected. J15 - one lymph node candidate, serially sectioned.","Adenocarcinoma with moderately differentiated histologic grade. Tumor involves peripancreatic soft tissues, duodenum, and ampulla. Lymphatic invasion and perineural invasion are present. Pancreatic neck margin is involved with tumor, while bile duct margin is free of tumor. Peripancreatic soft tissues are very close to the tumor. Metastatic adenocarcinoma involves one of one lymph node with extranodal extension of tumor. Additional pathologic findings include focal atrophic changes and chronic pancreatitis. Liver biopsies show no tumor, with cholestasis and small hyalinized granuloma in some segments. Gallbladder shows autolysis with no tumor. Bile duct margins have no tumor. Lymph nodes have metastatic adenocarcinoma with extranodal extension. Tumor has potential necrosis at the center of the mass."
TCGA-AA-A024.48C27265-38FC-4291-8CB8-B10F577B2FEB,"Diagnosis: The material presented is a left hemicolectomy specimen with a moderately differentiated,. invasive adenocarcinoma of the colon, G 2, of the type of a mucous carcinoma, with permeation. of all wall layers (p T 3), free resection margins, free lymph nodes (p N 0) and an additional. tubular adenoma in the mucosal region. Comment: Other diverticulum formations were also detectable over the course of the intestine.","Moderately differentiated invasive adenocarcinoma of the colon, of the type of a mucous carcinoma, with permeation of all wall layers. Tumor composed of cells with mucinous features and a glandular growth pattern. No lymphovascular invasion identified. Free resection margins, with no tumor involvement at the inked margin. Lymph nodes are free of tumor. Additional tubular adenoma present in the mucosal region, with no evidence of high-grade dysplasia or carcinoma. Diverticulum formations also detected in the intestinal wall."
TCGA-B3-3925.bfc6901a-70fe-4646-a576-5b0a27a1d0a9,"SPECIMEN. A. Left renal mass. CLINICAL NOTES. PRE-OP DIAGNOSIS: Renal mass,. FROZEN SECTION DIAGNOSIS. cortical carcinoma, margins negative for tumor. GROSS DESCRIPTION. A. Received fresh for frozen section and tissue. procurement labeled ""left renal mass"". It consist of. a. partial nephrectomy with loosely attached perinephric fat. It. consist of a rounded portion of renal cortical tissue the base of. which measures 3.9 x 4 cm. No grossly evident tumor is present at. the margin. This margin is inked black. On the surface of this. specimen there is a protruding dome-shaped yellow tumor mass. measuring 1.5 cm. above the surrounding renal surface. On section,. this corresponds to a soft dull tan yellow tumor measuring 3.1 x 3. 3.1 cm. On section it comes extremely close to the deep resection. margin. Peripheral margins are grossly spared. The attached. perinephric fat is without tumor nodules. A frozen section of the. deep margin is performed. Samples are also taken for tissue. procurement. Additional representative sections are submitted in 6. cassettes, following fixation. MICROSCOPIC DESCRIPTION. Histologic type: Papillary renal cell carcinoma. Histologic grade (Fuhrman Nuclear Grade) : 2. Primary tumor (pT) : The tumor measures 3.1 cm. in maximum. dimension. and extends through the renal capsule and minimally into perirenal. MICROSCOPIC DESCRIPTION. fat, pT3a. Margins of resection: All margins negative for tumor. Regional lymph nodes (pN) : Cannot be assessed. Distant metastasis (pM) : Cannot be assessed. Vascular invasion: Negative. Non-neoplastic kidney: No significant pathology. 14, 4. DIAGNOSIS. Left renal mass, partial nephrectomy - Portion of kidney with. papillary renal cell carcinoma, Fuhrman grade 2, minimally. extending. into perirenal fat. All margins negative for tumor.","Papillary renal cell carcinoma with a papillary growth pattern, composed of cells with distinct cell borders and variable nuclear features. Fuhrman nuclear grade 2. No necrosis identified. Tumor extends through the renal capsule and minimally into perirenal fat. No vascular invasion. All margins negative for tumor. Non-neoplastic kidney shows no significant pathology."
TCGA-DK-AA71.5C8A75F5-A08D-4CA9-A3D3-67F77C4A65EB,"M. Urology. Clinical Diagnosis & History: T1HG per TUR-BT, large volume tumor, possible extra bladder extension per imaging. Specimens Submitted: 1: Urethral margin (fs). 2: Right common iliac lymph node. 3: Left common iliac lymph node. 4: Right distal pelvic lymph node. 5: Left distal pelvic lymph node. 6: Bladder, prostate, seminal vesicles, peri vesicle lymph nodes. 7: Presacral lymph nodes. 8: Right distal pelvic lymph nodes #2. 9: Distal left ureter. 10: Distal right ureter. DIAGNOSIS: 1. Urethral margin (fs): Benign urothelium and prostatic tissue. 2. Right common iliac lymph node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 4. 3. Left common iliac lymph node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 3. 4. Right distal pelvic lymph node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 8. 5. Left distal pelvic lymph node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 6. 6. Bladder, prostate, seminal vesicles, peri vesicle lymph nodes: a. Tumor Type: Urothelial carcinoma with squamous differentiation Per TSS, squamous differentiation = <5?. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component;. Papillary and flat. Pattern of growth of the Invasive component: Infiltrating. Tumor Multicentricity: Not identified. Bladder Local Invasion: Deep half of muscularis propria. Extravesical Tumor Extension: Ureters uninvolved. Urethra uninvolved. Vascular Invasion: Identified. Perineural Invasion: Identified. Surgical Margins: Free of tumor. Non-Neoplastic Mucosa: Exhibiting chronic cystitis. Exhibiting ulceration. Prostate: Other See prostate template below. Seminal Vesicles: Not involved. Perivesical Lymph Nodes: Not identified. The Pathologic Stage is (AJCC 2002): pT2b (Invades deep half of muscularis propria). PRO (No involvement of prostate). b. Tumor Type: Adenocarcinoma. Gleason's Grade: Primary Gleason grade:3. Secondary Gleason grade:4. Total Gleason score:7. Tumor Location: Dominant tumor mass located in: left posterior apex. Vascular Invasion: Not Identified. Perineural Invasion: Not identified. Tumor Multicentricity: Not identifed. High Grade Prostatic Intraepithelial Neoplasia: Identified. Capsule: Tumor confined to prostate. Seminal Vesicles: Not involved. Bladder Neck: Not Involved. Surgical Margins: Free of tumor. Non-Neoplastic Prostate: Exhibits nodular hyperplasia. Staging (AJCC 1997): pT2a (confined to the prostate & capsule, involving one lobe). 7. Presacral lymph nodes: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 1. 8. Right distal pelvic lymph nodes #2: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 2. 9. Distal left ureter: Segment of benign and inflamed ureter. 10. Distal right ureter: Segment of benign and inflamed ureter. Note: Immunostains D2-40 and ERG were used to assess the presence of lymphovascular invasion. Some of the immunohistochemistry and ISH tests were developed and their performance characteristics were determined by the Department of Pathology. They have not been cleared or approved. by the US Food and Drug Administration The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as. investigational or for research. This laboratory is certified under Clinical testing. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (ANDIOR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh for frozen section consultation, labeled ""Urethral margin "" and consists of a tan pink piece of soft. tissue measuring 1.2 X 1.2 X 0.3 cm. Entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 2) The specimen is received fresh, labeled ""Right common iliac lymph nodes"" and consists of five pink tan firm, fatty lymph nodes. ranging from 0.5 to 2.7 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes, BL1 - BLN3 - bisected lymph nodes #1-3. 3) The specimen is received fresh, labeled ""Left common iliac lymph node"" and consists of six pink tan firm, fatty lymph nodes. ranging from 0,6 to 2.5 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes, BLN - bisected lymph node. 4) The specimen is received fresh, labeled ""Right distal pelvic lymph nodes"" and consists of eight pink tan firm, fatty lymph nodes. ranging from 0.6 to 3.5 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes, BLN - bisected lymph nodes, TLN - trisected lymph node. QL1 - quadrisected lymph node #1, QL2 - quadrisected lymph node #2. 5) The specimen is received fresh, labeled ""Left distal pelvic lymph nodes"" and consists of thirteenth pink tan firm, fatty lymph. nodes ranging from 0.6 to 3.2 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes, BLN - bisected lymph nodes, QLN - quadrisected lymph node. 6) The specimen is received fresh, labeled ""Bladder prostate, seminal vesicles and perivesicular lymph nodes"". It consists of a. bladder with attached prostate and adnexa measuring 17 cm from superior to inferior, 9 cm laterally and 8 cm from anterior to. posterior. The bladder measures 13.5 x 9.5 x 9 cm and is markedly distorted with an underlying non palpable mass. The prostate. measures 4.5 x 4 x 3.8 cm. The right half of the prostate is inked green; the left half of the prostate is inked blue. The anterior. aspect of the bladder is inked black and the posterior blue. The prostatic urethral margin is shaved and submitted. The bladder is. opened. along the anterior midline to reveal a tan-yellow fungating predominately necrotic mass fulfilling the majority of the bladder. cavity. measuring 12.5 x 9.5 x 6.2 cm. The tumor is more closely associated with the left lateral wall, but extends into all regions of. the bladder, completely covering the left anterior and posterior wall, dome mucosa. The attachment of the tumor to the bladder. mucosa is a 1.1 cm from the right ureteral orifice, completely obliterating the left ureteral orifice and is 4.2 cm from the prosthetic. urethral margin. The tumor is sectioned to reveal extension through the bladder wall into the perivesicular fat, predominantly to the. left aspect. The remaining bladder mucosa at the right anterior/posterior wall and trigone is tan yellow and granular. The. perivesicular fat is sectioned to reveal vascularity only. No perivesicular lymph nodes are identified. The prostate is serially. sectioned. to. reveal a diffuse tan nodular parenchyma with an edematous left and right seminal vesicle. The tumor is 1.4cm from. the underlying vasa deferentia. Representative sections are submitted. The specimen is photographed. TPS is submitted. Summary of sections: UTHM - urethral margin, RUM - right ureter margin, LUM - left ureter margin, RUO - right ureter orifice. LUO. left. ureter. orifice, TAW - tumor to anterior wall and perivesicular fat, TPW - tumor to posterior wall and perivesicular fat. TF - tumor to perivesical fat, TVD - tumor to vasa deferentia, TRP - tumor to right posterior wall, TTRI - tumor to trigone. RA - right anterior wall, RAP - right apex prostate, LAP - left apex prostate, RAM - right anterior mid prostate. RPM - right posterior mid prostate, LAM - left anterior mid prostate, LPM - left posterior mid prostate. RAB - right anterior base prostate, RPB - right posterior base prostate, LAB - left anterior base prostate. LPB - left posterior base prostate, RSV - right seminal vesicle, LSV - left seminal vesicle. ADD - additional sections of the base of the tumor. 7) The specimen is received fresh, labeled ""Presacral lymph nodes"" and consists of four pink tan firm, fatty lymph nodes ranging. from 0.7 to 3.2 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. 8) The specimen is received fresh, labeled ""Right distal pelvic lymph nodes #2"" and consists of a portion of yellow and tan adipose. tissue, measuring 2.5 x 2.0 x 1.2cm, two pink tan firm, fatty lymph nodes are identified measuring 0.6 x 0.5 x 0.2 and 0.5 X 0.5 x 0.2. cm All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. 9) The specimen is received in formalin, labeled ""Distal left ureter, unclipped end is margin"" and consists of a tan-white tubular. tissue fragment measuring 4.1 cm in length and 1.0 cm in average diameter, with attached adipose tissue measuring 0.5 cm in. thickness. There is a clip at one end of the specimen. On cross sections, the mucosa appears grossly unremarkable. The. specimen is sequentially sectioned from the clipped end to the non-clipped end and submitted entirely. Summary of sections: CE = clipped end (inked black), NCE = non-clipped end (inked blue). SS = sequential sections from clipped to non-clipped end. 10) The specimen is received in formalin, labeled ""Distal right ureter, unclipped end is margin"" and consists of a tan-white tubular. tissue fragment measuring 4.2 cm in length and 1.0 cm in average diameter, with attached adipose tissue measuring 0.6 cm in. thickness. There is a clip at one end of the specimen. On cross sections, the mucosa appears grossly unremarkable. The. specimen is sequentially sectioned from the clipped end to the non-clipped end and submitted entirely. Summary of sections: CE = clipped end, NCE = non-clipped end, SS = sequential sections from clipped to non-clipped end. Summary of Sections: Part 1: Urethral margin (fs). Blocks Block Designation. PCs. 1. FSC. 1. Part 2: Right common iliac lymph node. Blocks. Block Designation. PCs. 1. BL1. 2. 1. BL2. 2. 2. BL3. 2. 1. LN. 1. Part 3: Left common iliac lymph node. Blocks Block Designation. PCs. 1. BLN. 2. 3. LN. 4. Part 4: Right distal pelvic lymph node. Blocks Block Designation. PCs. 4. BLN. 8. 1. LN. 1. 4. QL1. 4. 4. QL2. 4. 3. TLN. 3. Part 5: Left distal pelvic lymph node. Blocks Block Designation. PCs. 3. BLN. 6. 3. LN. 9. 4. QLN. 4. Part 6: Bladder, prostate, seminal vesicles, peri vesicle lymph nodes. Blocks Block Designation. PCs. 10. ADD. 10. 1. LAB. 1. 1. LAM. 1. 1. LAP. 1. 1. LPB. 1. 1. LPM. 1. 1. LSV. 1. 1. LUM. 1. 1. LUO. 1. 1. RA. 1. 1. RAB. 1. 1. RAM. 1. 1. RAP. 1. 1. RPB. 1. 1. RPM. 1. 1. RSV. 1. 1. RUM. 1. 1. RUO. 1. 4. TAW. 4. 1. TF. 1. 3. TPW. 3. 2. TRP. 2. 2. TTRI. 2. 1. TVD. 1. 1. UTHM. 1. Part 7: Presacral lymph nodes. Blocks Block Designation. PCs. 2. LN. 4. Part 8: Right distal pelvic lymph nodes #2. Blocks Block Designation. PCs. 1. LN. 1. Part 9: Distal left ureter. Blocks Block Designation. PCs. 1. CE. 1. 1. NCE. 1. 5. SS. 10. Part 10: Distal right ureter. Blocks Block Designation. PCs. 1. CE. 1. 1. NCE. 1. 5. SS. 11. Special Studies: Special Stain. Comment. IMM RECUT. P16. HPV. IMM RECUT. NEGATIVE. ERG. D2-40. ERG. D2-40. IMM RECUT. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1. FROZEN SECTION DIAGNOSIS: Benign. PERMANENT DIAGNOSIS: same.","Urothelial carcinoma with squamous differentiation, high grade, with papillary and flat growth pattern in the non-invasive component and infiltrating growth pattern in the invasive component. Tumor exhibits vascular invasion and perineural invasion. Bladder local invasion extends into the deep half of the muscularis propria. Extravesical tumor extension is present, with tumor extending into the perivesicular fat. Surgical margins are free of tumor. Non-neoplastic mucosa shows chronic cystitis and ulceration. Prostate tissue exhibits adenocarcinoma, high grade, with Gleason score 7, and shows vascular invasion and perineural invasion are not identified. Seminal vesicles are not involved by tumor. Lymph nodes are benign, with no tumor identified in the right common iliac, left common iliac, right distal pelvic, left distal pelvic, or presacral lymph nodes. Ureters are uninvolved by tumor. Non-neoplastic prostate tissue exhibits nodular hyperplasia."
TCGA-KM-8439.174672ef-6475-44c2-9934-8726b8e5e98e,"DIAGNOSIS: 1. Renal, tumor #1, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 2. Renal, tumor #4, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 3. Renal, tumor #5, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 4. Renal, tumor #2, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 5. Renal, tumor #3, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 6. Renal, tumor #6, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 7. Renal, tumor #7, left, partial nephrectomy: Renal cell carcinoma, chromophobe type. 8. Renal, tumor #8, left, partial nephrectomy: Renal cell carcinoma, clear cell type, Fuhrman nuclear grade. Il / III. Renal cell Carcinoma, Chromophobe type. See note. 9. Renal, tumor #9, left, partial nephrectomy: Renal cell carcinoma, clear cell type, Fuhrman nuclear grade. Il / III. Renal cell carcinoma, Chromophobe type. See note. NOTE: In specimens 8 and 9, two grossly and morphologically different tumor masses are identified; one is a. clear cell RCC and the other one an RCC chromophobe type. Immunoperoxidase and in-situ hybridization tests performed here and used for diagnosis were developed and their performance. characteristics determined by the. They have not been cleared or approved by the U.S. Food and Drug. Administration. The FDA has also determined that such clearance or approval is not necessary. This laboratory is certified under the Clinical. Laboratory Improvement Amendments of. (CLIA) as qualified to perform high complexity clinical laboratory testing. CLINICAL INFORMATION: Brief Clinical History: yo. male with bilateral renal tumors and no known family history of renal. cancer, attention. PROCEDURE: Pre-Operative Diagnosis: renal tumors Post-Operative Diagnosis: renal. tumors Operative Findings: diffuse involvement of left kidney with. renal tumors; minimal normal parenchyma observed on intraoperative. sonogram. SPECIMENS SUBMITTED: 1. TUMOR, Left kidney # 1 (1FS). 2. TUMOR, Left kidney # 4 (2FS). 3. TUMOR, Left kidney # 5 (3FS). 4. TUMOR, Left kidney # 2. 5. TUMOR, Left kidney # 3. 6. TUMOR, Left kdieny # 6. 7. TUMOR, Left kidney # 7. 8. TUMOR, Left kidney # 8. 9. TUMOR, Left kidney # 9. INTRAOPERATIVE CONSULTATION: 1. ""Tumor #1 left kidney"". 1FS diagnosis: Oncocytic neoplasm, favoring oncocytoma. 2. ""Tumor #4 left kidney"". 2FS diagnosis: Oncocytic neoplasm. 3. ""Tumor #5 left kidney"". 3FS diagnosis: Oncocytic neoplasm. These findings were reported by. GROSS DESCRIPTION: Received fresh from the OR is a specimen labeled with the patient's name, medical record number, and further. specified as: 1. ""tumor #1 left kidney"". It is an ovoid red to pink nodular tissue fragment measuring 2 x 1.5 X 0.8 cm. It is. trisected revealing a pink-tan homogeneous cut surface. The central slice is frozen as ""1FS"". Received in. the Gross Pathology Lab is a specimen matching the above description. The portion submitted as frozen. section is transferred to an orange cassette labeled 1FS. A second of the trisected pieces is submitted in. cassette labeled. or permanent processing. 2. ""tumor #4 left kidney"". It consists of a red to tan 2.5 x 1.8 x 1 cm tissue fragment. It was trisected and the. middle section is submitted as 2FS. Received in the Gross Pathology Lab is a specimen matching the. above description. The section submitted for frozen is transferred to an orange cassette labeled 2FS for. permanent processing. Representative further sections are taken and submitted in cassettes 2A and 2B. 3. ""tumor #5 left kidney"". It consists of a red-tan 5 X 5 X 3.5-cm tissue fragment. It was bisected to reveal a. red to tan hemorrhagic cut surface. Representative sections are frozen as 3FS. Received in the Gross. Pathology Lab is a specimen matching the above description. The frozen specimen was transferred to an. orange cassette labeled 3FS for permanent processing. Cassettes 3A-3G contains representative. sections of the tumor. 4. ""tumor #2 left kidney"". It is a dome-shaped red to pink nodular tissue fragment measuring 2 x 1.4 x 0.7. cm. It is bisected revealing a homogeneous tan to pink cut surface with central hemorrhage. Approximately 60% of the tissue is procured for UOB. Gross photographs are taken and the remainder of. the specimen is placed in formalin and submitted to Pathology for permanent processing. In the Gross. Pathology Lab a specimen matching the above description is received. It is entirely submitted in a. cassette labeled. or permanent processing. 5. ""Tumor #3 left kidney"". It is a dome-shaped red to pink nodular tissue fragment measuring 1.8 X 1.4 X 0.5. cm. It is bisected revealing a hemorrhagic maroon/red cut surface. Approximately 50% of the tissue is. procured for UOB. Gross photographs are taken and the remainder of the specimen is placed into. formalin and submitted to Pathology for permanent processing. Received in the Gross Pathology Lab is a. specimen matching the above description. A representative section is submitted in a cassette labeled. or permanent processing. 6. ""Tumor #6 left kidney"". The specimen is a spherical pink to red nodular tissue fragment measuring 4.8 x. 4.8 x 4.7 cm. It is bisected revealing a focally disrupted tan to pink nodular tissue fragment that is. homogeneous. The surface is tan to pink and fleshy. Approximately 30% of the tissue is procured for. UOB. Gross photographs are taken and the remainder of the specimen is placed into formalin and. submitted to Pathology for permanent processing. Received in the Gross Pathology Lab is a specimen. matching the above description. Representative sections are submitted in cassettes 6A-6E. Cassette 6A. contains a portion of adjacent tissue that has a distinct smooth creamy texture compared to the rest of the. lesion. 7. ""Tumor #7 left kidney"". The specimen consists of 2 fragments that are red to tan soft tissue and 1 yellow. to pink soft tissue fragment measuring from 2.5 to 4.5 cm in greatest dimension. The largest fragment is. bisected revealing a variegated maroon to pink hemorrhagic cut surface measuring 4.5 X 3.5 x 3. Approximately 50% of tissue from the largest fragment is procured for UOB. Gross photographs are. taken and the remainder of the specimen is placed into formalin and submitted to Pathology for. permanent processing. Received in the Gross Pathology Lab is a specimen matching the above. description. Representative sections are taken and submitted in cassettes labeled 7A-7F for permanent. processing. 8. ""Tumor #8 left kidney"" is a focally disrupted ovoid pink to tan nodular tissue fragment measuring 5.5 X 5 X. 3.5 cm. It is bisected revealing a tan-pink fleshy cut surface with a well-circumscribed yellow to tan. spherical nodule, 1.2 cm in greatest diameter, at the periphery. Approximately 50% of the tissue,. spherical tan nodule, and 20% of the rest of the specimen are procured. The remainder of the specimen. is placed into formalin and submitted to Pathology for permanent processing. Received in the Gross. Pathology Lab is a specimen matching the above description. Representative sections of the specimen. are taken and submitted in cassettes 8A-8E. Please note that 8E contains a representative section of the. nodule described. 9. ""Tumor #9 left kidney"". It is a binodular pink to tan tissue fragment overall measuring 2 x 1.5 x 1.5 cm. One nodule is well-circumscribed and solid homogeneous and tan measuring 1.3 cm. The other is ill-. defined, hemorrhagic, and variegated maroon to tan and measuring 1.2 cm. Approximately 50% of tissue. is procured for UOB. Gross photographs are taken and the remainder of the specimen is placed into. formalin and submitted to Pathology for permanent processing. Received in Pathology is a specimen. matching the above description. The two fragments are submitted in white cassettes labeled 9A and 9B. AZR1. dentification. 4 of 5. NIH-2772 (7/97). P.A. 09-25-0099. File in Section 3: Tissue Examination.","Renal cell carcinoma, chromophobe type, with a solid growth pattern and cells having distinct cell borders and pale cytoplasm. Fuhrman nuclear grade II/III for clear cell components. No necrosis identified. Local invasion not identified. Renal vein invasion not identified. Tumors confined to the renal parenchyma with no extension into perirenal fat. No tumor involvement at the inked surgical margin. Non-neoplastic kidney shows focal chronic inflammation and focal superficial glomerulosclerosis. Adrenal gland not identified. Lymph nodes not identified. In specimens with both clear cell and chromophobe renal cell carcinoma, two morphologically different tumor masses are identified, one with clear cells and the other with chromophobe cells. Lymphovascular space invasion not identified. Tumors have a well-circumscribed appearance with a homogeneous cut surface, and some show a variegated maroon to pink hemorrhagic cut surface. Some tumors have a distinct smooth creamy texture compared to the rest of the lesion."
TCGA-21-5784.5d154faf-bb6e-4237-80cf-9d02e2127adb,"Clinical History/Diagnosis: Right Lung CA. Source of Specimen(s). 1: 11R Lymph Node. 2: 3A Lymph Node. 3: 10 R Lymph Node. 4: Right upper lobe Lung, resection (segmental or lobe). 5: Level 7 Lymph Node. 6: Level 10 Lymph Node. ESTE: 7: Level 4R Lymph Node. Gross Description: Received in seven parts. Source of Tissue: 1. Labeled #1, ""11R lymph node"". Gross Description: Received fresh labeled, 11R. lymph node"". It consists of multiple soft black-brown anthracotic lymph. nodes measuring from 0.1 up to 0.5 cm in greatest dimension. The lymph. nodes are entirely submitted in 1A-1B. Source of Tissue: 2. Labeled #2, ""3A lymph node"". Gross Description: Received fresh labeled, 3A. lymph node"". It consists of a soft black-brown anthracotic lymph node. measuring 0.8 x 0.6 x 0.3 cm. The specimen is entirely submitted in 2A. Source of Tissue: 3. Labeled #3, ""10R lymph node"". Gross Description: Received fresh labeled "", 10R. lymph node"". It consists of three soft black-brown anthracotic lymph nodes. measuring from 0.2 up to 0.5 cm in greatest dimension. Entirely submitted. in 3A. Source of Tissue: 4. Labeled #4, ""right upper lobe"". Intraonerative Consultation: BRONCHIAL MARGIN WITH NO TUMOR SEEN PER. Gross Description: Received fresh labeled,. right upper lobe"". It consists of a lobe of lung weighing 197 grams and. measuring 14 X 9 X 4 cm. A gray nodular indurated area is identified on. the pleura measuring 3 x 2.5 cm in greatest dimension. The bronchial and. vascular margins are grossly unremarkable. The specimen is serially. sectioned to reveal a 4 x 3.2 X 2.1 cm ill-defined gray mass located. approximately 1.5 cm from the bronchial and vascular margins. The mass. grossly corresponds to the previously described pleural induration. The. remaining lung parenchyma is red-brown, congested with no other masses. present. The bronchial margin is frozen in 4FS. Additional random sections. of the remainder of the specimen are submitted in 4A-4H. Designation of Sections: 4FS - frozen section, 4A- vascular margins, 4B-4E-. random section of tumor with closest pleura, 4F- tumor with adjacent. normal uninvolved parenchyma, 4G- peribronchial lymph nodes, 4H-. uninvolved parenchyma. Source of Tissue: 5. Labeled #5, ""level 7 lymph nodes"". Gross Description: Received fresh labeled "",. level 7 lymph nodes"". It consists of multiple soft black-brown. anthracotic lymph nodes measuring from 0.1 up to 1.5 cm in greatest. dimension. The lymph nodes are entirely submitted in 5A-5B. Source of Tissue: 6. Labeled #6, ""level 10 lymph nodes"". Gross Description: Received fresh labeled. level 10 lymph nodes"". It consists of a soft black-brown anthracotic. lymph node measuring 0.8 x 0.5 x 0.5 cm. The lymph node is bisected and. entirely submitted in 6A. Source of Tissue: 7. Labeled #7, ""level 4R lymph nodes"". Gross Description: Received fresh labeled "", ,. level 4R lymph nodes"". It consists of multiple soft black-brown. anthracotic lymph nodes measuring from 0.1 up to 0.7 cm in greatest. dimension. The lymph nodes are entirely submitted in 7A-7C. Final Diagnosis: 1. 11R lymph nodes, excision: - No tumor seen in thirteen lymph nodes (0/13). 2. 3A lymph nodes, excision: - No tumor seen in three lymph nodes (0/3). 3. 10R lymph nodes, excision: - No tumor seen in two lymph nodes (0/2). 4. Right lung, upper lobe, lobectomy: - Squamous cell carcinoma, high grade (4.0 cm). - Angiolymphatic invasion is not identified. - Visceral pleura free of tumor. - Vascular and bronchial margins free of tumor. - Two peribronchial lymph nodes with no tumor seen (0/2). 5. Level 7 lymph nodes, excision: - No tumor seen in two lymph nodes (0/2). 6. Level 10 lymph nodes, excision: - No tumor seen in four lymph nodes (0/4). 7. Level 4R lymph nodes, excision: - No tumor seen in sixteen lymph nodes (0/16). LUNG TEMPLATE. Specimen Type. Lobectomy. Laterality. Right. Tumor Size. Greatest dimension: 4.0 cm (T1 if <=3.0 cm; otherwise T2). Histologic Type. Squamous cell carcinoma. Histologic Grade. Poorly differentiated. Extension of Tumor. Carcinoma does not involve visceral pleura (T1 unless > 3.0 cmT2)/. Venous (Large Vessel) Invasion. Absent. Arterial (Large Vessel) Invasion. Absent. Margins. Margins uninvolved by invasive carcinoma. Regional Lymph Nodes. 32 regional lymph nodes examined. No regional lymph node metastasis. pTNM: T2 NO Mx.","Squamous cell carcinoma, high grade, with no angiolymphatic invasion identified. Visceral pleura free of tumor. Vascular and bronchial margins free of tumor. No tumor seen in peribronchial lymph nodes. Carcinoma does not involve visceral pleura. Venous and arterial invasion absent. Margins uninvolved by invasive carcinoma. No regional lymph node metastasis identified in multiple lymph nodes examined from various levels, including 11R, 3A, 10R, level 7, level 10, and level 4R lymph nodes."
TCGA-24-1434.0a5fd2a4-560b-4769-ba4e-868854471961,"Other Related Clinical Data: DIAGNOSIS: OVARIES, RIGHT AND LEFT, BILATERAL SALPINGI-OOPHORECTOMY. - PAPILLARY SEROUS ADENOCARCINOMA. - DIFFUSE LYMPHVASCULAR SPACE INVASION IDENTIFIED. - SEE COMMENT AND SYNOPTIC. FALLOPIAN TUBE, SIDE NOT SPECIFIED, BILATERAL SALPINGO-OOPHORECTOMY. - METASTATIC PAPILLARY SEROUS ADENOCARCINOMA. - DIFFUSE LYMPHVASCULAR SPACE INVASION IDENTIFIED. UTERUS, CERVIX, TOTAL ABDOMINAL HYSTERECTOMY. - DIFFUSE LYMPHVASCULAR SPACE INVASION BY PAPILLARY SEROUS ADENOCARCINOMA. - METASTATIC PAPILLARY SEROUS ADENOCARCINOMA IN PARACERVICAL SOFT TISSUE. UTERUS, ENDOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - INACTIVE. - ENDOMETRIAL POLYP. UTERUS, MYOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - DIFFUSE LYMPHVASCULAR SPACE INVASION BY PAPILLARY SEROUS ADENOCARCINOMA. UTERUS, SEROSAL SURFACE, TOTAL ABDOMINAL HYSTERECTOMY. - EXTENSIVE METASTATIC PAPILLARY SEROUS ADENOCARCINOMA. SOFT TISSUE, ANTERIOR CUL-DE-SAC, BIOPSY. - METASTATIC PAPILLARY SEROUS ADENOCARCINOMA. OMENTUM, EXCISION. - METASTATIC PAPILLARY SEROUS ADENOCARCINOMA. By this signature, I attest that the above diagnosis is based upon my. personal. examination of the slides (and/or other material indicated in the diagnosis). Intraoperative Consultation: FS Tumor, anterior cul-de-sac, biopsy. ""Adenocarcinoma, consistent with Mullerian origin, by. Microscopic Description and Comment: Sections of both ovaries show. extensive poorly differentiated papillary serous adenocarcinoma. The tumor has a high. nuclear grade, a well developed papillary architecture in many areas, and is associated with. numerous psammoma bodies. The tumor effaces large areas of the ovaries and is present on. the ovarian surfaces, and extends into the paratubal soft tissue. Of note, foci of in situ. papillary serous adenocarcinoma are noted in the tubal epithelium. Diffuse lymphvascular. space invasion in the adnexa is also noted. Extensive sectioning of the additional fragments. of tissue received with the TAH/BSO specimen show large fragments of soft tissue entirely. effaced by tumor. One fallopian tube is not identified in the multiple sections submitted. Sections of the uterus show diffuse serosal metastasis by papillary serous carcinoma. In. addition, there is extensive lymphvascular space permeation by tumor in the myometrium,. lower uterine segment, and cervix, and in some areas the foci of intravascular tumor. are invading into the immediately adjacent stroma. In addition, extensive metastatic. adenocarcinoma is present in the paracervical soft tissue. The endometrium is inactive, and. an endometrial polyp is identified as an incidental finding. Sections of the anterior cul-de-sac biopsy show metastatic papillary serous carcinoma. Similarly, sections of the omentum show almost complete effacement by metastatic papillary. serous adenocarcinoma. History The patient is a. with a pelvic mass and malignant ascites. Operative procedure : Exploratory laparotomy, total abdominal hysterectomy, bilateral. salpingo-oophorectomy. Clinical diagnosis: Pelvic mass, malignant ascites. Specimen (s) Received: A: TUMOR ANTERIOR CULDESAC. B: HYSTERECTOMY, BSO. C: OMENTUM, ROUTINE. Gross Description The specimens are received in three containers of formalin, each labeled. with the patient's name. The container is additionally labeled ""tumor anterior cul-de-sac. It contains a white cassette. Labeled FS1. Tissue remaining from frozen section labeled A1. Also in this container are four pieces of pink-tan tissue ranging in size from 1.2 cm in. greatest dimension to 3.2 cm in greatest dimension. Two sections submitted in one cassette. labeled A2. Jar 1. I. The second container is labeled ""uterus, tubes, and ovaries. "" It contains greater than. 20. pieces of tissue ranging in size from 0.2 cm in greatest dimension to 8 X 6 x 3.0 cm. The. largest piece of tissue is grossly identifiable as a uterus. The serosal surface of the. uterus is not identifiable and the uterus is encased in a combination of dense fibrous. tissue, and possibly tumor. The uterus is unable to be oriented. A small, 0.6 cm in greatest. dimension, endometrial polyp is present. Also identifiable is one set of adnexa measuring. 7.5 X 6.0 x 3.5 cm. A 7.5 x 5.5 x 2.5 cm cystic space is present. This cystic space has. been previously opened, and contains friable dark brown material with focal papillary areas. The serosal surface is partially identifiable, and large amounts of tumor is present on. the serosal surface. A portion of partial fallopian tube is identified measuring 4.5 cm. in length. On cut section, the lumen is patent. The remainder of the tissues present in. the container consist of solid, tan masses of tumor with fibrous tissue and focal adipose. tissue. Labeled B1 - section of cervix; B2 - lower uterine segment; B3 - endometrium. myometrium; B4 - cervix from opposite side; B5. - lower uterine segment from opposite side; B6 - opposite side endometrium myometrium; B7. fallopian tube; B8 - solid area tumor adjacent to cystic structure; B9 - sections of cyst. wall, along with surface tumor; B10 - papillary area within cyst; B11 - representative. sections of solid tumor infiltrating fat from loose fragments of tissue. B12 - B14 -. sections of second adnexa. Jar 2. The third container is labeled ""omentum. "" It contains a 20 X 5 X 4 cm piece of omentum,. which is essentially completely replaced by tumor. One section of tumor labeled C1. Jar 2. Synopsis SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS 1. A neoplasm is. PRESENT 2. The HISTOLOGIC DIAGNOSIS is Serous papillary adenocarcinoma 3. The LOCATION (S). OF THE PRIMARY TUMOR (S) is/are: Right and left ovary (synchronous primary tumors) 4. AND. 5. The NUCLEAR (BRODERS') GRADE of the tumor is: G3 (Poorly-differentiated) 6. Tumor. IS identified on the ovarian surface (s) . 7. Tumor DOES invade the mesovarium. 8. Tumor. DOES invade the adjacent fallopian tube. 9. Tumor DOES invade the pelvic soft tissue. 10. Tumor involvement of the pelvic peritoneum is PRESENT. 11. Metastatic involvement of the. EXTRAPELVIC peritoneum CANNOT BE EVALUATED. 12. Metastatic involvement of the omentum is. PRESENT. 13. The maximum dimension of tumor implants outside the true pelvis is greater. than 4 cm 14. Metastatic involvement of the uterine serosa is PRESENT. 15. Metastatic. involvement of the endometrium is ABSENT. 16. Regional lymph node metastases CANNOT BE. EVALUATED. 17. The total number of regional lymph nodes examined is 0. 18. The total number. of metastatically-involved regional lymph nodes cannot be determined. 19. DETAILED STAGING. INFORMATION: Based on the above information, the PRIMARY TUMOR is classified as : TNM Scheme. FIGO Scheme. Definition. T3c. IIIC. Macroscopic. peritoneal metastasis beyond true pelvis measuring > 2 cm in. greatest dimension. THE REGIONAL LYMPH NODES are classified as: NX. (Nodal status cannot be assessed). THE STATUS OF DISTANT TUMOR SITES is classified as: MX (Status cannot be assessed) 20. The. FINAL AJCC/UICC/FIGO STAGE IS: AJCC/UICC/FIGO. IIIC. (T3c/NX/MX). The pathologic stage assigned here should be regarded as provisional, and may change after. integration of clinical data not provided with this specimen. Amendments. Reason : The report was amended to correct a typographical error.","Papillary serous adenocarcinoma of ovarian origin with extensive involvement of both ovaries, displaying a high nuclear grade and a well-developed papillary architecture, associated with numerous psammoma bodies. Diffuse lymphovascular space invasion is identified in the adnexa. The tumor effaces large areas of the ovaries, is present on the ovarian surfaces, and extends into the paratubal soft tissue. Foci of in situ papillary serous adenocarcinoma are noted in the tubal epithelium. One fallopian tube is not identified, while the other shows metastatic papillary serous adenocarcinoma. The uterus shows diffuse serosal metastasis by papillary serous carcinoma, with extensive lymphovascular space permeation by tumor in the myometrium, lower uterine segment, and cervix. The endometrium is inactive, with an incidental endometrial polyp. Metastatic adenocarcinoma is present in the paracervical soft tissue and the anterior cul-de-sac biopsy. The omentum is almost completely effaced by metastatic papillary serous adenocarcinoma."
TCGA-28-1751.19f9b34f-8fd6-4b0b-b4a5-bdf247570394,"Department of Pathology & Laboratory Medicine. DIAGNOSIS: A. BRAIN, LEFT FRONTAL, EXCISIONAL BIOPSY: Glioblastoma multiforme, WHO grade IV. B. BRAIN, LEFT OCCIPITAL, EXCISIONAL BIOPSY, NCI #1: Glioblastoma multiforme, WHO grade IV. Up to 5% of tumor necrosis. Up to 90% of tumor cellularity. C. BRAIN, LEFT OCCIPITAL, EXCISIONAL BIOPSY, NCI #2: Glioblastoma multiforme, WHO grade IV. Up to 70% of tumor necrosis. Up to 90% of viable tumor cellularity. D. BRAIN, LEFT OCCIPITAL, EXCISIONAL BIOPSY, NCI #3: Glioblastoma multiforme, WHO grade IV. Up to 30% of tumor necrosis. Up to 90% of viable tumor cellularity. E. BRAIN, LEFT OCCIPITAL EXCISIONAL BIOPSY, NCI #4: Glioblastoma multiforme, WHO grade IV. Up to 30% of tumor necrosis. Up to 90% of viable tumor cellularity. F. BRAIN, LEFT OCCIPITAL, EXCISIONAL BIOPSY, NCI #5: Glioblastoma multiforme, WHO grade IV. Up to 1% of tumor necrosis. Up to 90% of tumor cellularity. G, H. BRAIN, LEFT OCCIPITAL, EXCISIONAL BIOPSY: Glioblastoma multiforme, WHO grade IV. COMMENT: A high percentage of tumor cells (greater than 20%) immunostaining for MGMT has been reported. to be associated with a relatively diminished response to Temodar (. Hence, the. low 5% result in this case suggests a likelihood of this tumor being responsive to Temodar. Recent studies indicated an adverse prognostic significance of increased expression of laminin beta 1 and decreased. expression of laminin beta 2 predicting a worse survival of patients with gliomas. between laminin-8 and glial tumor grade, recurrence, and patient survival. Patient Case(s). Page I or -. PATIENT RESULIS. DR. Accordingly, elevated expression of beta 1 and focally suppressed expression of beta 2 in this tumor predict more. aggressive behavior. Recent studies have shown that co-expression of EGFRvIII and PTEN as detected by immunostaining was. significantly correlated with a clinical response of glioblastomas to EGFR kinase inhibitors. Hence the preserved expression of PTEN in this case, when combined with EGFRvIII. mutation, permits a possibility of this tumor being responsive to EGFR-kinase inhibitors. Retained expression of PTEN was found to be associated with a more favorable prograncie in national with high. grade gliomas (. Molecular subclasses of high-grade glioma. predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. Presence of activated (phosphorylated) p42/44 Mitogen-Activated Protein Kinase (pMAPK) has been shown to be. associated with a relative resistance of glioblastoma multiforme to radiation therapy. Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in. Glioblastoma. Correspondingly, a high percentage of tumor cells immunoreactive to pMAPK antibody in this case predicts a. relative resistance to radiation therapy. The use of these tests in guiding therapy has limitations. Review of the relevant literature and clinical correlation is. advised. These test results do not obligate or preclude use of the relevant therapeutic agents. IDC2a: Selected slides were reviewed in consultation with. HISTORY: Neurologic symptoms multiple. MICROSCOPIC: Sections disclose high-grade infiltrating astrocytic neoplasm composed of pleomorphic hyperchromatic nuclei. featuring numerous mitotic figures and associated with florid microvascular proliferation and extensive foci of. neutrophil and macrophage-rich abscess-like necrosis with focal palisading. IMMUNOSTAINS: MGMT (G1): Up to 5%. PTEN (G1): Retained (2-3+). pMAPK (G1): Up to 10% of tumor nuclei are positive and up to 60% of tumor cytoplasm is positive. Laminin beta-1 (8/411) (G1): Upregulated (3+ in endothelial cells). Laminin beta-2 (9/421) (G1): Focal down-regulated (1-2+ in endothelial cells). EGFR by FISH is pending. GROSS: A. LEFT FRONTAL. Labeled with the patient's name, labeled ""left frontal"", and received fresh in the Operating Room for intraoperative. frozen consultation and subsequently fixed in formalin is a 2.2 x 1.4 x 0.3 cm aggregate of multiple tan-red soft. tissue fragments. Representative portion of tissue was submitted for frozen section analysis. Entirely embedded. A1. FSA remnant - multiple. A2. Remaining tissue - I. B. LEFT OCCIPITAL NCI #1. Labeled with the patient's name, labeled ""left occipital NCI #1"", and received in a cassette in formalin is a 2.1 x 1.4. x 0.2 cm aggregate of tan-red soft tissue fragments. Entirely embedded. 81. Multiple. C. LEFT OCCIPITAL NCI #2. Labeled with the patient's name, labeled ""left occipital NCI #2"", and received fresh and subsequently fixed in. formalin in a cassette is a 2.3 x 1.4 x 0.2 cm aggregate of multiple tan-red soft tissue fragments. Entirely embedded. CI. Multiple. D. LEFT OCCIPITAL NCI #3. Labeled with the patient's name, labeled ""left occipital"", and received in a cassette labeled ""D"" are two tan-red soft. tissue fragments amounting to 2.1 x 1.2 x 0.2 cm in aggregate. Entirely embedded. D1. 2. E. LEFT OCCIPITAL NCI #4. Labeled with the patient's name, labeled ""B-F left occipital"", and received fresh and subsequently fixed in formalin. in cassette labeled ""E"" is a 2.0 x 1.2 x 0.2 cm aggregate of multiple tan-red soft tissue fragments. Entirely. embedded. E1. Multiple. F. LEFT OCCIPITAL NCI #5. Labeled with the patient's name, labeled ""D-F left occipital"", and received fresh and subsequently fixed in formalin. in a cassette labeled ""F"" are two tan-red soft tissue fragments amounting to 1.5 x 1.1 X 0.3 cm in aggregate. Entirely. embedded. F1. 2. G. LEFT OCCIPITAL PERMANENT. Labeled with the patient's name, labeled ""left occipital"", and received in formalin is a 6.1 x 3.5 x 1.5 cm aggregate. of multiple tan-red friable soft tissue fragments. Entirely embedded. Slide key: GI. 3. G2. 5. G3. I. G4. Multiple. G5. 1. G6. 1. H. LEFT OCCIPITAL. Labeled with the patient's name, labeled ""left occipital"", and received in formalin are two friable tan-red soft tissue. fragments amounting to 3.0 X 2.5 x 1.0 cm in aggregate. The portions of tissue are serially sectioned and entirely. embedded. Slide key: HI-H3. 2,2,2. Gross dictated by. OPERATIVE CALL. OPERATIVE CONSULT (FROZEN): OCCIPITAL FS AND TP: High-grade glioma. If this report includes immunohistochemical test results, please note the following: Numerous immunoltistochomicnl tests were developed and their performance characteristics determined by (. and Laboratory Medicine. Those immunohistochemical tests have not been cleared or approved by the. U.S. Food and Drug Administration (FDd), and FDA approval is not required. I have personally examined the specimen. interpreted the results. reviewed the report and signed it electronically.","Glioblastoma multiforme, WHO grade IV, characterized by a high-grade infiltrating astrocytic neoplasm composed of pleomorphic hyperchromatic nuclei, numerous mitotic figures, and associated with florid microvascular proliferation and extensive foci of neutrophil and macrophage-rich abscess-like necrosis with focal palisading. Tumor necrosis is present, ranging from up to 5% to up to 70% in different areas. The tumor exhibits a high percentage of viable tumor cellularity. No lymphovascular or perineural invasion is mentioned. The tumor margins are not described in terms of involvement. Non-neoplastic brain tissue is not described. The tumor cells display retained PTEN expression and upregulated laminin beta-1, with focal down-regulation of laminin beta-2."
TCGA-27-1837.fab9682a-0940-4815-8789-81799ff395f6,Birth date. Tumor site. Left frontal. Histological diagnosis. Glioblastoma multiforme.,Glioblastoma multiforme.
TCGA-MY-A913.E17EECA7-26DE-4456-94B2-6B5A9F4931AD,"Med Rec. #: Report Name: : Surg Path Case - STATUS: Final. ES NOTE. Collect/Perform: Department: Physician who Performed Procedure: Requesting Physician: Attending Pathologist : DIAGNOSIS: Cervix, biopsy: - Fragments of invasive poorly differentiated squamous carcinoma. - Orientation precludes measurement of depth of invasion. COMMENT: There is a copious amount of sampled tigsue, almost all of which. is composed of. tumor. A p63 stain is strongly positive supporting the diagnosis. CLINICAL INFORMATION: Cervical cancer. GROSS DESCRIPTION: The specimen is received fresh labeled ""cervical biopsy . It consists of a. 2 x 0.7 x 0.4 cm. irregular portion of tan rubbery tissue. One aspect demonstrates apparent. tan smooth mucosa. The tissue is inked and serially sectioned. The cut. surfaces are tan and smooth. Also received are two tan rubbery tissue. fragments measuring 0.5 x 0.4 x 0.2 cm in aggregate. The specimen is. entirely submitted in three cassettes as follows: 1A-1B- largest portion of tissue, sectioned. 1C separately received tissue fragments. The following special studies were performed on this case and the. interpretation is incorporated in the diagnostic report above: Report Name: I certify that I personally conducted the diagnostic evaluation of the. above specimen (s) and have rendered the final diagnosis (es). Note: The histology, immunochemistry and in situ hybridization components. for this case were performed at. The Attending Pathologist reviewed this case and made the diagnosis. Where applicable, immunohistochemistry and in situ hybridization teats were. developed and the performance characteristics determined by the. have not been cleared or approved by the US Food and Drug Administration. and the results should be correlated with other clinical and laboratory. data. Appropriate controls were performed for all immunohistochemistry; in. situ hybridization and histochemical tests.","Invasive poorly differentiated squamous carcinoma of the cervix, with fragments of tumor composing almost all of the sampled tissue. The tumor cells are positive for p63, supporting the diagnosis of squamous carcinoma. Orientation precludes measurement of depth of invasion. No lymphovascular invasion or other structures involvement is identified in the biopsy specimen. The non-neoplastic tissue is not described, and no other histologically evident findings are noted. Tumor cells are present, but the extent of invasion cannot be determined due to the orientation of the biopsy fragments."
TCGA-CK-5914.6a2276bb-99c0-4e2f-b673-3077ddb9c9d3,"PATHOLOGIC DIAGNOSIS: A. SPECIMEN DESIGNATED ""SIGMOID COLON, PARTIAL COLECTOMY"" (17 cm) : ADENOCARCINOMA, low grade, moderately differentiated (4.9 cm. in greatest dimension). Tumor forms a polypoid mass and has an infiltrating border. Tumor invades through muscularis propria. Proximal, distal, and radial resection margins are negative for tumor. Invasive tumor is 5.0 cm from proximal resection margin, 5.1 cm from. distal resection margin, and 2.5 cm from radial resection margin. Lymphovascular invasion is not identified. Extramural venous invasion is not identified. Perineural invasion is not identified. Peritumoral lymphoid response (including Crohn?s-like infiltrate) is. mild. Residual adenoma is absent. Regional lymph nodes (positive:total) : 2:13 (see also part B). AJCC Classification (6th edition) : T3 N1 MX. B. SPECIMEN DESIGNATED ""ADDITIONAL PROXIMAL MARGIN"": Segment of colon, negative for tumor. Two lymph nodes, negative for tumor (0:2) . C. SPECIMEN DESIGNATED ""DISTAL DONUT"": Segment of colon, negative for tumor. D. SPECIMEN DESIGNATED ""PROXIMAL DONUT"": Segment of colon, negative for tumor. CLINICAL DATA: History: Not provided. Operation: Sigmoid resection. Operative Findings: Not provided. Clinical Diagnosis: Not provided. TISSUE SUBMITTED: A. sigmoid - staple side is proximal to FS open + return. B. additional proximal margin. C. distal donut. D. proximal donut. GROSS DESCRIPTION: The specimen is received fresh, in four parts, labeled with the patient's name. and medical record number. Part A, ""#1. Sigmoid, staple side is proximal, open and return"", consists of. one sigmoid colectomy (17.0 cm in length x 6. 6 cm in diameter) with a proximal. stapled resection margin (6.6 cm, inked black) and a distal open resection. margin (2.0 cm, inked blue) with attached mesentery (17.5 x 6.0 cm) . The. antimesenteric side is inked red where the bowel is opened by the prosector. The mucosal surface demonstrates one tan/pink fungating polypoid mass (4.9 x. 4.5 x 1.6 cm) present 5.0 cm from the proximal resection margin, 5.1 cm from. the distal stapled resection margin, and 2.5 cm from the radial resection. margin (inked orange), The tumor grossly invades into the muscularis, but not. the pericolonic fat. There is a white/tan soft nodule (? necrotic lymph node. metastasis) (1.5 x 0.9 x 1.5 cm) which is present in the mesentery adjacent and. 2.0 cm from the main mass and 1.1 cm from the radial margin. The remainder of. the mucosa is tan/brown and unremarkable. Twelve candidate lymph nodes are. identified, the largest measuring 0.7 cm in greatest dimension. Gross. photographs are taken. Micro A1: Proximal and distal stapled resection margins, 2 frags,. Micro A2: Tumor, 2 frags,. Micro A3 through A4: Tumor with deepest extent of invasion, 1 frag each,. Micro A5 through A6: Tumor to normal mucosa, 1 frag each,. Micro A7 through A8: Mesenteric nodule, 1 frag each,. Micro A9: Radial margin, 1 frag,. Micro A10: Normal mucosa, 1 frag,. Micro A11 through A19: Candidate lymph nodes, multi frags each,. ss. Micro A20 through A22: Representative sections of fat,. Part B, ""#2. Additional proximal margin"", consists of one unoriented segment of. colon (1.1 cm in length x 2.5 cm in diameter) with two stapled resection. margins (4.5 cm inked black, 4.1 cm inked blue) with attached mesentery (2.1 x. 6.0 cm) No lesions are grossly identified. Two candidate lymph nodes are. identified, the largest measuring 0.5 cm in greatest dimension. Micro B1 through B2: Proximal margin, full length sections, 2 frags each,. Micro B3: Candidate lymph nodes, 3 frags,. Micro B4 through B5: Additional adipose tissue, multi frags each,. Part c,"" #3. Distal donut"", consists of one segment of colon (0.8 cm in length. x 2.5 cm in diameter) No lesions are grossly identified. Micro C1 through C2: Distal donut, 2 to 3 frags each,. Part D, ""#4. Proximal donut"", consists of one metal disc (2.8 x 2.8 x 0.5 cm). with an attached stem (4. cm in length x 0.7 cm in diameter) with a segment of. colon (0.5 cm in length x 1.2 cm in diameter) No lesions are grossly. identified. The metal object is submitted for gross examination only. Micro D1: Proximal donut, 1 frag,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto.","Adenocarcinoma, low grade, moderately differentiated, forms a polypoid mass with an infiltrating border, invades through muscularis propria. Proximal, distal, and radial resection margins are negative for tumor. Lymphovascular invasion is not identified. Extramural venous invasion is not identified. Perineural invasion is not identified. Peritumoral lymphoid response is mild. Regional lymph nodes are positive for tumor. Tumor invades into the muscularis, but not the pericolonic fat. A white/tan soft nodule, possibly a necrotic lymph node metastasis, is present in the mesentery adjacent to the main mass. Additional proximal margin, distal donut, and proximal donut are negative for tumor."
TCGA-E7-A3X6.BC75580D-4F4D-408C-9E9C-116A260DDED3,Laterality: Path Report:BLADDER TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Bladder. Tumor size: 3 x 2.5x4cm. Tumor features: None specified. Histologic type: Transitional cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Muscularis propria. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,"Transitional cell carcinoma, moderately differentiated, with tumor extent into the muscularis propria. No lymphatic or venous invasion identified. Tumor margins are uninvolved."
TCGA-UB-A7MA.82349CD5-39AA-42F8-80A1-B438B2300D09,"Result Impression. Sex: Female. Soc. Sec. #: Service Date: Client: FINAL PATHOLOGIC DIAGNOSIS. A. Bile duct margin, biopsy: No tumor. B. Liver, left lobe, partial hepatectomy: Mixed. lepatocellular/cholangiocarcinoma extending to margin and invading. large vessels; see comment. C. Hepatic artery lymph node, excision: No carcinoma in one lymph node. (0/1). D. Anterior common hepatic artery lymph node, excision: No carcinoma. in one lymph node (0/1). E. Portacaval lymph node, excision: No carcinoma in one lymph node. (0/1). COMMENT: Liver Tumor, Including Intrahepatic Bile Duct, Synoptic Comment. - Tumor type: Mixed hepatocellular/cholangiocarcinoma. - Histologic grade: Moderately differentiated. Tumor size (maximum diameter of largest lesion) : 12.1 cm. - Tumor necrosis: <30%. Multifocality (more than one tumor separated by nontumorous liver. parenchyma) : Present. - Estimated total tumor diameter of all HCC foci: >12 cm. - Vascular invasion: Present in both large and small vessels (B2, B3,. B8). - Hepatic capsule: Tumor abuts capsule. - Local extension of tumor: Confined to liver. - Hepatic surgical margins: Positive (slide B3) ; see comment. - Bile duct margin (for cholangiocarcinoma) : Negative. - Non-neoplastic liver: No significant pathologic abnormality. - Lymph node status: Negative. - Negative; total number of nodes examined: 3. - AJCC Stage: pT3bNO. Immunoperoxidase and special stains were performed to confirm the. diagnosis and show the following staining pattern in tumor cells: - Chromogranin: Negative. - Synaptophysin: Negative. Arginase: Patchy positive, negative in some areas showing glandular. lifferentiation. - CK19: Strong and diffusely positive. - Mucicarmine: Negative. - MIB1: Briskly positive, with nuclear staining up to 40-50% of cells. Overall, the histopathology and immunohistochemical profile support a. diagnosis of mixed hepatocellular/cholangiocarcinoma. Histologic. sections show divergent differentiation with some larger cells showing. eosinophilic cytoplasm or fatty differentiation. These cells are. arranged in a trabecular architecture. Both the morphology as well as. strong positive staining for arginase supports hepatoid differentiation. in these areas. In other areas, discrete glands within sclerotic stroma. are seen. Luminal necrosis is seen within glands. A subset of these. areas of glandular differerentiation lack arginase staining. This. finding, along with the presence of necrosis provide evidence for a. component of cholangiocarcinoma. Of note, a mucicarmine stain is. negative, indicating a lack of mucin; however, this does not preclude a. diagnosis of cholangiocarcinoma. MIB1 staining shows a proliferative. index of up to 40-50%, suggesting a highly proliferative malignancy. Negative staining for synaptophysin and chromogranin argues against. neuroendocrine differentiation. Sections at the periphery of the main mass show multiple smaller. nodules, some of which are only apparent microscopically One of these. small nodules is found at the margin (slide B3) It is possible that. this nodule may represent venous invasion. have reviewed portions of this case. and concur with the diagnosis. Specimen (s) Received. A:Bile duct left (ink marks distal margin) FS. B:Left lobe liver. C:Hepatic artery lymph node. D:Anterior common hepatic artery lymph node. E:Portacaval lymph node. Intraoperative Diagnosis. FS1. (A) Bile duct, left, biopsy: Benign bile duct, almost entirely. denuded. Dr. agrees. Clinical History. The patient is a. -year-old woman with a left-sided liver mass. According to. she presented with left upper quadrant in. and a CT. at that time revealed a left-sided liver mass and no risk. factors for hepatocellular carcinoma. A core biopsy revealed. hepatocellular carcinoma with focal glandular differentiation. CK19-positive, AFP-negative, arginase-positive) . She is additionally. noted to have a history of splenectomy for hereditary spherocytosis and. is status post cholecystectomy in. for cholecystitis, which work-up. revealed papillary stenosis with a narrowing of the common bile duct. Gross Description. The case is received in five parts, labeled with the patient's name and. medical record number. Part A is received fresh and additionally labeled ""2 bile duct left ink. marks distal margin frozen, and consists of a single fragment of. red-tan soft tissue (0.7 x 0.3 x 0.1 cm) marked by a circle of black ink. on the one end. The entire specimen is frozen for frozen section. diagnosis 1, and subsequently submitted in cassette A1. Part B is received fresh and additionally labeled ""left lobe liver. orientation P, and consists of a partial hepatectomy (739.5 gm fixed;. 14.5 cm from right to left x 16.5 cm from anterior to posterior x 8.3 cm. from superior to inferior) without attached gallbladder. The specimen. is previously disrupted at the capsule with a section taken by the. surgeon for banking prior to receipt in Pathology. GROSS ABNORMALITIES: There is a white-tan, firm, multinodular. well-circumscribed mass (12.1 cm from right to left x 8 cm from superior. to inferior x 14 cm from anterior to posterior) that extends to the. capsule, which is distorted and contracted by the mass. The mass is. noted 0.5 cm from the resection margin (slice 6). There is no grossly. evident necrosis within the mass. Additionally, scattered smaller. white-tan nodules are seen adjacent to, but apparently distinct from the. mass. The liver parenchyma is otherwise red-brown, firm, and. unremarkable. No gallbladder is present. No lymph nodes are. identified. ORIENTED BY: Anatomic landmarks; hepatic ligament. INKING: - Liver capsule overlying mass: Inferior in blue and superior in green. - Resection margin: Black. POTENTIAL STUDIES: Normal and tumor are taken for tissue banking. CASSETTES: Representative sections are submitted: B1-B2: Mass, approach to margin, and vessels, slice 6. B3: Mass, approach to margin, and vessels, slice 7. B4-B9: Representative sections of mass, including mass. adjacent to capsule. B10: Uninvolved liver. Part C. is received fresh and additionally labeled ""hepatic artery. lymph node, "" and consists of a single, curved/irregular, soft, rubbery. red-tan lymph node (2.5 x 1 x 0.7 cm). The specimen is bisected and. entirely submitted in cassettes C1-C2. Part D is received fresh and additionally labeled ""anterior common. hepatic artery lymph node, "" and consists of a single, roughly ovoid,. soft, rubbery pink-tan lymph node (2.8 x 1.2 x 0.6 cm). The specimen is. bisected and entirely submitted in cassettes D1-D2. Part E is received fresh and additionally labeled ""porta caval lymph. node, "" and consists of a single, irregular, soft, rubbery pink-tan lymph. node (2.8 x 1.6 x 1 cm). The specimen is trisected and entirely. submitted in cassettes C1-C3. Diagnosis based on gross and microscopic examinations. Final diagnosis. made by attending pathologist following review of all pathology slides. The attending pathologist has reviewed all dictations and preliminary. interpretations performed by any resident involved in the case and. performed all necessary edits before signing the final report. Pathology PDF Report. Show images for Surgical Pathology. Authorizing. Date/Time. Result History. This is NOT a Requisition. Requisition hyperlink below. Surgical Pathology (Order. Authorizing: Pathology and Cytology. Department: Images. Show images for Surgical Pathology. Release Date/Time. Start Date/Time. End Date/Time. Release Information. Released On. Released By. Frequency. Duration. Priority. Once. 1 occurence. Routine. Normal. Lab Collection and Receipt Information. Collect Time. Collected By. Lab Receipt Date. Lab Receipt Time. Office. Pager/beeper E-mail. Authorizing Provider. Parent Status: Completed. Result Impression. Sex: Female. Soc. Sec. #: FINAL PATHOLOGIC DIAGNOSIS. Histochemical staining for iron and interpretation on. Background liver with 2+ positive staining (0-4+) . . COMMENT: A histochemical stain for iron was performed on block B10 of. This shows 2+ staining of hepatocytes and kupfer cells (scale 0-4+). Gross Description. block B10 is selected for histochemical staining. Clinical History. The patient is a -year-old woman with mixed. nepatocellular/cholangiocarcinoma and a history of hereditary. spherocytosis. An iron stain was requested by. Diagnosis based on gross and microscopic examinations. Final diagnosis. made by attending pathologist following review of all pathology slides. The attending pathologist has reviewed all dictations and preliminary. interpretations performed by any resident involved in the case and. performed all necessary edits before signing the final report. Pathology PDF Report. Show images for Surgical Pathology. Authorizing Provider Information. Result History. This is NOT a Requisition. Requisition hyperlink below. Surgical Pathology (Order. Pathology and Cytology. Department: Show images for Surgical Pathology. Release Date/Time. Start Date/Time. End Date/Time. Release Information. Released On. Released By. Frequency. Duration. Priority. Once. 1 occurrence. Routine. Normal. Lab Collection and Receipt Information. Collect Time. Collected By. Lab Receipt Date. Lab Receipt Time. Office. Authorizing Provider. Parent Status: Completed. (This order does not yet have any children).","Mixed hepatocellular/cholangiocarcinoma with a trabecular architecture and areas of glandular differentiation. Tumor cells show eosinophilic cytoplasm and fatty differentiation, with arginase staining supporting hepatoid differentiation. Discrete glands within sclerotic stroma are seen, with luminal necrosis and lack of arginase staining in some areas, providing evidence for a component of cholangiocarcinoma. Vascular invasion is present in both large and small vessels. Tumor abuts the hepatic capsule and extends to the margin, with a positive surgical margin. Non-neoplastic liver shows no significant pathologic abnormality. Lymph nodes are negative for carcinoma. Tumor necrosis is present, with multifocality and multiple smaller nodules adjacent to the main mass. MIB1 staining shows a high proliferative index, suggesting a highly proliferative malignancy."
TCGA-GR-A4D5.97EAEC1D-1C5A-4FE8-8D2B-80DD433DB18C,"PATIENT. INFORMATION. NAM. M). MED. SPECIMEN REQUEST FORM. Month. Day. Male. Female. (AFFIX PATIENT LABEL HERE UF AVAILABLE). CLINICAL HISTORY, PRE OPERATIVE DIAGNOSIS, POST OPERATIVE DIAGNOSIS, OR OTHER PERTINENT LABORATORY FINDINGS: SPECIAL REQUEST: (Please $8 Far hyaphona Study. OROERING PROVIDER: FROZEN SECTION: OR NO. EXT. DATE/TIME SPECIMEN COLLECTION: FROZEN SECTION DIAGNOSIS: SPECIMEN SOURCE: PATHOLOGIST SIGNATURE: REPORT TO: CREW CHECKLIST. LAB USE ONLY. Patient's ID Check. site Verification. Label Verification. Form Complete. Specimen and Form Bagged. Nursing Signature. NOT TO BE PILED IN PERMANENT MEDICAL RECORD. SURGICAL PATHOLOGY SPECIMEN REQUEST FORM. NOPEROXID ASE REPORT. Surgical #: Outalde Surgical #: Referral Immunostains Reviewed AND / OR Dona at. PARAFFIN TISSUE - Outside Surgical #. B-Cell Markers. T-Cell Markers. Other Markets. CD20(L26 +. CD45RO(UCHL1). CD45(LCA). CD79a. CD43 (L60). CD30(Ber-H2). Kappa (ISH). CD3. CD15(Leul M1). Lambda (ISH). CD5. CD22. CD2. BCL-6. CD10. CD4. CyclinD1. CD7. ALK. BMA. Ki-67. CD21. EBERs. I - Indetetminate. If to situ hybridization, please chock as appropriates. ASR: Kappa/Lambda. EBV. Kappa/Lambda and EBV. Quik Texe. ASREBY. ASRKLEBY. INTERPRETATION (Circle): 1. Monoolonal B-coll lymphonia ( IgG, IgA, IgM, IgD, kappa, lambda ). 2. B-cell lymphoma, surface Ig negative,. 3. Consistent with peripheral T-cell lymphoma, (helper/inducer, cytotoxio/suppressor) cell type. 4. Consistent wifh Hodgkin's disease, ( classical type, lymphocyte-predominant type). 5. The paraffin markets indicate a ( B-ceil; T-oell, null) phenotype. 6. Specify: (GNOPEROXIDASE REPORT. Surgical #: Patieut: LR#. Outside Surgical it: Referral Immubostains Reviewed AND/OR Done at. PARAFTIN TISSUE - Outside Surgical #. T-Cail Markers. Other Markers. B-Cell Markers. CD45(LCA). CD20(L25). CD45RO(UCHLI). CD43(I.60). CD30(Bex-H2). CD79a. CDIS(Leu M1). Kappu (ISH). CD5. BCL-2. Lambda (ISH). CD2. BCL-6. CD22. CD10. CD4. Cyclin DI. CD7. ALK. CD8. EMA. CD21. EBERs. I = Indeterminats. If in situ hybridization, please check as appropriate: EBV. Kappa/Lambda and EJ3Y. ASR: ASREAV. ASRILEBY. Oulk Tex: ASRKL. INTERPRETATION (Circle): 1. Monoclogal B-ceil lymphome ( IgG, [gA, IgM, IgD, kappa, lambda ) . 2. B-call lyzuphoma, surface Ig nugative. 3. Conajatent with periphera) T-cell lymphoma, (helpet/inducer, cytotoxic/suppressor) celltype. 4. Consistent witb Hodgkin's disezse, ( cinssical type, lymphocyte-predorvizuent type). 5. The parafÃ±a indicate'a B-cell, f--cell, >mil). phenotype. 6. Specify: Department of Pathology and Microbiology. Accession No: Hosp No: Acct No: Date Taken: Date Received: F. Submitted by: Loc: Room: Client: Final Diagnosis: A LEFT LEVEL 2B LYMPH NODE, EXCISION: LYMPH NODE WITH REACTIVE HYPERPLASIA. AND BENIGN SALIVARY GLAND TISSUB WITH NO DIAGNOSTIC PATHOLOGY. RIGHT NECK LESION, BIOPSY: SKIN WITH DIFFUSE LARGE B-CELL LYMPHOMA,. NONCLEAVED. (B-DLCL-NC). ( LEFT DEEP LEVEL 2 LYMPH NODE EXCISION: LYMPH NODE WITH DIFFUSE LARGE B-CELL. LYMPHOMA, NONCLBAVED. (B-DLCL-NC). Addendum. Addendum. has reviewed the case. History: TRese materials were examined by all those usted to establich the diagrosis with the signature being the responsible staff ""pathologiat. 1 of 5. P. 003. Sex: F. Accession No: Submitted by. Date Take: Hosp No: The patientisa. ear-old female with a history of cervical lymphadenopathy and skin lesions. Intraoperative Diagnosis: Lymph node, level 2B, excision (FSA1 and touch prep): Lymphoid tissue present, pending additional. workup. This was performed by Dr. and reported to Dr. over the phone by Dr. Source/Gross: The specimens are received fresh in three containers labeled. Part A is designated ""left level 2B lymph node"" and consists of a 0.9 x 0.7 x 0,4 cm lymph node. The. specimen is biseoted and entirely submitted for frozen section diagnosis in cryoblock FSA1. Following. frozen section diagnosis, half of the specimen is sent for molecular diagnostic studies (one piece - 1.9 x 0.9. x 0.2 cm). The remainder of the specimen is entirely submitted in block Al in B-plus for permanent. sections (one piece - 1.9 x 0.9 x 0.2 cm). Part B is designated ""right skin lesion"" and consists of a 1.6 x 0.9 cm ellipse of skin with attached. subcutaneous tissue measuring 1.2 x 1.6 x 0.5 cm. The skin surface is white and unremarkable, no lesions. are identified. Sectioning demonstrates an ill-defined pale area underlying the skin surface, measuring 0.9 x. 0.5 x 1.0 cm. The specimen is submitted as per the Lymphoma Study Group Protocol: Touch preps are made - One. Fixed in formalin for 24 hours - One piece, 1.4 x 0.9 x 0.4 cm, block B1. Frozen in OCT for immunohistochemical studies - One piece, 1.1 x 0.5 x 0,5 cm. Placed sterilely in medium for cytogenetics - One piece. Frozen in foil for molecular diagnostic studies - One piece, 0.9 x 0.6 x 0.5 cm. Fixed in B-plus -one piece, 1.1 x 1.0 x 0.4 block, block B2. Placed in cytogenetic media for moleoular research: One piece, 1.4 x 0.3 x 0.3 om). Part C is designated ""left deep level 2 lymph node"" and consists of a 4.3 x 1.7 x 1.4 cm lymph node. candidate. Sectioning demonstrates a 2.7 x 1.8 x 0.8 cm tan-gray nodule. Adjacent to this larger nodule is. a. smaller nodule which measures 0.9 x 0.5 x 0.4 cm. The entire specimen is submitted as per the Lymphoma Study Group Protocol: Touch preps are made - Two. Fixed in formalin for 24 hours - Two pieces, 2.1 x 1.4 x 0.3 cm and 1.4 x 0.9 x 0.3 cm,. cassettes. C1-C2. Frozen in OCT for immunohistochemical studies - One piece, 1.8 x 0.9 x 0.3 cm. Placed sterilely in medium for cytogenetics - One piece, 1.4 x 1.9 x 0.3 cm. Frozen in foil for molecular diagnostic studies - One piece, 1.9 x 1.0 x 0.3 cm. Fixed in B-plus - Two pieces, 1.9 x 1.4 x 0.3 cm and 2.0 x 1.4 x 0.3 cm, blocks C3-C4. 2 of 5. P. 004. P.O.B. Sex: F. Accession No: Submitted by: Date Taken: Hosp No: The remainder of the specimen is entirely submitted in blocks C5-C7 for 24-hour formalin fixation. 3 of 5. P. 005. (ex: F. Accession No: Submitted by: Date Takei. Hosp No: Gross dictated by: Microscopic: IMMUNOPEROXIDASEREPORT. PARAFFIN TISSUB - The. B-Cell Markers. T-Cell Markers. CD20(L26). CD43(L60). Kappa (ISH). CD3. Lambda (ISH). CD5. CD10. INTERPRETATION: The paraffin markers indicate a reactive phenotype. The in-situ hybridization tests for kappa and lambda light chains were developed and the performance. characteristics determined by. immunoperoxidase Laboratory. It has not been. cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded. as. investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments. CLIA) as qualified to perform high complexity clinical laboratory testing. PARAFFIN TISSUE - The. B-Cell Markers. T-Cell Markers. Other Markers. CD20(L26). CD45RO(UCHL1) ND. CD45(LCA). CD79a. ND. CD43(L60). ND. CD30(Ber-H2). + (rare). CD10. CD3. CD15(LeuM1). CD5. BCL-2. + v. BCL-6. MUMI. = Done also on block B2. INTERPRETATION: The paraffin markers indicate a B-cell lymphoma, non-GCB phenotype. 4 of 5. P. 006. 0x: P. Accession No: Subruitted by: Date Take. Hosp No: 5 of 5. Department of Pathology and Microbiology. Accession No: Acct No: Date Taken: Hosp No: Date Received: Submitted by: Rooms. Client: Loct. Addendum Report. Addendum. has reviewed the case. Thest materiais were examined by all those listed la establish the diagrosts with the signature being the responsible slaff pathologise. 1 of 1. ANATOMIC PATHOLOGY. INTRADEPARTMENTAL CONSULTATION FORM. From: To: Slides: Case =: Spurce of Specimen: Sex: F. Prior Diagnoses: Relevant lab xira) physical findings: 200 Signature .- - Difficult Case. Specific questionis for consultape. Consultant's impression: diagnosis: PATHOLOGY DEPARTMENT FILES ONLY. P. 009. PATIENT INFORMATION. MEDICALI. DATE OF &. SPECIMEN REQUEST FORM. Male. Female. (AFFIX PATIENT LABEL HERE IF AVAILABLE). CLINICAL HISTORY, PRE OPERATIVE DIAGNOSIS, POST OPERATIVE DIAGNOSI8, OR OTHER PERTINENT LABORATORY FINDINGS: POSSIBLE DUPLICATE. SPECIAL REQUEST: (Plesse specifiti. FROZEN SECTION: OR NO. EXT. DATE/TIME SPECIMEN COLLECTION: FROZEN SECTION DIAGNOSIS: SPECIMEN SOURCE: PATHOLOGIST SIGNATURE: REPORT TO: LAB USE ONLY. CREW CHE. Patient's ID Check. Site Verification. Label Verification. Form Complete. -Specimen and Form Bagged. NOT TO BE FILED IN PERMANENT MEDICAL RECORD. SURGICAL PATHOLOGY SPECIMEN REQUEST FORM. PATIENT INFORMATV. Last. MEDICAL RECORO NO. dey. DATE OF BIRTH: SPECIMEN REQUEST FORM. Month. Day. Yea. Male. Female. (AFFIX PATIENT LABEL HERE IF AVAILABLE). CLINICAL HISTORY, PRE OPERATIVE DIAGNOSIS, POST OPERATIVE DIAGNOSIS, OR OTHER PERTINENT LABORATORY FINDINGS: SPECIAL REQUEST. (Plasse specity. FROZEN SECTION: OR NO. EX). DATE/TIME SPECIMEN COLLECTION. ROZEN SECTION DIAGNOSIS: SPECIMEN SOURCE: K 3 Right Ski Neek hesion. PATHOLOGIST SIGNATURE: REPORT TO: CREW CHECKLIST. LAB USE ONLY. Patient's ID Check. Site Verification. Label Verification. Form Complete. Specimen and Form Bagged. NOT TO BE FILED IN PERMANENT MEDICAL RECORD. SURGICAL PATHOLOGY SPECIMEN REQUEST FORM.","Diffuse large B-cell lymphoma, non-cleaved, with a B-cell lymphoma, non-GCB phenotype. The lymph node exhibits reactive hyperplasia. The skin lesion shows diffuse large B-cell lymphoma. The lymph nodes are involved by lymphoma with a non-cleaved morphology. The paraffin markers indicate a B-cell lymphoma. The lymphoma cells are positive for CD20 and BCL-2, and negative for CD45RO and CD79a. The lymph nodes have a tan-gray nodule with a diffuse large B-cell lymphoma infiltrate. The skin lesion has an ill-defined pale area underlying the skin surface with a lymphoma infiltrate. The lymphoma cells have a non-cleaved morphology with a high nuclear-to-cytoplasmic ratio. No necrosis is identified. The lymphoma infiltrate is present in the lymph node and skin lesion. The lymph node and skin lesion margins are not evaluated for involvement by lymphoma. Benign salivary gland tissue is present with no diagnostic pathology."
TCGA-XG-A823.D4647CF2-A0D5-49BF-943D-CE9A8A314874,"Clinical History. with SDHD mutation and multiple pheo/paraganglioma left adrenalectomy at age. Pheochromocytoma. Preoperative Diagnosis. Pheochromocytoma. Gross Description. Specimen: A. Right paraganglioma. Procedure: Excision. Fixative: Formalin. Patient Identifiers: Cassette case number is. for patient!. Container case number i. Container. label is for. and the MRN is. Requisition form is for. and the MRN is. Specimen Size and Pathologic Findings: The specimen consists of a red-tan soft tissue fragment. with a focal area of tan-yellow soft tissue, measuring 1.1 x 0.7 x 0.3 cm. A frozen section is. performed on the specimen. Section Key: The specimen is submitted entirely in A1. Specimen: B. Paraganglioma. Procedure: Excision. Fixative: Formalin. Patient Identifiers: Cassette case number is. for patiente. e. Container case number is. Container. label is for. and the MRN is. Requisition form is for. nd the MRN is. Specimen Size and Pathologic Findings: The specimen consists of a 2.5 x 2.0 x 0.8 cm. irregularly shaped, tan-pink and yellow soft tissue fragment. The specimen contains two ovoid. tan-pink nodules measuring 1.0 cm each and a 1.3 x 1.3 x 0.6 cm tan-pink partial fragment. of. possible lymph node. The remainder of the specimen consists of adipose tissue. Section Key: The specimen is submitted as follows: B1 & B2: one nodule, each bisected. B3: partial fragment of lymph node, bisected. B4: adipose tissue. Specimen: C. Right adrenal,. Procedure: Excision. Fixative: Formalin. Patient Identifiers: . Cassette case number ist. for patient. Container case number is. Container. label is for. and the. Requisition form is for. and the. Specimen Size and Pathologic Findings: The specimen consists of a 42 gram, 5.5 x 4.3 x 3.5 cm. adrenal gland removed with 2.5 cm of periglandular adipose tissue. There is a 2.5 x 2.0 cm surgical. defect which is inked black (this area corresponds to the area of tumor procurement per the surgeon. and does not represent a true surgical margin). The specimen is serially sectioned revealing a 2.2. x. 2.5 x 2.5 cm nodule with sharp, well demarcation from the adrenal gland. The nodule has a. variegated, tan-pink and red cross section with cystic areas and focal areas of calcification and. necrosis. The remaining adrenal gland has a triangular shape measuring 3.5 x 1.0 x 2.5 cm with a. tan-pink medulla and yellow cortices. Section Key: The specimen is submitted as follows: C1: area of tumor procurement. C2-C6: representative sections of the nodule. Intraoperative Consult Diagnosis. Frozen section diagnosis by. on. is ""RIGHT PARAGANGLIOMA: PARAGANGLIOMA."". Microscopic Diagnosis. A. Right paraganglioma (excision): -Paraganglioma. Frozen section diagnosis confirmed. B. Paraganglioma (excision): -Paraganglioma. -Four benign lymph nodes. C. Right adrenal (adrenalectomy): -Pheochromocytoma, 2.5 cm, completely excised. Comment: This case has been reviewed by. and 1. who agree with the diagnosis. I have personally reviewed the diagnostic material and this report represents my interpretation.","Paraganglioma with a variegated, tan-pink and red cross section, having cystic areas and focal areas of calcification and necrosis. The tumor has sharp, well-demarcated borders from the adrenal gland. Pheochromocytoma with a well-circumscribed nodule, having a tan-pink medulla and yellow cortices. The nodule is composed of cells with distinct cell borders and a nested growth pattern. No lymphovascular invasion is identified. Four benign lymph nodes are present. The tumor is completely excised with no involvement of the adrenal gland margins. No necrosis is identified in the paraganglioma. The pheochromocytoma has focal areas of necrosis and calcification. The adrenal gland has a triangular shape with a tan-pink medulla and yellow cortices."
